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V. Abstract 
Biotechnology is emerging as a key technology in the 21st century. In the past years, scientific 
and technological advances have established the field of biocatalysis as a competitive 
alternative to traditional metallo- and organocatalysis in chemical synthesis [1]. Yet many, 
often basic challenges remain in the key steps of biocatalytic processes, which include the 
biocatalyst production, characterization, engineering, and application as well as down-
stream processing [2]. In the scope of this thesis, three case studies were performed to 
illustrate solutions for selected, critical challenges in these key steps. 
The first case study featured dirigent proteins, which are involved in the stereoselective 
control of the first step of lignan biosynthesis, the phenoxyl radical coupling of coniferyl 
alcohol radicals to yield optically pure (+)- or (-)-pinoresinol. Up to now, extraction of 
dirigent proteins from plant material or expression in plant and insect cell culture systems 
resulted in low yields. For biotechnological applications and the solution of a structure, 
which might help in elucidation of the exact reaction mechanism, a heterologous expression 
platform allowing the cost-effective, fast, and robust expression in high yields is necessary. A 
comprehensive study with the heterologous expression host Escherichia coli revealed severe 
complications in the high yield expression of dirigent proteins. The metylotrophic yeast 
Pichia pastoris was subsequently evaluated as a possible host for recombinant protein 
expression. A reliable high yield fed-batch fermentation process with Pichia pastoris 
resulting in 47 mg mL-1 of the dirigent protein AtDIR6 representing a more than 250-fold 
increase compared to other sources was established. Biochemical characterization of AtDIR6 
produced with Pichia pastoris showed an overall agreement in protein structure, N-
glycosylation sites, and dirigent activity compared to AtDIR6 produced by plant cell cultures 
of Solanum peruvianum, validating Pichia pastoris as a suitable expression system for 
dirigent proteins. Enzymatic deglycosylation of the protein induced conformational changes 
leading to the loss of function and subsequent protein aggregation. This demonstrated that 
the glycan structures of AtDIR6 are essential for structure, solubility, and function of the 
protein. 
The second case study focused on a ribokinase from Saccharomyces cerevisiae, which was 
engineered for an altered substrate spectrum by rational protein design. The enzyme was 
produced in high yields in a heterologous expression system using Escherichia coli as host 
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and biochemically characterized for the first time. Optimum reaction conditions were 
investigated regarding the dependency on mono-, di-, and pentavalent ions and the pH. 
Conditions featuring 100 mM potassium phosphate at pH 6.0 with 2.5 mM magnesium 
chloride were found to offer the highest catalytic activity. Based on a family alignment and 
rational design using a homology model of the protein, a small focused library of the 
ribokinase featuring 72 variants was established, including combinations of single, double, 
triple, and quadruple mutations at four residues in the substrate binding area.  The library 
was evaluated for alterations in the substrate spectrum with a focus on D-xylose, which is an 
epimer to the natural substrate D-ribose. More radical alterations such as triple and 
quadruple mutations abolished catalytic activity towards D-ribose and D-xylose almost 
completely. Several variants were identified broadening the substrate spectrum to other 
tetroses, pentoses, and hexoses, albeit with low catalytic efficiency. A single variant 
exhibited about twice the activity of the wild-type enzyme towards D-xylose (0.77 s-1 versus 
0.38 s-1), which can serve as a basis for further studies. In this regard, an attempt to solve a 
crystal structure for more information about D-xylose binding in the active site was started. 
While several well diffracting crystals were obtained, molecular replacement did not lead to 
a solution of the structure so far. 
The third case study featured a cutinase from the ascomycete Humicola insolens, which was 
applied as a novel biocatalyst for the synthesis of functionalized acrylic esters by 
transesterification. The transesterification of methyl acrylate with 6-mercapto-1-hexanol at a 
high molar ratio in a solvent free system was studied. The enzyme was employed in 
immobilized form on a microporous, polystyrenic resin to facilitate the usability and stability 
in a non-aqueous environment and allow simple recovery of the biocatalyst. Besides two 
minor by-products, 6-mercapothexyl acrylate ester was identified as the main product with 
the thiol as the functional end group. By optimization of the reaction conditions and critical 
water content, the transesterification yielded 95.4 ± 0.3% of 6-mercaptohexyl acrylate ester 
after 6 h at 40°C in the presence of 0.025% (w/w) water without formation of by-products in 
a solvent free system. When applying methyl methacrylate as an acyl acceptor, 
transesterification with 6-mercapto-1-hexanol was significantly lower (43.6 ± 0.1%).  
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VI. Zusammenfassung 
Die Biotechnologie erweist sich als Schlüsseltechnologie des 21. Jahrhunderts. In den letzten 
Jahren konnte durch wissenschaftliche und technologische Fortschritte die industrielle 
Biokatalyse als kompetitive Alternative zu traditioneller Metall- bzw. Organokatalyse in der 
chemischen Synthese etabliert werden [1]. Allerdings verbleiben grundlegende 
Herausforderungen in der Etablierung von biokatalytischen Prozessen. Die grundlegenden 
Schritte eines biokatalytischen Prozesses umfassen sowohl die Produktion, die 
Charakterisierung, die Optimierung, die Anwendung sowie die Wiederverwertung von 
Biokatalysatoren als auch die Aufarbeitung der Produkte [2]. Im Rahmen der vorliegenden 
Arbeit wurden ausgewählte, kritische Herausforderungen in diesen Schlüsselschritten in drei 
Fallstudien näher untersucht. 
Dirigierende Proteine sind in der stereoselektiven Kontrolle des ersten Schrittes in der Lignan 
Biosynthese beteiligt. In einem Radikalkupplungsschritt werden zwei 
Koniferylalkoholradikale unter Beteiligung von dirigierenden Proteinen so verknüpft, dass 
optisch reines (+)- bzw. (-)-Pinoresinol entsteht. Bisher wurden Dirigierende Proteine in 
geringen Ausbeuten durch Extraktion aus Pflanzenmaterial oder durch heterologe 
Expression in pflanzlichen Zellkulturen sowie Insektenzellkulturen gewonnen. Für eine 
biotechnologische Anwendung und um eine Strukturaufklärung voranzutreiben, welche in 
der Bestimmung des genauen Reaktionsmechanismus dirigierender Proteine nützlich wäre, 
sind allerdings höhere Proteinausbeuten notwendig. Dies könnte durch die Etablierung einer 
heterologen Expressionsplattform ermöglicht werden, welche eine kosteneffiziente, schnelle 
und robuste Expression von dirigierenden Proteinen erlaubt. Eine umfassende Studie zur 
heterologen Expression in Escherichia coli zeigte allerdings schwerwiegende Probleme für 
eine Expression von dirigierenden Proteinen mit hohen Ausbeuten. Die Hefe Pichia pastoris 
wurde deshalb anschließend als möglicher Expressionswirt für die rekombinante 
Proteinproduktion evaluiert. Mit Pichia pastoris konnte ein zuverlässiger Fed-Batch 
Fermentationsprozess etabliert werden, welcher in Ausbeuten von 47 mg mL-1 des 
dirigierenden Proteins AtDIR6 resultierte. Dies entspricht einer ca. 250-fachen Steigerung 
der Ausbeute verglichen mit den bisherigen Systemen. Die biochemische Charakterisierung 
von AtDIR6, welches mit Pichia pastoris hergestellt wurde, zeigte eine vergleichbare 
Proteinstruktur und dirigierende Aktivität sowie eine Glykosylierung an den gleichen 
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N-Glykosylierungsstellen im Vergleich zu AtDIR6 aus einem heterologen Pflanzenzellsystem 
(Solanum peruvianum). Diese Ergebnisse bestätigten die Verwendung von Pichia pastoris als 
geeigneter Expressionswirt für die Herstellung dirigierender Proteine. Eine enzymatische 
Deglykosylierung des Proteins induzierte strukturelle Veränderungen, welche zu einem 
Verlust der Funktion und anschließender Proteinaggregation führten. Dadurch konnte die 
essentielle Bedeutung der Glykanstrukturen von AtDIR6 für die Proteinstruktur sowie die 
Löslichkeit und Funktion des Proteins demonstriert werden. 
In der zweiten Fallstudie wurde eine das Substratspektrum einer Ribokinase aus 
Saccharomyces cerevisiae durch rationales Proteindesign verändert. Das Enzym konnte zum 
ersten Mal in hoher Ausbeute mit Escherichia coli als heterologer Expressionswirt hergestellt 
und biochemisch charakterisiert werden. Die optimalen Reaktionsbedingungen bezüglich der 
Abhangigkeit des Enzyms von mono-, di- und pentavalenten Ionen als auch dem pH Wert 
wurden ermittelt. Dabei zeigte das Wildtyp Enzym die höchste katalytische Aktivität in 
100 mM Kaliumphosphatpuffer bei pH 6.0 mit 2,5 mM Magnesiumchlorid. Basierend auf 
einem Sequenzvergleich von 200 Ribokinase Sequenzen aus der Familie der Ribokinasen und 
rationalem Proteindesign mit einem Homologiemodell des Proteins konnte eine kleine, 
fokussierte Mutantenbibliothek erstellt werden. Insgesamt wurden 72 verschiedene 
Varianten mit Kombinationen aus einfach, zweifach, dreifach und vierfach Mutationen an 
vier unterschiedlichen Aminosäureresten in der Substratbindetasche erstellt. Die fokussierte 
Bibliothek wurde in Bezug auf Veränderungen im Substratspektrum evaluiert. Dabei lag der 
Fokus auf D-Xylose, welches ein Epimer zu dem natürlichen Substrat D-Ribose ist. Starke 
Veränderungen der Substratbindetasche durch dreifach und vierfach Mutationen führten zu 
einem nahezu vollständigen Verlust der katalytischen Aktivität gegenüber D-Ribose und D-
Xylose. Mehrere Varianten zeigten ein erweitertes Substratspektrum mit geringen 
Aktivitäten gegenüber Tetrosen, Pentosen und Hexosen. Eine einzelne Variante wies eine 
etwa verdoppelte Aktivität im Vergleich zu dem Wildtyp Enzym gegenüber D-Xylose auf 
(0.77 s-1 gegenüber 0.38 s-1), was als Basis für weitere Studien verwendet werden kann. Für 
weitere Studien wurde auch versucht, die Struktur des Proteins zu lösen. Dies könnte mehr 
Informationen über die Bindung von D-Xylose in der aktiven Tasche geben. Obwohl 
Diffraktionsmuster mehrerer Kristalle erhalten wurden, konnte die Struktur durch die 
„Molecular replacement“ Methode bisher nicht gelöst werden. 
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In der dritten Fallstudie wurde eine Cutinase aus dem Schlauchpilz Humicola insolens als 
neuartiger Biokatalysator für die Synthese von funktionalisierten Acrylestern eingesetzt. 
Dabei wurde als Modellreaktion die Transesterifizierung von Methylacrylat mit 6-Mercapto-
1-hexanol in einem lösungsmittelfreien System untersucht. Das Enzym wurde auf 
mikroporösem Trägermaterial aus Polystyren immobilisiert um die Verwendbarkeit und 
Stabilität in einer nicht-wässrigen Umgebung sowie das einfache Wiederverwenden des 
Biokatalysators zu ermöglichen. Als Hauptprodukt wurde ausschließlich 
6-Mercaptohexylacrylatester mit der freien Thiogruppe als funktionelle Endgruppe 
identifiziert. Die Bildung zweier Nebenprodukte, welche durch Michael-Additionsreaktionen 
entstanden waren, konnte durch die Optimierung der Reaktionsbedingungen verhindert 
werden. Die optimierte Transesterifizierung erreichte den Umsatz von 95,4 ± 0,3 % zu dem 
Hauptprodukt 6-Mercaptoacrylatester in 6 h bei 40°C in der Anwesenheit von 0,025 % (w/w) 
Wasser in einem lösungsmittelfreien System. Die Verwendung von Methylmethacrylat als 
Acyl-Akzeptor in einer Transesterifizierung mit 6-Mercapto-1-hexanol lieferte einen deutlich 
geringeren Umsatz zum entsprechenden Hauptprodukt (43,6 ± 0,1%). 
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VII. Abbreviations 
(v/v) volume per volume 
(w/v) weight per volume 
(w/w) weight per weight 
°C degrees Celsius 
µL microlitre 
µm micrometre 
µM micromolar 
ADP adenosine diphosphate 
AMP-PNP adenylyl imidodiphosphate 
APS ammonium persulfate 
AtDIR6 dirigent protein from Arabidopsis thaliana 
ATP adenosine triphosphate 
bp base pair 
cdw cell dry weight 
CV column volume 
cww cell wet weight 
DAD diode array detector 
DIR dirigent proteins 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
DTT dithiothreitol 
E. coli Escherichia coli 
EDTA ethylenediaminetetraacetic acid 
FPLC fast protein liquid chromatography 
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g gram 
GC gas chromatography 
GC/MS gas chromatography coupled to mass spectrometry 
h hour 
HiC cutinase from Humicola insolens 
HPLC high performance liquid chromatography 
IPTG isopropyl-β-D-thiogalactopyranoside 
kb kilo-base pair 
kcat catalytic turnover number 
kcat/Km catalytic efficiency 
KCl potassium chloride 
kDa kilodalton 
Kiu inhibition constant for substrate (uncompetitve) inhibition 
Km Michaelis-Menten constant 
L litre 
LB lysogenic broth 
LC/MS liquid chromatography coupled to mass spectrometry 
M molar 
mg milligram 
MgCl2 magnesium chloride 
min minute 
mL millilitre 
mM millimolar 
mm millimetre 
NaCl sodium chloride 
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NADH nicotinamide adenine dinucleotide 
nm nanometre 
NMR nuclear magnetic resonance 
OD600
 optical density measured at 600 nm 
P. pastoris Pichia pastoris 
PCR polymerase chain reaction 
PEP phosphoenolpyruvate 
Pi Inorganic phosphate 
pmol picomol 
PMSF phenylmethanesulfonylfluoride 
PNGase F peptide-N-glycosidase from Flavobacterium meningosepticum 
pNP para-nitrophenol 
RBK1 ribokinase from Saccharomyces cerevisiae 
RID refractive index detector 
rpm rounds per minute 
S. cerevisiae Saccharomyces cerevisiae 
S. peruvianum Solanum peruvianum 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SEC size exclusion chromatography 
TB terrific broth 
TEMED N,N,N´,N´-tetramethylethylenediamine 
Tris tris(hydroxymethyl)aminomethane 
U units 
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1. Introduction 
1.1 Challenges in biocatalysis 
1.1.1 Industrial biocatalysis 
In the field of biocatalysis enzymes or whole cells are applied as biocatalysts in synthetic 
chemistry for the production of bulk or fine chemicals [1]. Enzymes, comparable to chemical 
catalysts, lower the activation energy of (bio)chemical reactions with a high catalytic 
efficiency yielding catalytic improvements up to 1019-fold compared to the corresponding 
uncatalyzed reactions [3]. Rapid developments and technological advances in the last two 
decades established biocatalysis as an economically successful and environmentally friendly 
alternative to the traditional metallo- and organocatalysis in chemical synthesis. While 
biocatalysts show many favorable advantages such as providing high selectivity with regard 
to regio- and stereochemistry, high catalytic turnover, and being environmentally benign 
offering safe processes at mild conditions, ultimately the economy dictates whether a 
biocatalytic process will be realized or if a traditional chemical approach is chosen [4]. 
Although fermentation processes such as the brewing of beer and baking of bread as early 
examples for “biotechnology” are known for centuries, the intentional use of biocatalysts 
started in the beginnings of the 20th century. The synthesis of R-(+)-mandelonitrile from 
benzaldehyde and hydrogen cyanide using a plant extract preparation, which included 
hydroxynitrile lyase, is one of the first descriptions of an asymmetric biocatalysis [5]. More 
examples for successful biocatalytic processes include the production of high-fructose corn 
syrup, i.e., isomerization of D-glucose to D-fructose by the action of xylose isomerase, which 
was established in the mid-1970s runs on a multi-million ton scale underlining the economic 
significance [6,7]. Furthermore, prominent examples are the preparation of semisynthetic 
penicillins by penicillin G acylase [8] and the use of proteases in laundry detergents [9]. In all 
cases, limited stability of the biocatalysts could be overcome by immobilization of the 
enzyme, which additionally facilitated the recycling of the biocatalyst [1]. 
The advent of protein engineering technologies in the late 1980s to 1990s allowed the 
optimization of the biocatalyst itself regarding its activity, process stability, and selectivity. In 
this light, extending the substrate spectrum enabled the synthesis of unusual, synthetic 
intermediates especially for pharmaceutical compounds and fine chemicals [1]. Examples 
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include the lipase catalyzed resolution of alcohols and amines yielding enantiopure 
compounds [10] and the hydration of acrylonitrile to acrylamide for polymers catalyzed by a 
nitrile-hydratase [11,12]. 
Biocatalysis today is promoted by key developments like advanced protein engineering 
strategies, gene synthesis, sequence analysis, bioinformatics tools, and computer modeling 
[1,13,14]. The development of molecular tools for a fast modification of biocatalysts by 
iterative cycles of mutagenesis and screening for improved versions, which was termed 
“directed evolution”, set the basics for many new processes featuring these improved 
biocatalysts [15]. Examples for engineered enzymes in industrial biocatalysis include an 
engineered amine transaminase (27 out of 330 amino acids were exchanged) in the 
biosynthesis of optically pure sitagliptin (pharmaceutical compound for treating of type 2 
diabetes), which reduced total waste, eliminated all transition metals, and increased overall 
yield and productivity of the process compared to the chemical hydrogenation process [16]. 
Furthermore, several processes featuring engineered ketoreductases in (semi)purified form 
replacing whole cell reductions and metal-ligand based chemocatalysis were established 
recently [17]. The use of isolated enzymes compared to whole cell biocatalysis offers easier 
downstream-processing, removes diffusion limitations caused by cell membranes, tolerates 
harsher conditions, and simplifies logistical issues. Seven enzymatic approaches differing in 
the choice of engineered enzyme, starting material, and yield and purity of the product, for 
the synthesis of atorvastatin, the active ingredient in Lipitor (cholesterol-lowering drug with 
global sales of US$ 11,900,000,000 in 2010 [1]), have been developed, again pointing out the 
potential of biocatalysis.  
Besides engineering of individual enzymes for specific reaction steps, biocatalysis also 
involves metabolic engineering of whole biochemical pathways. One of the still few success 
stories is the process set up by Genencor and DuPont for production of 1,3 propanediol in an 
metabolically engineered Escherichia coli (E. coli) strain, yet many new concepts especially 
for the conversion of biomass into second generation biofuels have been proposed [18,19]. 
Furthermore, heterologous pathways, which enable Saccharomyces cerevisiae (S. cerevisiae) 
to metabolize the pentoses D-xylose and D-arabinose from pretreated lignocellulosic 
feedstocks for second generation biofuels production have been introduced into this 
organism [20]. The rationale for developing pentose-utilizing S. cerevisiae strains is that this 
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yeast has been used for the production of ethanol for millennia and that new processes can 
easily be integrated into existing plants already using this yeast for first generation biofuels 
from crops. While S. cerevisiae, cannot utilize D-xylose, it can ferment its isomer D-xylulose. 
Therefore, pathways converting D-xylose to D-xylulose have been introduced. Successful 
attempts included an introduction of xylose isomerases from the thermotolerant bacterium 
Thermus thermophilum [21] and the obligate anaerobe fungus Pyromyces spec [22] for direct 
conversion of D-xylose to D-xylulose. Another pathway involved the action of a xylose 
reductase and a xylitol dehydrogenase from the yeast Pichia stipitis yielding D-xylulose via 
xylitol [23,24]. However, the fermentation rates are still hampered by metabolic repression 
in the presence of D-glucose and the ethanol yield is still too low for industrial processes 
[25]. 
1.1.2 The biocatalysis cycle 
Despite the advances in biocatalysis, many challenges regarding the production, 
characterization, engineering, and application of biocatalysts for establishing competitive 
biocatalytic processes remain. In many cases, traditional chemical processes are still 
economically more competitive. In establishing a biocatalytic process, several key aspects 
have to be considered [4]. This regards the availability, purity and costs of educts and 
medium components, whether a reduction of reaction steps compared to traditional 
processes can be achieved, space-time-yield or productivity and overall yield, the selectivity 
of the biocatalyst and potential by-products, and the final product quality. Furthermore, the 
next critical issue is how the biocatalyst is applied in the process. The biocatalyst can be used 
in free or immobilized form. While immobilization provides certain advantages like recycling 
and sometimes higher process stability, it also has to earn back the concomitant costs by 
allowing a more efficient process. Application of whole cells or isolated enzyme (crude 
preparation or purified) is often based on co-factor requirements. More decisions concern 
the type of reaction medium, whether the process will be performed in conventional 
aqueous environment or nonconventional media such as organic solvents. While water can 
be seen as a “green” solvent with low environmental impact, organic synthesis suffers from 
severe restrictions in aqueous media. Many apolar organic compounds are poorly soluble in 
water, side reactions due to hydrolysis, polymerization or racemization can take place in 
water, organic compounds can be degraded, the downstream processing is often inefficient 
and cost extensive since water cannot easily be evaporated, and extraction of products 
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might not be ecological due to low product concentrations [26]. Additionally, chemical 
equilibria can be shifted in organic media allowing new reactions such as transesterifications 
instead of hydrolysis. Since it was shown that enzymes can work in neat organic solvents 
without being denatured, this was exploited for many asymmetric synthetic transformations 
[27]. Prominent examples are lipases like Candida Antarctica lipase B (CalB) used e.g. for the 
transacylation of industrially relevant compounds like acrylates [28]. Finally, on the basis of 
biocatalyst kinetics and decisions made for the application of the biocatalyst, the reactor 
configuration and mode of operation of the bioreactor have to be established [4].  
A new biocatalytic process can be based on the availability of a biocatalyst with a novel 
function or on a desired product for which a new biocatalyst needs to be selected [2]. 
Therefore, the first key issue is producing the biocatalyst or providing an organism capable 
of performing the desired reaction (see Figure 1-1). For a robust process, the biocatalyst 
needs to be characterized regarding its activity, stability, kinetics, and other parameters, 
which might influence the process such as substrate and product inhibition and the optimum 
reaction conditions. Whenever possible, gaining structural information from X-ray 
crystallography or protein nuclear magnetic resonance (NMR) spectroscopy can be a huge 
asset especially for the next step, the engineering of the biocatalyst. Biocatalysis requires 
stable, selective and productive biocatalysts operating under the desired process conditions 
to be able to minimize costs and compete with chemical processes [1]. Since most 
biocatalysts often lack in one of these traits, engineering strategies to improve the 
biocatalyst were developed. Today, rational design based on structural information and 
directed evolution by mutagenesis and selection/screening of improved variants or a 
combination thereof allow the engineering of many desired traits, which can contribute to 
an improved biocatalytic process [17]. When a suitable biocatalyst is found or engineered, it 
needs to be prepared for application. This often includes steps such as lyophilization, 
immobilization on various resins, or cross-linking. These techniques can help increase the 
stability of the biocatalyst under process conditions, but also facilitate a recycling for 
repeated (fed)-batch processes or application in a continuous fashion. A critical issue in this 
regard is the choice of the solvent system. Since many enzymes show good activities in neat 
organic solvents, this allows many further advantageous applications compared to the 
traditional aqueous solvent [27]. In the last step of the process, the product is recovered, 
often in a second batch process after the separation of biomass or immobilisate in processes 
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with whole cells or immobilized enzymes, respectively [2]. However, in situ product-recovery 
processes like crystallization, distillation, solid-phase-, and liquid-phase recovery, which are 
based on physical and chemical parameters of the reactants are used more often [29]. 
In the upcoming chapters, selected challenges in the distinct steps of establishing 
biocatalytic processes are introduced. 
 
Figure 1-1 – The biocatalysis cycle (modified from [2]). The figure illustrates key steps and selected challenges 
in the creation of a biocatalytic process including the production, characterization, engineering and application 
of the biocatalyst itself as well as the downstream processing. 
 
1.1.3 Biocatalyst production 
Both, isolated enzymes and whole cell biocatalysts are used in industrial processes and are 
intensively researched. While whole cell biocatalysts are often used for synthetic reactions 
requiring cofactors, which need to be regenerated, isolated enzymes are typically used for 
hydrolytic or isomerization reactions [2]. Recently, focus has shifted towards the application 
of isolated enzymes as crude extracts or in a purified form yielding more economic and 
practical processes. Advantages include an easier removal of the biocatalyst (since less is 
used due to higher specific activities), preclusion of diffusion limitations by the cell 
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membrane, toleration of harsh conditions, which might be toxic for whole cells, and easier 
logistics for global companies [1]. In this respect, e.g. ketoreductase based processes 
replaced whole cell reductions and metal-ligand based chemocatalysis, which used to be the 
industrial standard for years [17]. The development of recombinant DNA technology in the 
early 1970s enabled the production of recombinant proteins in pro- and eukaryotic hosts. 
This led to the production of recombinant biopharmaceuticals and facilitated a strong 
increase in the industrial enzyme market. It was then possible to produce enzymes in much 
larger quantities, lower costs, and to develop easier downstream-processing methods 
compared to the laborious extraction from plants and animals [30]. The main difference 
between industrial enzymes and biopharmaceuticals are the production costs. While 
industrial enzymes need to be produced at 7-14 € per kilogram with low margins on sales, 
biopharmaceuticals can be sold at prices 100 to 1,000 times higher. For the production of 
many biopharmaceuticals, correct post-translational modifications, especially glycosylation, 
is required and can only be achieved when using mammalian cell systems [30]. Here, Chinese 
hamster ovary cells are by far the most commonly used cell line for the production of 
glycoproteins. Industrial enzymes are mainly produced in filamentous fungi. These fungi 
species naturally secrete large amounts of industrially relevant enzymes, can grow on cheap 
substrates and are GRAS organisms (Generally Recognized As Safe). The most important 
species, which secrete enzymes like amylases, cellulases, lipases, and proteases, are 
Aspergillus, Trichoderma, and Penicillum. 
For recombinant protein production (RPP), E. coli remains the most commonly used 
expression host [31]. In 2006, about 40% of all biopharmaceuticals were produced in E. coli 
[32]. E. coli offers several advantages, including well characterized genetics, broad spectrum 
of available molecular tools, growth in cheap media, rapid biomass accumulation, 
amenability to high cell-density fermentations, and a simple process scale-up [30,31]. 
Recently, other bacterial hosts than E. coli are used more often for RPP. The gram-positive 
Bacillus strains share many advantages with E. coli, but excel with their ability to secrete the 
recombinant protein into the medium [32,33]. Furthermore, unlike E. coli, they do not 
contain lipopolysaccharides (endotoxins), which are pyrogenic to humans and need to be 
specifically removed in additional purification steps for biopharmaceuticals. About 60% of 
the commercially used bulk enzymes such as alkaline proteases as washing agents are 
produced in Bacillus species. However, the lack of suitable expression vectors, plasmid 
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instability, complicated transformation procedures, difficulty of high cell density cultivations 
and the presence of secreted proteases complicate the use in RPP.  
Expression of recombinant proteins in bacteria such as E. coli often results in insoluble, 
nonfunctional protein aggregates (inclusion bodies) due to improper folding. This is 
particularly true for eukaryotic proteins requiring post-transcriptional modifications, such as 
glycosylation and disulfide bond formation, which can be important for stability and/or 
bioactivity [30]. In contrast to bacteria, yeasts possess an effective glycosylation machinery 
and they share the advantages of E. coli as an expression host, e.g. simple cultivation and 
well-characterized genetics and metabolism. In this regard, the yeast Pichia pastoris (P. 
pastoris) is of particular interest as this organism offers protein expression levels, which are 
often 10- to 100-fold higher compared to S. cerevisiae [34], and has already been used for 
the production of more than 1,000 proteins [35]. The typical glycosylation pattern of 
secretory P. pastoris proteins is Man8GlcNAc2 or Man9GlcNAc2 lacking α1,3-terminal 
mannose units of the oligosaccharide chains [36]. This differs from the paucimannosidic and 
complex types of glycosylation of plant and mammalian cells. Since many studies showed 
that a more stable and active protein can be achieved if the glycosylation pattern of 
recombinantly expressed proteins mimics the native one very well, various attempts to 
engineer the glycosylation pattern of Pichia for more human-like glycans have been reported 
[30]. In this regard, an attempt to introduce a functional glycosylation pathway from 
Campylobacter jejuni into E. coli has been made as well [37].  
Besides bacterial, yeast, and mammalian expression hosts, insect and plant cell cultures are 
also used for RPP [38,39]. While the genetic modifications are generally more complicated 
compared to bacterial expression systems like E. coli, both systems offer the ability for post-
translational modifications, low risk of contamination with pathogens, low to medium 
production costs, and the possibility for scale-up. 
In addition to an optimum quality of the produced proteins, maximizing the volumetric or 
specific productivity is the second main goal in RPP. Many strategies can be used and have 
been implemented to improve the expression hosts such as E. coli and the downstream-
processing to improve the yield of the target protein. While chromosomal integration of 
genes is necessary for higher eukaryotic hosts, plasmid-based RPP with self-replicating, 
extra-chromosomal vectors is common for bacterial hosts [30]. This allows a high gene 
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dosage, easy genetic manipulation, and inducible expression of the target protein. A large 
series of E. coli strains is commercially available with key features like being deficient in 
distinct proteases (E. coli BL21 and derivatives), facilitating cytoplasmic disulfide bond 
formation (E. coli Origami), or adjusting the need for rare tRNAs to help with the codon bias 
of heterologous gene sequences (E. coli Rosetta) [32]. Various promoter systems allow the 
inducible expression of the target protein, e.g. the T7 RNA polymerase system and the PBAD 
promoter of the arabinose operon.  
Although the choice of the expression host and plasmid system can help overcome many 
problems with recombinant expression, overexpressed proteins still often accumulate as 
inclusion bodies [40]. There are two main strategies to solve this issue, either adapting the 
expression parameters to yield highly soluble protein or refolding the protein from inclusion 
bodies. For the first strategy, the simplest way to improve protein solubility is to lower the 
cultivation temperature, which leads to a reduced protein translation rate, reduced stress on 
the folding machinery of the cell, and lower proteolytic degradation of the target protein. 
Another method to solve the problem with rare codons is to use synthetic genes, which are 
codon optimized for the use in the specific expression host, i.e., a systematic study with 30 
codon optimized human genes showed improved expression and solubility in E. coli [41]. 
Translational fusion to highly soluble proteins such as thioredoxin, maltose-binding protein, 
or bacterioferritin can drastically enhance the solubility of the target protein [42–44]. 
Furthermore, the co-expression of molecular chaperones aiding in the protein quality 
control can facilitate proper folding of overexpressed proteins and reduce aggregation 
[45,46]. Various combinations of the DnaK/DnaJ/GrpE and GroES/GroEL chaperone systems 
[47] and the E. coli trigger factor (TF) [48] are commercially available for co-expression from 
co-transformed plasmids. Although many proteins were successfully expressed in E. coli with 
this strategy, undesired side effects related to their activities such as promoting proteolysis 
of the target protein were also reported [49].  
The second main strategy comprises the in vitro refolding of proteins from inclusion bodies 
[50,51]. While several more steps in downstream-processing are necessary, it avoids the 
need to optimize the soluble expression in RPP. Inclusion bodies contain the overexpressed 
protein in a paracrystalline form as insoluble aggregates. They have a high density allowing 
easy separation by centrifugation after cell homogenization. Further advantages are the 
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resistance to proteolysis and often high purity (over 90%) after few washing steps. After 
solubilization with chaotropic buffers, the denatured protein is refolded at low protein 
concentrations (under 0.1 mg mL-1). The correct folding competes with misfolding and 
aggregation and refolding yields decrease with higher initial protein concentration, since this 
favors aggregation of unfolded or partially folded proteins, which still contain accessible 
hydrophobic patches. Due to the low protein concentrations, large volumes of refolding 
buffer, huge reactors, and additional concentration steps are necessary. In industry, batch 
dilution is the standard method, which needs to be carefully optimized in order to reduce 
costs and waste disposal. 
Although several studies suggest schemes or workflows, which should be followed in order 
to minimize costs and time and maximize the return of investment in RPP, the main problem 
with all the above mentioned strategies is that it almost always has to be empirically 
determined, how to operate for each individual protein [52–54]. Also, as it was shown that 
protein quality does not necessarily correlate with solubility, the latter should eventually be 
reconsidered as the main optimization goal and universal indicator for a successful process 
[55]. 
1.1.4 Biocatalyst characterization and engineering 
A useful biocatalyst for industrial applications is characterized by high catalytic turnover, 
high selectivity (chemo-, regio-, and stereoselectivity), and high process stability under the 
required conditions [14,56]. Basic knowledge about the biocatalysts biochemistry like 
activity and kinetics, especially in regard to substrate and product inhibition, is 
indispensable. Further structural information about the native oligomerization state, overall 
secondary structure or post-translational modifications gained by techniques such as 
analytical gel filtration, circular dichroism spectroscopy, and MALDI-TOF or LC/MS-MS 
analysis can help in understanding the basic reaction mechanism and issues related to 
stability or solubility of the biocatalyst [57].  
As most biocatalysts lack in some vital trait like activity, stability, or selectivity for the 
application in biocatalytic processes, many new strategies for improvement have been 
developed and are continuously advanced [13]. These protein engineering strategies differ in 
the degree of change introduced into the protein and the amount of information required 
about the protein. In the mid-1990s, Stemmer and Arnold set the foundation for the 
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optimization of enzyme features by directed evolution [58,59]. Generation of a gene library 
by mutagenesis is followed by the expression of the genes and the screening of improved 
enzymatic traits like solvent tolerance or enantioselectivity [59,60]. Early methods like DNA-
shuffling and error-prone PCR (epPCR) and advanced methods like sequence saturation 
mutagenesis (SeSaM) [61] are used to establish large gene libraries, which need efficient 
screening techniques like fluorescence-activated cell sorting, phage display, or growth assays 
[14]. In order to reduce the screening effort, techniques to reduce the library size with a 
concomitant increase in library quality have been made. In directed evolution, one way to 
reduce the library size is by eliminating duplicate codons by using a degenerate codon 
yielding only 12 instead of 20 possible amino acids [62]. Rational design offers another 
solution to generate smaller and smarter libraries [13]. Guided by crystal structures or 
homology models, certain amino acids or hotspots are identified, which are usually in the 
vicinity of the active site of the protein. Rational substitution of amino acids then leads to 
small focused libraries, which can easily be screened for the desired alteration.  
Preferentially, the structure of the protein should be solved with the substrate of interest, 
product, or an inhibitor, which resembles the substrate transition state [17]. This can help in 
identifying the residues (in)directly involved in catalysis. Combined approaches of rational 
design and directed evolution such as iterative saturation mutagenesis (ISM) or iterative 
CASTing (combinatorial active site testing) developed by Reetz et al. combine the advantages 
of both approaches [63–65]. 
1.1.5 Biocatalyst application and downstream-processing 
Biocatalytic applications are frequently limited by the need to operate under conditions 
unsuited for biocatalysts [29]. While chemical catalysts are prepared for specific conversions 
at defined conditions, enzyme kinetics and protein stability under technical conditions are 
key features, which strongly differentiate biocatalysts from chemical catalysts [2]. Ideally, 
the biocatalyst operates under a broad range of physical parameters like different pH and 
temperatures. Also, additional factors like ion requirements or cofactors need to be taken in 
account.  
In industrial biocatalysis, enzymes and also whole cells are mostly used in immobilized form. 
Various immobilization techniques, e.g. immobilization on hydrophobic, porous resins, cross-
linked enzyme aggregates, or encapsulation [66], have been shown to be able to improve 
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not only the stability, but also activity, specificity, and reduction of inhibition of biocatalysts 
[67]. Immobilized or lyophilized enzymes can be used in neat organic solvents [27]. While 
most proteins are denatured in organic/aqueous mixtures, they were shown to be very rigid 
and stable in neat (hydrophobic) organic solvents. This circumvents many restrictions of 
aqueous media as already discussed above (see 1.1.1). Prime examples here are many 
lipase-catalyzed asymmetric (trans)esterifications to produce optically pure intermediates 
and products [10]. 
Many enzymes show far lower catalytic activity in organic solvents compared to water [68]. 
In this regard, a low water activity can “activate” the rigid enzyme in the organic solvent by 
providing hydrogen bonds [69]. Interestingly, usage of various organic solvents can alter 
enzyme specificities like substrate-, enantio-, regio-, or chemoselectivity [70]. This “solvent 
engineering” can be synergistically used with protein engineering. In aqueous media, 
enzymes are strongly dependent on a distinct pH value or range. While the concept of pH 
has no meaning in organic solvents, it has been shown that the catalytic activity of an 
enzyme reflects the pH of its last aqueous solution [71]. Consequently, this pH memory 
effect should be exploited, i.e. enzymes should be lyophilized from or immobilized in 
aqueous solutions of the pH optimal for catalysis. 
One of the most relevant advantages of an immobilization of biocatalysts is still the 
possibility to easily recover the biocatalyst for further process cycles [2]. This is usually done 
by filtration or centrifugation and precedes the product recovery. In situ product recovery 
methods, in which the product is removed during the biotransformation, are based on 
physical and chemical parameters of the reactants [29]. This includes ultrafiltration, 
crystallization, distillation, adsorption, solid-phase-, and liquid-phase recovery based on 
properties like molecular weight, volatility, charge, hydrophobicity, or solubility. Advantages 
of the in situ recovery are e.g. avoiding substrate or product inhibition and product decay in 
aqueous solvents. One example of in situ product recovery in an industrial process by simple 
precipitation is the acrylamide production from acrylonitrile [2].  
 
Introduction 31 
 
1.2 Dirigent proteins 
1.2.1 Secondary plant metabolites 
Secondary plant metabolites are organic compounds, which are, unlike the primary 
metabolites, not directly involved in anabolic and catabolic reactions or the energy 
production in cells [72]. Since secondary plant metabolites often share enzymatic pathways 
with primary metabolites in their biosynthesis, a differentiation by the chemical structure is 
not possible. The assignment is therefore based on a physiological role in the organism, 
which is often an important role in plant defense against herbivors and pathogens, but also 
against abiotic stress factors like coldness, drought, high salinity or ultraviolet radiation 
resulting in an increased selective advantage [73,74]. Today, more than 105 different 
secondary metabolites in plants are known [75,76]. Despite this large number, all secondary 
metabolites can be traced back to a few basic chemical structures like terpenoids, alkaloids, 
glycosides, polyketides and phenolic compounds. Further chemical diversity is generated by 
oligomerization as well as glycosylation, hydroxylation, methylation or other chemical 
modifications. 
Besides the physiological role in plants, many secondary metabolites exhibit remarkable 
pharmacological activities or can be used as flavoring agents or dyes [77,78]. In this regard, 
the chirality of the compounds is very important, since different enantiomers have been 
shown to exhibit strongly different bioactivities. A prime example for this is the use of the 
two enantiomers of thalidomide, which was introduced in the late 1950s as an anti-nausea 
and sedative drug especially for pregnant women leading to the “contergan” scandal [79]. 
While the (R)-enantiomer exhibits the desired sedative effect, the (S)-enantiomer was found 
to lead to a teratogenic effect on fetal development. For an organic synthesis of natural 
compounds, the regio- and stereoselectivity needed to achieve optically pure compounds 
can be a great challenge mostly involving complicated protecting and deprotecting steps 
[2,78].  
1.2.2 Lignans 
Lignans represent a structurally diverse class of secondary plant metabolites and belong 
together with flavonoids, stilbenes, and coumarines to the phenolic compounds [78,80]. The 
molecular backbone is formed by two C-C-coupled phenylpropanoids (C6-C3 units) [81]. 
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While various coupling modes are possible, only 8-8´coupled compounds are referred to as 
lignans (see Figure 1-2a). Compounds coupled via other carbon atoms or via oxygen are 
referred to as neolignans and oxyneolignans, respectively, according to IUPAC nomenclature 
(see Figure 1-2a) [82]. Importantly, the coupling of two achiral phenylpropanoids leads to 
the formation of chiral centers. Depending on the number of chiral carbon atoms, several 
stereoisomers of a basic lignan structure do exist. Modifications of the basic structure lead 
to a wide variety of compounds. For example, a common modification is the formation of 
glycosides [83], which allows the storage of physiologically active compounds in the plant 
vacuole by increasing the water solubility of the compound. 
 
Figure 1-2 – Nomenclature of lignans (a) and selected examples (b). (a) Coupling of two phenylpropanes (1) 
and its hydroxylated derivatives lead to lignans (2), neolignans (3), or oxyneolignans (4). (b) Structures of 
lignans with pharmacologically interesting activities. NDGA (1), podophyllotoxin (2), teniposide (3), etoposide 
(4, R=H), and etopophos (5, R=PO(OH)2) 
 
Lignans have been found in liverworts [84], hornworts [85], ferns [86], and higher plants 
[80]. While the localization of lignans in plants can be diverse including roots, rhizomes, 
stems, leaves, seeds, and fruits [73], very high concentrations of lignans were found for 
example in the heart wood of Thuja plicata  [87]. 
Lignans exhibit a variety of important physiological activities. While some lignans, e.g. 
nordihydroguiaretic acid (NDGA) (see Figure 1-2b), act as antioxidants in reducing cell 
damage by free oxygen species, many lignans exhibit antimicrobial, fungicidal and 
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insecticidal properties for the defense against pathogens in planta [73]. Additionally, some 
lignans also show allelopathic effects. For example, NDGA effectively inhibits the root 
growth of many grasses [88]. 
Moreover, lignans have been demonstrated to possess significant pharmacological activities, 
including anti-inflammatory, anti-tumor, immunosuppression, cardiovascular, antioxidant 
and antiviral properties [77]. A well-known example is the antiviral podophyllotoxin from 
Podophyllum peltatum (may apple) used in the treatment of warts [89] and its semi-
synthetic derivatives Etoposide™, Etopophos™ and Teniposide™, representing important 
anti-cancer drugs [90] (see Figure 1-2b). While the organic synthesis of derivatives of natural 
products is prevalent [78], first examples for a biotechnological production were presented 
[91,92]. 
The phenylpropanoid biosynthesis pathway generates various building blocks for the 
biosynthesis of coumarins, flavonoids, isoflavonoids, and stilbenes as well as the monolignols 
p-coumaryl-, coniferyl-, and sinapyl alcohol, which are used in the biosynthesis of lignin and 
lignans (see Figure 1-3) [93,94]. The starting molecules phenylalanine (1) and tyrosin (3) are 
derived from the shikimate pathway. From these, p-coumaric acid (4) is formed either by the 
action of phenylalanine ammonia lyase (PAL) and cinnamate 4-hydroxylase (C4H) or tyrosine 
ammonia lysase (TAL), respectively [94]. In a further enzymatic step, p-coumaric acid (4) is 
activated by the action of a hydroxycinnamoyl CoA ligase (4CL) yielding the central 
metabolite p-coumaryl CoA (5), which provides the basis for all subsequent branches and 
resulting metabolites. From here, further reduction steps lead to the monolignol p-coumaryl 
alcohol (7). The Cytochrome P450 enzyme C4H allows the entry into the broad majority of 
the phenylpropanoid pathway derived metabolites. Further hydroxylation steps performed 
by the P450 enzymes p-coumarate-3-hydroxylase (pC3H) and ferulate 5-hydroxylase (F5H) 
coupled with subsequent methoxylation and reduction steps lead to the monolignols 
coniferyl alcohol (11) and sinapylalcohol (14). 
From the three monolignols, mainly coniferyl alcohol is used for the biosynthesis of lignans 
in higher plants [80]. The first step in the biosynthesis of lignans involves an oxidation of 
coniferylalcohol to the corresponding radical, which is usually catalyzed by laccases or 
peroxidases [95,96]. The lignan specific 8,8´-coupling of two radicals with the addition of two 
water molecules leads to the furofuran lignan pinoresinol. Other coupling modes include an 
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8,5´- and 8-O-4´-coupling yielding the neolignan (±)-dehydroconiferylalcohol and the 
oxylignans erythro/threo-(±)-guaiacyl-glycerol coniferyl ethers. Further reduction and 
oxidation steps catalyzed by pinoresinol-lariciresinol reductases (PLR) and 
secoisolariciresinol dehydrogenases (SDH) result in lariciresinol, secoisolariciresinol and 
finally matairesinol formation, which is an educt for the subsequent synthesis of various 
lignan structures by modification of the structure backbone or the aryl residues [97,98] (see 
Figure 1-4b). While all these enzymes exhibit a direct, stereoselective control leading to 
optically pure compounds [99–102], even the random, chemical coupling of two coniferyl 
alcohol radicals can be affected in a stereoselective fashion by so called dirigent proteins 
(DIR). 
 
Figure 1-3 – Phenylpropanoid biosynthesis pathway leading to the monolignols p-coumaryl alcohol, coniferyl 
alcohol and sinapyl alcohol (modified from [94]). PAL: phenylalanine ammonia lyase; C4H: cinnamate 4-
hydroxylase; TAL: tyrosine ammonia lyase; 4CL: hydroxycinnamoyl CoA ligases; pC3H: p-coumarate-3-
hydroxylase; CCOMT: hydroxycinnammoyl CoA O-methyltransferases; CCR: cinnamoyl-CoA oxidoreductases; 
F5H: ferulate 5-hydroxylase; COMT: caffeic acid O-methyltransferases; CAD: cinnamyl alcohol dehydrogenases. 
Dotted arrows: Further enzymatic steps are involved in the formation of (8) from (5) (see [94]). 
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1.2.3 Stereoselective control of lignan biosynthesis by dirigent proteins 
The first step in the biosynthesis of lignans is performed by the one-electron oxidation of 
monolignols followed by a phenoxy radical coupling reaction [94]. The resonance stabilized 
phenoxy radicals can couple in various ways leading to a mixture of different chemical 
compounds and racemates in vitro [73,103]. However, these reactions can also occur in a 
regio- and enantioselective fashion in planta [104]. The identification of the DIR FiDIR1 from 
Forsythia intermedia by Davin and coworkers in 1997 offered first insights into the 
proteinaceous basis for these control mechanisms [95]. In this study, FiDIR1 was found to 
guide the formation of (+)-pinoresinol from two coniferyl alcohohl radicals (see Figure 1-4a). 
Although other enzymes also exhibit selectivity in lignan biosynthesis (see 1.2.2), the 
existence of DIRs might explain the presence of optically pure 8,8´-linked lignans and led to a 
new paradigm for the stereospecificty of phenoxy radical coupling in biological systems 
[104,105]. 
Recent data indicates that the stereoselective control of phenoxy radical coupling reactions 
might not be limited to the phenylpropanoid metabolism, but rather plays a more general 
role in various biosynthetic pathways in vivo. In this respect, DIR genes have been identified 
in many plants and a large gene family including 35 members in spruce (Picea spp.), 25 in 
thale cress (Arabidopsis thaliana) and 54 in rice (Oryza sativa) was established [106]. This 
implied a more general role of DIRs in the stereoselective control of bimolecular phenol 
coupling. Further, the atropselective coupling of hemigossypol to (+)-gossypol has recently 
been shown to involve the activity of a not yet characterized DIR in cotton (Gossypium 
hirsutum) [107]. 
Up to now, eleven DIRs have been expressed and characterized including FiDIR1 from 
Forysthia intermedia [95,105], TpDIR1 to TpDIR9 from Thuja plicata [108] and AtDIR6 from 
Arabidopsis thaliana [109,110]. While FiDIR1 and TpDIR1-9 favor the formation of (+)-
pinoresinol, AtDIR6 mediates the enantiocomplementary formation of (-)-pinoresinol (see 
Figure 1-4a). 
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Figure 1-4 – Phenoxy radical coupling of coniferyl alcohol (a) and further biochemical pathway (b). (a) One 
electron oxidation of coniferyl alcohol (1) initiates the unspecific, oxidative coupling of resonance-stabilized 
radicals (2) to (±)-pinoresinol ((±)-3), erythro/threo-(±)-guaiacyl-glycerol coniferyl ethers (4), and (±)-
dehydroconiferylalcohol (5). In the presence of FiDIR1 and TpDIRs, the product formation is strongly shifted to 
(+)-pinoresinol, while the enantiocomplementary AtDIR6 shifts the product formation to (-)-pinoresinol. (b) The 
8,8´-coupled lignan pinoresinol is subsequently converted into lariciresinol, secoisolariciresinol, and 
matairesinol by the action of pinoresinol-lariciresinol reductase (PLR) and secoisolariciresinol dehydrogenase 
(SDH). 
 
1.2.4 Reaction mechanism of dirigent proteins 
Although the precise reaction mechanism of DIRs is still elusive, a model was proposed 
based on the detailed biochemical and kinetic analysis of FiDIR1 [95,104,111,112]. Since DIRs 
do not have any oxidative capacity for the initiation of the reaction on their own, free 
coniferyl alcohol radicals need to be generated by enzymes like laccases and peroxidases or 
by chemical oxidants such as ammonium peroxydisulfate in this model.  
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In a subsequent step, the two subunits of the functional DIR homodimer are thought to bind 
one coniferyl alcohol radical each. These radicals are then specifically oriented so that 8,8´-
coupling yielding a quinone-methide intermediate and a subsequent intramolecular 
cyclization reaction is favored [112,113]. The model describes hence the formation of 
optically pure (+)- or (-)-pinoresinol by FiDIR1 and AtDIR6, respectively, instead of racemic 
mixtures of 8,8´-coupled (±)-pinoresinol, 8,5´-coupled (±)-dehydroconiferylalcohol and 8-O-
4´-coupled erythro/threo-(±)-guaiacyl-glycerol coniferyl ethers obtained by random coupling 
[104,108,112]. 
1.2.5 Biochemical characterization of dirigent proteins 
DIRs are generally small proteins of about 180 amino acids and a molecular mass of about 18 
to 19 kDa [105,108,109]. So far, all characterized DIRs were either extracted from plant 
material or expressed in systems based on higher organisms such as plant and insect cell 
cultures, yielding only up to 200 µg per L of culture. Characterization of the quarternary 
structure of FiDIR1 and AtDIR6 implied a homodimeric assembly as the native form, which is 
in accordance with the proposed reaction mechanism (see 1.2.4) [110,111]. DIRs have been 
shown to be post-translationally modified by glycosylation in planta as well as in 
heterologous expression systems [105,108,110] at two to four N-glycosylation sites leading 
to a processed molecular mass of 21 to 26 kDa. In plants, the complex (2190 Da) and 
paucimannosidic (1170 Da) type of glycosylation patterns are the most prevalent [114]. 
While for most DIRs only the approximate size of the glycosylation, but not the exact pattern 
is known, a more detailed characterization of AtDIR6 expressed in tomato cell cultures 
revealed a paucimannosidic type of glycosylation (Mannose3–Xylose–N-acetylglucosamine2–
Fucose) with a core fucose residue at two N-glycosylation sites [110]. Further post-
translational modification included a disulfide bond connecting the N- and C-terminus of 
AtDIR6. Together with the glycosylation, both post-translational modifications were 
predicted to contribute to the stability and/or solubility of the protein. 
Immunolocalization studies with FiDIR1 revealed that the protein is located in the apoplast 
in planta [115]. This is in accordance with the observed N-terminal signalpeptides for all 
characterized DIRs [105,109]. The signal peptides are cleaved during secretion to form the 
mature protein. In this regard, it was found that the cleavage site in animal and plant 
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expression systems can vary leading to a non-native amino terminus in the heterologous 
expression system [105]. Yet, this did not afflict the dirigent activity of the protein. 
Recently, conceptual similarities between the proposed DIR mode of action and that of 
allene oxide cyclases (AOC) were noted [110,116]. AOCs also mediate a stereochemical 
control on a cyclization reaction, where the substrates are unstable allylic epoxides, which 
rapidly hydrolyze to ketols in aqueous media or can undergo spontaneous cyclization to yield 
racemic cyclopentenones [117,118]. However, in the presence of AOC, the hydrolysis is 
suppressed and the stereospecific cyclization of the substrate is favored. DIRs seem to share 
the ability of AOCs to bind hydrophobic ligands and impose a steric restriction on the 
substrate via the protein environment to preclude all but one possible reaction outcome. 
Besides similarities in function, a homology model of AtDIR6 based on the crystal structure 
of the allene oxide cyclase from Arabidopsis thaliana (AtAOC2) could be established (see 
Figure 1-5) [110,119]. 
 
Figure 1-5 – Homology model of AtDIR6 ([110]). The model of AtDIR6 is shown in cartoon style with an 80% 
transparent surface. The two N- and C-terminal cysteine residues Cys40 and Cys186 forming a disulfide bond 
are shown as yellow sticks, while the two N-glycosylation sites N59 and N123 are shown as orange sticks. 
Numbering is according to Pickel et al. (2012) for the plant derived AtDIR6 with the N-terminal secretion signal 
peptide. The model was visualized using Pymol 1.1. The model data is available in the PMDB database under 
the accession number PM0078038 (http://mi.caspur.it/PMDB/). 
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Although the sequence identity is rather low (11%) between AtDIR6 and AtAOC2, based on 
CD spectroscopic data the proteins (including FiDIR1) all shared the fold of an AOC-like, 
eight-stranded antiparallel -barrel with a central hydrophobic cavity for potential substrate 
binding. Based on this and the notion that DIRs like AOCs can be primarily seen as binding 
proteins for unstable lipophilic molecules, it was suggested to classify DIRs as homologs of 
AOCs belonging to the calycin superfamily of proteins. A distant relationship to lipocalins 
known for their capacity to bind hydrophobic ligands was proposed as well [110,120]. 
Recent mutational studies including alanine scanning mutagenesis and domain-swapping 
experiments between the (+)- and (-)-pinoresinol-forming DIRs ScDIR from Schizandra 
chinensis and AtDIR6 revealed further insights into the binding of the hydrophobic 
substrates to the DIR proteins [121]. Exchange of the phenylalanine residues F90, F113 and 
F163 in ScDIR resulted in the loss of dirigent function supporting the presumed interaction in 
binding of the substrate. Based on the established homology model of AtDIR6, residue F82 
(F90 in ScDIR), among other residues, was already suggested to partake in substrate binding 
[110]. In addition, domain swapping experiments uncovered that the region comprising 
residues K90 to L138 in AtDIR6 is important for its stereoselectivity [121].  
1.2.6 Physiological function 
So far, the physiological function of DIRs is not completely clear. The molecular function in 
the stereoselective control of phenoxy radical coupling seems to be important for the first 
step of the lignan biosynthesis in planta. Based on the physiological function of lignans for 
the plants (see 1.2.2), a preventive function in the protection against pathogens by 
accumulation of lignans like plicatic acid in heartwood tissue seems reasonable [108]. This is 
supported by the induced transcription and expression of DIRs and DIR-like genes in e.g. 
Picea spp., Gossypium hirsutum and Pisum sativum upon infection by pathogens [106,122–
124]. 
The participation of DIRs in the lignification process in plants is discussed controversially. 
Lignin, being the second most abundant organic plant substance in the terrestrial 
environment, is mainly composed of the three monolignols p-coumaryl alcohol, 
coniferyl alcohol, and sinapyl alcohol [125]. It functions to impart strength to the cell walls, 
facilitate water transport, impede degradation of wall polysaccharides, and as a major 
defense against pathogens, insects and herbivores in vascular plants [126]. Historically, the 
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lignin biosynthesis was described by a random (combinatorial) coupling model lacking 
stereoselective control [103]. With the discovery of DIRs and the differential targeting of the 
lignin monomers to distinct lignin initiation sites, evidence was found to support the theory 
that lignin primary structure is actually controlled at the proteinaceous level 
[105,115,125,127]. While several inconsistencies regarding the random coupling model such 
as implausible cross-linking frequencies in the lignin polymer and results based on unclear 
analytical results are discussed [125], the dirigent protein model also lacks proof for 
numerous problems. For example, there are no hints on the assembly of the lignin polymer 
by monolignol dimers, no evidence for optically active building blocks in the lignin polymer, 
the lack of DIRs facilitating 8-O-4´-coupling and the overall huge number of dirigent proteins 
needed in order to fulfill all the observed coupling specificities [126,128]. 
 
1.3 Ribokinases 
1.3.1 D-ribose transport and metabolism 
D-ribose is among the most abundant and important sugars in biological systems being a 
component of nucleic acids and many other biomolecules [129]. While there is only little 
knowledge of the ribose transport in eukaryotes, it has been intensively studied in E. coli. 
Here, the rbs operon encoding six proteins RbsDACBKR controls the D-ribose transport and is 
induced by the presence of ribose [130,131]. Like all monosaccharides, D-ribose exists in 
multiple configurations in solution, which are the β-pyranose (58.9%), α-pyranose (20.3%), 
β-furanose (13.3%), α-furanose (7.4%), and the acyclic aldehyde or hydrate forms (0.13%) 
[132] (see Figure 1-6a).  
After D-ribose enters the periplasm of the cell by diffusing through pores in the outer 
membrane, the ribose binding protein RbsB recognizes and binds to β-D-pyranoribose, which 
is the major form in solution [133]. In an active transport step mediated by the permease 
RbsC and the ATP binding cassette component RbsA, β-D-pyranoribose is transported across 
the inner membrane into the cytoplasm [134].  
Before entering the biosynthetic or metabolic pathways, D-ribose needs to be 
phosphorylated to D-ribose-5-phosphate by the action of the ribokinase RbsK [130]. This step 
also functions to trap the D-ribose in the cell after its uptake, since the negatively charged 
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phosphate prevents leakage over the cell membrane [129]. Interestingly, while the most 
abundant β-D-pyranose form of D-ribose is transported, RbsK binds and phosphorylates the 
least populated cyclic α-furanose form of D-ribose, which is the only configuration that is 
used in biomolecules [135–137].  
 
Figure 1-6 – D-ribose configurations in solution (a) and transport (b). (a) Monosaccharides like D-ribose exist in 
various configurations in solution. The cyclic forms of the sugar interconvert via the acyclic aldehyde form. The 
β-pyranose and the α-furanose configurations of D-ribose are highlighted since they represent the forms, which 
are transported into the cell and phosphorylated, respectively. (b) D-ribose diffuses into the periplasm, where 
the β-D-pyranose form is bound by RbsB, actively transported into the cytoplasm and converted into the β-D-
furanose form by RbsD. The β-anomer spontaneously changes to the α-anomer, which is phosphorylated by 
RbsK to α-D-furanoribose-5-phosphate. 
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The cyclic forms of sugars can interconvert spontaneously via the acyclic aldehyde form. 
While it was shown for D-glucose that the α-β anomeric change (mutarotation) is a very slow 
process, which can be accelerated by a galactose mutarotase [138], the conversion between  
α- and β-furanoses is a fast and spontaneous process due to a lower energy barrier for the 
necessary ring opening for furanoses compared to pyranoses [137]. Although mutational 
studies showed that RbsD is not essential [139], it was characterized as a pyranase, which 
increases the exchange rate between the β-anomers β-ribopyranose and β-ribofuranose. 
This allows an efficient supply of the α-furanose form of D-ribose for the phosphorylation by 
RbsK and eliminates the discrepancy in the substrate specificities for uptake and 
phosphorylation. Figure 1-6b summarizes the transport steps, changes in configuration and 
phosphorylation of D-ribose leading to the formation of D-ribose-5-phosphate. 
In further biosynthetic and metabolic steps, D-ribose-5-phosphate is used as a carbon source 
for the synthesis of nucleotides, cofactors like NADH and FAD, histidine, and tryptophane as 
well as for energy production after conversion to other sugar compounds in the non-
oxidative phase of the pentose phosphate pathway [129,130]. Besides the formation of D-
ribose-5-phosphate by phosphorylation of free D-ribose, two main pathways are involved in 
pentose phosphate biosynthesis: the oxidative branch of the pentose phosphate pathway 
and the phosphorylase mediated pathway [131]. For the de novo as well as the “salvage” 
synthesis of purine and pyrimidine nucleotides, the essential compound phosphoribosyl-5-
pyrophosphate (PRPP) is generated from D-ribose-5-phosphate. 
1.3.2 The ribokinase family of proteins 
The first step in the metabolism of D-ribose is catalyzed by ribokinases, which are classified 
as phosphotransferases with an alcohol group as acceptor acting on the pentose sugar D-
ribose (E.C. 2.7.1.15). Ribokinase genes have been found in both prokaryotes and 
eukaryotes, e.g. in E. coli, yeast and mammals [140–142]. Sequence comparisons have 
shown that they belong to the ribokinase (RK, also called PfkB) family of sugar kinases, which 
also includes other members like adenosinekinase, fructokinase, 2-dehydro-3-
deoxygluconokinase, 1-phosphofructokinase, tagatose-6-phosphate kinase, inosine kinase, 
and 6-phosphofructo-2-kinase (PfkB or PFK2) [129]. All members of the RK family can be 
identified by the presence of two highly conserved sequence motifs. The first motif is a 
glycine-rich area in the N-terminal region with two consecutive glycine residues forming part 
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of the hinge between lid and α/β domain (see 1.3.3). The second motif (GXGD) found in the 
C-terminal region contains a conserved aspartic acid serving as the catalytic base and is 
furthermore involved in ATP binding and formation of an oxyanion hole. While the overall 
sequence identity of members of the RK family is less than 30%, the structures are all very 
similar. The main structural differences can be found in the sugar substrate-binding site and 
the peripheral regions leading to broad substrate specificities within a distinct structural 
framework. 
Besides the RK family, the hexokinase family and the galactokinase family form two other 
non-homologous branches of sugar kinases [141] classified according to the most abundant 
sugars. No significant sequence similarities or shared motifs between the different families 
can be found. Furthermore, the enzyme structures greatly differ as well. Interestingly, 
despite large differences in the primary and tertiary/quarternary structures, some enzymes 
e.g. fructokinases from various organisms show similar substrate specificities. Here, 
convergent evolution led to distinct three-dimensional enzyme folds, which can be classified 
into different enzyme families, but catalyze a chemically equivalent reaction on similar or 
identical substrates. Other examples for convergent evolution include e.g. serine proteases, 
tRNA synthases or superoxide dismutases. 
In a comparison of sequence similarity and identity of genes annotated as ribokinases from 
eukaryotic and bacterial organisms (including Homo sapiens, Drosophila melanogaster, 
Arabidopsis thaliana, S. cerevisiae, E. coli and further organisms) it was noted that human 
ribokinase shared a higher sequence identity with protist and bacterial species (35 to 40% 
identity) as compared to the homologs from plants and fungi [143]. These results were 
unexpected since animals are more closely related to fungi and plants than to bacteria. The 
biochemical characterization of the human ribokinase protein established it as a true 
ribokinase, however, since the annotation of proteins from plants and fungi as ribokinases is 
mostly based on observed sequence similarities, a characterization of the proteins regarding 
their substrate specificity is also necessary to verify these as ribokinases and not some other 
kind of sugar kinases. 
1.3.3 Structure and reaction mechanism of the Escherichia coli ribokinase 
The first crystal structure of a protein of the ribokinase family, the ribokinase from E. coli, 
was solved and refined to a resolution of 1.8 Å in 1998 [135] (see Figure 1-7). The E. coli 
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ribokinase is a protein with a molecular mass of about 33 kDa consisting of 309 amino acids. 
Earlier experiments suggested that it exists as a homodimer in solution [144], although only 
one monomer was found in the asymmetric unit of the original structure. Further structure 
solutions of the apo structure and various substrate containing structures contained dimers 
in the asymmetric unit and also lead to a more detailed understanding of the conformational 
changes upon substrate binding [136]. Each monomer consists of two domains. The large 
α/β domain is made up by a nine-stranded β-sheet, which is flanked by 10 α-helices, and the 
smaller domain is formed by four β-strands [135].  While the large domain provides for the 
specific binding of the sugar substrate D-ribose and the nucleotide ATP and therefore also 
contains the catalytically active residues, the smaller domain acts as a lid over the active site. 
Additionally, the outer face acts as the interface for the dimer interaction forming a 
flattened β-barrel with the β-sheet of the smaller domain of the second monomer.  
 
Figure 1-7 – Structure of the E. coli ribokinase. The biological assembly of the ribokinase dimer is shown in a 
cartoon style with an 80% transparent surface based on the PDB file 1RKD [135]. The data represents the 
closed form of the enzyme with an ADP analogue (orange) and D-ribose (yellow) bound. The conserved 
aspartate residues at position 255 of each monomer serving as the catalytic bases are shown as sticks (red). 
 
The native homodimer harbors two active sites and each subunit contributes in forming the 
active site of the dimer partner by the interaction of the lid domains. D-ribose, in its α-
furanose form, binds in the cleft of the α/β domain, where it is stabilized via various direct 
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and indirect hydrogen bonds from amino acid side chains and main chain nitrogens. 
Comparison of the apo structure to the substrate-bound forms revealed drastic 
conformational changes [135,136], which can be seen as an opening and closing of the lid 
domain. The apo structure resembles the open conformation, while the substrate bound 
structure takes the closed conformation with the D-ribose buried almost completely under 
the small lid domain. This leads to further interactions of the lid domain with D-ribose, 
however these are mainly of hydrophobic nature involving four isoleucine and one alanine 
residue. ATP binds in a Rossmann fold-like domain known for NAD binding with fewer direct 
hydrogen bondings compared to the interactions with D-ribose. Yet, the closing of the lid 
upon D-ribose binding is supposed to enhance the affinity for the nucleotide. It was 
suggested that kinases in general use an ordered binding of substrates as a means of 
preventing premature ATP hydrolysis in an induced fit mechanism. In this light, the accepted 
reaction mechanism is an ordered Bi-Bi mechanism similar to those of other kinases 
[129,145]. After binding the co-substrate ATP, small conformational changes orient the γ-
phosphate group of ATP in the vicinity of the O5´-hydroxyl group of D-ribose [136]. The 
conserved aspartate at position 255, which is found in the GXGD motif (see 1.3.2), serves as 
the catalytic base abstracting a proton from the O5´-hydroxyl group [135]. The negatively 
charged oxygen atom subsequently makes a nucleophilic attack on the γ-phosphate group of 
ATP in an in-line SN2 reaction leading to a pentacovalent transition state, which is stabilized 
by an anion hole. Further movements of the lid domain lead to the breakdown of the 
transition state and the release of the products, ADP and D-ribose-5-phosphate. 
1.3.4 Biochemical characterization of ribokinases 
First characterization of a ribokinase was performed with the protein identified and purified 
from calf liver more than 50 years ago [140]. The biochemical characterization of eukaryotic 
ribokinases from Homo sapiens and Leishmania major and bacterial ribokinases from E. coli, 
Salmonella typhimurium, and Staphylococcus aureus has been reported up to now as well, 
with the best studied ribokinase coming from E. coli [143,146–149]. So far, although 
ribokinase genes have been also found in plants and fungi [141,150], no proteins from these 
kingdoms were characterized. 
All characterized ribokinases show a strong dependence on mono-, di- and pentavalent ions 
for their activity [129]. The divalent cation Mg2+ is a prerequisite in the binding of ATP and 
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the transfer of the phosphate group. The actual co-substrate for ribokinases is the metal 
chelate (ATP4-Mg2+)2- and divalent cations are supposed to neutralize the negative charges 
on the phosphate groups of the nucleotide. No activity is found without divalent cations, 
however others such as Mn2+ can substitute for Mg2+.  
Ribokinases, like all other known carbohydrate kinases, show an additional requirement for 
monovalent cations. Here, two general types of activation can be distinguished. A direct 
(catalytic) activation with the monovalent cation binding in the active site can be found for 
enzymes such as the pyruvate kinase or the molecular chaperone GroEL [151]. In the case of 
ribokinases, an indirect (conformational) type of activation by the physiological cation K+ has 
been suggested [152]. The structural basis for this activation was recently elucidated by 
comparison of the crystal structure of the E. coli ribokinase in presence of Cs+ as monovalent 
cation and the structure of the Staphylococcus aureus ribokinase in the absence of a 
monovalent cation [148]. A structural rearrangement of the large ATP loop forming the 
nucleotide binding pocket upon binding of the monovalent cation was proposed to enable 
ATP binding and enhance catalytic efficiency. 
A detailed study showed the importance of an NXXE motif in adenosine kinase for activation 
by the pentavalent cation phosphate and its effect on Mg2+ binding [153]. The human form 
of adenosine kinase shows a remarkable structural homology to ribokinase from E. coli. In 
the crystal structure of the E. coli ribokinase, a phosphate bound in the active site with close 
contacts to Asn187 and Glu190 forming an NXXE motif was also found [135].  The activation 
by phosphate was shown to increase the catalytic turnover and the substrate affinity for D-
ribose [154]. Importantly, ribokinase and other enzymes depending on a activation by 
phosphate such as adenosine kinase, 6-phosphofructo-1-kinase and PRPP synthetase, which 
are all important for the synthesis of essential metabolites, can be fully regulated by 
physiological levels of phosphate [129]. While other pentavalent ions like vanadate or 
arsenate can substitute for phosphate, there are also a large number of phosphorylated 
compounds known, which serve as activators or inhibitors of adenosine kinase and 
ribokinase [143,155,156].  
Ribokinases show high substrate specificity towards the phosphate-accepting substrate. 
While the phosphorylation of D-ribose is exceptionally efficient, many other comparable 
sugars are only very weak substrates or not accepted at all. The ribokinase from E. coli 
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accepts 2-deoxy- D-ribose rather well, while D-arabinose and D-xylose, which differ at the C2 
or C3 functional group, as well as D-fructose, which varies in the chain length (C6), are 
already very poor substrates. Further sugars such as D-lyxose, L-ribose, L-arabinose, and D-
glucose were not phosphorylated [146]. Ribokinases from Homo sapiens and Salmonella 
typhimurium showed comparable substrate specificity with the E. coli enzyme, while the 
ribokinases from calf liver and Leishmania major did not show activity towards any other 
sugar [140,143,147,149]. In this respect, ribokinase from E. coli showed the highest catalytic 
efficiency of all characterized enzymes, while the relative activities towards other accepted 
sugars was only about 1%, which might explain why no activity towards these sugars was 
measured with the some of the other enzymes.  
1.3.5 Biotechnological and medicinal applications 
The metabolism of D-ribose has received much attention recently since the beneficial effects 
of D-ribose supplementation on the cardiovascular system have been studied [129]. By the 
action of ribokinase and PRPP synthetase (PRPPS), PRPP is formed from D-ribose, which is an 
essential precursor for the production of energy-rich purine and pyrimidine nucleotides. As 
the availability of PRPP under pathologic cardiac conditions is limited, nucleotide synthesis is 
hampered. As the repletion of nucleotides following ischemic insults is important for the 
recovery of the heart function, a steady supply with D-ribose, which is metabolized into 
ribose-5-phosphate and then PRPP is advantageous for the cells´ ability to regenerate ATP 
and restore proper function. 
A more direct application for ribokinase was suggested in the enzymatic synthesis of 
nucleosides and analogues (see Figure 1-8) [146,157]. Chemical preparations of α-D-
pentofuranose-1-phosphates (α-PFP-1) as precursors for the enzymatic synthesis of purine 
nucleosides by purine nucleoside phosphorylase (PNP) are rather complicated. An enzymatic 
approach is the transformation of pentofuranose-5-phosphates (PFP-5) via the action of 
phosphopentomutase (PPM) to α-PFP-1 [146]. PFP-5 can be synthesized chemically; 
however an enzymatic step employing ribokinase for the formation of PFP-5 from D-ribose 
was suggested. The high specificity found for many ribokinases could limit this approach, yet 
an alteration or extension of the substrate spectrum of the employed ribokinase by enzyme 
engineering, specifically rational design based on the available structural and biochemical 
information, might solve this limitation. Instead of the conversion of PFP-5 into α-PFP-1, it 
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can also be used for the formation of PRPP by PRPPS, which can then be used for the 
synthesis of nucleosides [131]. Gross et al. compared the chemical synthesis of PRPP with an 
enzymatic transformation including ribokinase and PRPPS [157]. They found the enzymatic 
method to be the most attractive procedure in principle, however it lacked specifically in the 
high yield production of ribokinase, which otherwise showed beneficial traits regarding 
activity, stability and immobilization yield. 
 
 
Figure 1-8 – Enzymatic synthesis of purine nucleosides from pentoses (modified from [146] and [157]). 
 
1.4 Cutinases 
1.4.1 Structure and function 
Cutinases (E.C. 3.1.1.74) belong to the enzyme class of hydrolases and are named for their 
ability to degrade cutin, the cuticular polymer matrix of higher plants [158]. Cutin is a 
polymer of hydroxy and epoxy fatty acids with common chain lengths of n-C16 and n-C18. It is 
essential for plants in the protection from microbial infection and dehydration. Many 
phytopathogenic fungi produce extracellular cutinases for the enzymatic hydrolysis of cutin 
to support the initial infection of plants. Cutinases were found in a variety of different 
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organism including fungi such as Alternaria brassicicola, Aspergiulls oryzae, Fusarium solani 
f. pisi, Fusarium oxysporum or Humicola insolens [159]. 
Based on the work with the cutinase from Fusarium solani f. pisi (FsC), cutinases were shown 
to belong to the class of serine esterases and the α/β hydrolase superfamily [158]. For FsC, 
the crystal structure has been solved several times up to a resolution of 1.0 Å [160–163]. 
With a molecular mass of 22 kDa, cutinases are the smallest members of this group, which 
have been described so far. The catalytic triad is comprised of an active serine, an essential 
histidine and a carboxyl residue (usually aspartate) and the reaction mechanism is based on 
the formation of an acyl-enzyme intermediate (see Figure 1-9) [164].  
In FsC, the catalytical serine is situated in an α/β hairpin and the consensus sequence Gly-
Tyr-Ser-Gln-Gly containing the active serine matches the consensus sequence in most lipases 
(Gly-His/Tyr-Ser-X-Gly) [165]. Interestingly, unlike in lipases, the catalytic site is solvent-
accesible, i.e., no lid completely covers the catalytic site. With lipases, the presence of a lid 
leads to a so-called interfacial activation. For activity, most lipases need to interact with a 
hydrophobic interface (e.g. substrate emulsion in water), which leads to a conformational 
change of the lid rendering the catalytic site accessible to substrate and thereby increasing 
the rate of hydrolysis. Cutinase binding to interfaces does not lead to a main-chain 
reaarangement, but only the reorientation of a few hydrophobic residues [158,165]. 
Therefore, cutinases are considered to be intermediates between lipases and esterases 
[166]. 
 In lipases, the lid movement also allows the formation of the oxyanion hole, which stabilizes 
the negative charge of the tetrahedral intermediate during the nucleophilic attack on the 
substrate [167]. In cutinases, the oxyanion hole seems to be pre-formed instead of being 
induced by ligand binding [162]. However, 3D NMR studies [168] and comparison of various 
crystal structures [160] showed some divergence indicating that the region comprising the 
oxyanion hole might also feature small conformational changes upon substrate binding. 
Cutinases show a broad substrate spectrum including soluble synthetic esters and emulsified 
triglycerides under and above the critical micellar concentration [158]. They prefer short-
chain length substrates such as para-nitrophenylbutyrate and tributyrin, which is related to 
the narrow and interrupted substrate binding site [169]. Like lipases, cutinases are able to 
catalyze esterification, transesterification and interesterification in organic media or at low 
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water activities. When acting on triacylglycerol substrates, cutinases show high stereo- and 
regioselectivity towards the sn-3 position. Since cutinases and lipases both belong to the 
class of serine hydrolases, the basic mechanism of hydrolysis and esterification reactions is 
comparable [164,170] (see Figure 1-9). 
 
Figure 1-9 – Reaction mechanism of cutinases (modified from [171]). In a transesterification reaction 
(alcoholysis) with cutinases, first the ester binds to the enzyme (1). The catalytic serine, activated by the 
histidine and aspartate, starts the nucleophilic attack on the carbonyl forming the first tetrahedral intermediate 
(TI), which is stabilized by the oxyanion hole (2). The TI collapses and releases the first product leaving the 
enzyme acylated (3). During hydrolysis, a water molecule attacks the acyl enzyme, in a transesterification 
(alcoholysis) reaction an alcohol attacks forming a second TI (4). Dissociation releases an acid (hydrolysis) or a 
new ester (transesterification). The enzyme is free and ready for the next cycle (1). 
 
1.4.2 Biocatalytic applications 
Cutinases offer interesting biotechnological and industrial applications, which have been 
comprehensively reviewed [158,172]. Potential applications would be in the dairy industry, 
as industrial cleaning or household detergents, in the oleochemical-, polymer-, textile-, or 
food industry as well as for the synthesis of ingredients for personal-care products, 
agrochemicals and pharmaceuticals. For biocatalytic applications, cutinases are mostly used 
in immobilized form e.g. immobilized onto solid supports, covalently coupled, absorbed or 
microencapsulated in reversed micelles. Microencapsulation of cutinases in reversed 
micelles of surfactants such as AOT, SDS or Triton X-100 was successfully used in hydrolysis, 
esterification and transesterification. However, it was found that cutinases display relatively 
low stability in anionic surfactants like AOT [173]. Studies were performed to increase the 
stability in the presence of AOT [174,175]. Examples for the application of cutinases are the 
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synthesis of aromatic esters by employing FsC in reversed micelles of AOT/isooctane [172], 
degradation and detoxification of the organophosphate malathion by the Fusarium 
oxysporum cutinase [176], degradation of the synthetic polyester polycaprolactone with FsC 
[177], and the enzymatic modification of polyesters like PET with FsC [178]. Furthermore, 
Humicola insolens cutinase (HiC) was used in polyester synthesis and lactone ring-opening 
polymerizations [179,180]. Recently, Baker et al. compared five cutinases from Alternaria 
brassicicola, Aspergillus fumigatus, Aspergillus oryzae, HiC and the well characterized FsC 
[181]. Interestingly, all newly characterized cutinases showed higher activity for the 
hydrolysis of small soluble esters as compared to FsC. In this regard, HiC exhibited the 
highest stability and activity versus small soluble esters and in the degradation of synthetic 
polyester (poly(ε-caprolactone)) compared to the other cutinases. 
1.4.3 Functional monomers and polymers 
Functional polymers with thiol and acrylate functional groups based on standard acrylic 
monomers have a great potential for industrial application. Traditionally, they are prepared 
using thiol-ene chemistry and are already in use as lacquers for improved scratch-resistance, 
adhesive formulations for high tack and instant bond strength or sizing of paper and textiles 
for improved printability and reduced abrasiveness [182]. However, the preparation of 
functionalized acrylic esters by chemical synthesis employs harsh reaction conditions often 
leading to premature polymerization and is further hampered by undesired side-reactions 
like the Michael addition of alcohols to acrylic esters and the thiol-Michael-addition of 
mercaptoalcohols to acrylic esters [183]. Polymerization inhibitors and acid catalysts have 
been used to avoid these problems and allow reactions at 80°C to 100°C [184]. Enzymatic 
processes employing biocatalysts such as hydrolases could be beneficial in the 
functionalization of acrylic ester monomers since the high chemoselectivity allows the 
introduction of functional groups into acrylic esters by transesterification. 
The transesterification of acrylates with sterically hindered diols has been described for the 
first time with a lipase from Chromobacterium viscosum [185] and the lipase CalB from 
Candida antarctica was found to be the superior catalyst compared to other enzymes in the 
transesterification of methyl acrylate with 1-undecanol [186]. N-(2-hydroxyethyl)-acrylamide 
(HEA), which can be used as polymer for the application as matrix in DNA sequencing, was 
synthesized in a lipase catalyzed transesterification (aminolysis) reaction of ethyl acrylate 
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with 2-amino-1-ethanol [187]. Highest yields of HEA were obtained in diisopropyl ether as 
solvent with addition of 3% (w/w acrylate ester) butylated hydroxytoluol (BHT). BHT is a 
radical inhibitor, which helped to reduce formation of Michael-addition by-products. It was 
shown for the acrylation of octanol in a solvent-free system with ethyl acrylate as donor of 
the acrylic group that the water activity is an important factor, which needs to be controlled 
[188]. Furthermore, the choice of the solvent is critical for high reaction rates of enzymatic 
acrylation [189]. Recently, the enzymatic synthesis of thiol functionalized acrylic monomers 
by CalB (Novozyme 435®) was coupled with a subsequent one pot reaction involving free 
radical polymerization, removal of thiol protection groups and thiol-ene ´click´reactions to 
yield thiol functionalized poly(meth)acrylates [190]. After removal of the enzyme by 
filtration, no further purification steps of monomers or intermediates were necessary and no 
side product formation influenced the reaction course. Many patents in this field by 
chemical companies like BASF SE emphasize the industrial interest for enzymatic synthesis of 
acrylates [191,192], e.g. the monoacrylation of polyols with CalB [193]. 
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1.5 Objectives of the thesis 
In the scope of the present thesis, selected steps are highlighted, which remain challenging 
in biocatalysis. The focus was set on case studies in the expression and characterization of 
proteins as well as in the enzyme engineering and optimization of reaction parameters in a 
biocatalytic application. These are key steps in establishing biocatalytic processes (see Figure 
1-1). 
1.5.1 Expression of the Arabidopsis thaliana dirigent protein AtDIR6 
Dirigent proteins are involved in the stereoselective control of the first step of lignan 
biosynthesis, the phenoxyl radical coupling of coniferyl alcohol radicals to yield optically pure 
(+)- or (+)-pinoresinol. Extraction of dirigent proteins from plant material or expression in 
systems based on higher organisms such as plant and insect cell cultures only resulted in low 
yields. For the solution of a structure, which might help in the elucidation of the exact 
reaction mechanism, and possible biotechnological applications, larger amounts of protein 
are needed.  
The expression of AtDIR6 was chosen to serve as a model for challenges in the production 
and characterization of biocatalysts. The goals of this case study were to: 
 establish a heterologous expression platform, which allows the cost effective-, fast-, 
and robust expression of AtDIR6 in high yields 
 characterize AtDIR6 in regard to function and structure compared to AtDIR6 derived 
from other expression systems 
 analyze the glycosylation pattern of AtDIR6 derived from Pichia pastoris and evaluate 
its impact on function, structure, and solubility of the protein 
1.5.2 Enzyme engineering of the Saccharomyces cerevisiae ribokinase RBK1 
Ribokinase catalyzes the first step in the metabolism of D-ribose, which is the 
phosphorylation using ATP as co-substrate. The enzyme is highly conserved and shows high 
selectivity towards D-ribose since it catalyzes an essential step in the central metabolism. For 
a possible biocatalytic application, a broad substrate spectrum would be interesting. In this 
regard, an increase in activity of the ribokinase RBK1 from S. cerevisiae towards D-xylose was 
of interest. This could allow establishing a novel D-xylose metabolizing pathway in 
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S. cerevisiae for the production of second generation biofuels from lignocellulosic 
feedstocks. 
The alteration of the substrate spectrum of RBK1 was chosen to serve as a model for 
challenges in the protein engineering and characterization of biocatalysts. The goals of this 
case study were to: 
 establish a heterologous expression system for RBK1 
 characterize the optimum reaction conditions and the substrate spectrum of RBK1 
 establish a small focused library of RBK1 variants based on rational design and screen 
the library for alterations in the substrate spectrum with a focus on D-xylose 
 solve a crystal structure of RBK1 with co-crystallized substrates to allow more precise 
bioinformatic predictions to support the rational design approach 
1.5.3 Biocatalytic application of the Humicola insolens cutinase HiC 
Cutinases are hydrolytic, cutin-degrading enzymes with a broad substrate spectrum. They 
offer potential applications in polymer chemistry and could be used, along with lipases, in 
the synthesis of functional polymers by transesterification of acrylates. For a biocatalytic 
application, the optimum process parameters need to be established. 
The use of immobilized HiC for the synthesis of thiol-functionalized acrylic esters by 
transesterification was chosen to serve as a model for challenges in the application and 
characterization of biocatalysts. The goals of this case study were to: 
 characterize the kinetics of HiC with various pNP esters 
 prepare thiol-functionalized acrylic esters by employing immobilized HiC and 
optimize the reaction parameters 
 purify and characterize the main product 
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2. Materials & Methods 
2.1 Materials 
2.1.1 Chemicals and enzymes 
All chemicals and media were of analytical grade or higher and purchased from Fluka (Buchs, 
Switzerland), Sigma (Taufkirchen, Germany) or Bio-Rad (Munich, Germany) unless otherwise 
stated. All enzymes and enzyme buffers were from Thermo Scientific (St. Leon-Rot, 
Germany) or New England Biolabs (Ipswich, MA, USA) unless otherwise stated. Diaion HP20 
was a gift from BASF SE (Ludwigshafen, Germany). Primary antibody towards AtDIR6 was a 
kind gift of Prof. Dr. Andreas Schaller (University of Hohenheim, Stuttgart). Purified AtDIR6 
expressed in tomato cell cultures for comparison with our Pichia pastoris (P. pastoris) 
derived AtDIR6 in SDS PAGE analysis and dirigent activity assays was also kindly provided by 
Prof. Dr. Andreas Schaller. The expression vector p4782.1 (pJOE) was kindly provided by Dr. 
Josef Altenbuchner (University of Stuttgart, Germany). D-xylose-5-phosphate (>95% purity) 
was synthesized and purchased from Synovo GmbH (Tübingen, Germany). 
2.1.2 Media 
BMGY (buffered glycerol complex medium for yeast) 
       20 g L-1 peptone 
       10 g L-1 yeast extract 
       10  % 1 M potassium phosphate buffer at pH 6.0 
         1 % glycerol 
 
BMMY (buffered minimal medium methanol yeast) 
       20 g L-1 peptone 
       10 g L-1 yeast extract 
       10 % 1 M potassium phosphate buffer at pH 6.0 
      0.5 % methanol 
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YPD medium (yeast peptone dextrose) 
       10 g L-1 yeast extract 
       20 g L-1 peptone 
       16 g L-1 agar (solid media only) 
       20 g L-1  dextrose 
 
YPDS medium (yeast peptone dextrose sorbitol) 
       10 g L-1 yeast extract 
       20 g L-1 peptone 
 182.2 g L-1 sorbitol 
       16 g L-1 agar (solid media only) 
       20 g L-1 dextrose 
LB (lysogenic broth) [194] 
      10  g L-1 tryptone 
        5  g L-1 sodium chloride 
        5  g L-1 yeast extract 
      16  g L-1 agar (solid media only) 
 
TB (terrific broth) 
      12  g L-1 tryptone 
       24  g L-1 yeast extract 
         8 mL L-1 glycerol (50%) 
      10 % 1 M potassium phosphate buffer at pH 7.0 
All media were sterilized before use in an autoclave and supplemented with 
ampicillin (100 µg mL-1), kanamycin (30 µg mL-1) or zeocin™ (25 µg mL-1 for 
Escherichia coli (E. coli) and 100 µg mL-1 for P. pastoris) when necessary. 
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2.1.3 Plasmids 
Table 2-1 – Plasmids 
PLASMID INSERT (USED RESTRICTION SITES) SOURCE 
pPICZαA  Invitrogen, Carlsbad, 
CA, USA 
pET16b  Merck, Darmstadt, 
Germany 
pET22b  Merck, Darmstadt, 
Germany 
pET28a  Merck, Darmstadt, 
Germany 
pET32a  Merck, Darmstadt, 
Germany 
p4782.1 (pJOE) Maltose binding protein “malE” (NdeI, BamHI) 
and enhanced green fluorescent protein “´eGFP” 
(BamHI, HindIII) 
Dr. Joseph 
Altenbuchner, 
University of 
Stuttgart 
pRN754 Saccharomyces cerevisiae ribokinase Rbk1 DSM, Netherlands 
pTf16  Takara, Otsu, Japan 
pG-Tf2  Takara, Otsu, Japan 
pG-KJE8  Takara, Otsu, Japan 
pPICZαA_HIC Humicola insolens cutinase hic  
(EcoRI, KpnI) 
this work (pITB118) 
pPICZαA_AtDIR6 Arabidopsis thaliana dirigent protein Atdir6 
(EcoRI, XbaI) 
this work (pITB762) 
 
pET16b_AtDIR6 Arabidopsis thaliana dirigent protein Atdir6  
(NdeI, BamHI) 
this work (pITB763 ) 
 
pET22b_AtDIR6 Arabidopsis thaliana dirigent protein Atdir6  
(NcoI, HindIII) 
this work (pITB764) 
 
pET28a_AtDIR6 Arabidopsis thaliana dirigent protein Atdir6  
(NdeI, BamHI) 
this work (pITB765) 
 
pET32a_AtDIR6 Arabidopsis thaliana dirigent protein Atdir6  
(NcoI, HindIII) 
this work (pITB766) 
 
pJOE_AtDIR6 Arabidopsis thaliana dirigent protein Atdir6  
(NdeI, HindIII) 
this work (pITB767) 
 
pET28a_RBK1 Saccharomyces cerevisiae ribokinase Rbk1 
 (NdeI, HindIII) 
this work (pITB768) 
pJOE_RBK1 Saccharomyces cerevisiae ribokinase Rbk1  
(NdeI, HindIII) 
this work (pITB769) 
Vector maps of the pET series vectors, the Takara chaperone plasmids, pJOE4782.1 (pJOE) 
and pRN754 can be found in the supplementary figures (see 9.1). 
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2.1.4 Strains 
Table 2-2 – Strains 
NAME GENOTYPE SOURCE 
Escherichia 
coli DH5α 
F- φ80/lacZ∆M15 ∆(lacZYA-argF) U169 recA1 
endA1 hsdR17(r-k m
-
k) phoA supE44 λ
- thi-1 gyrA96 
relA1 
Invitrogen, Carlsbad, 
CA, USA 
Escherichia 
coli XL-1 blue 
endA1 gyrA96(nalR) thi-1 recA1 relA1 lac glnV44 
F'[ ::Tn10 proAB+ lacIq Δ(lacZ)M15] hsdR17(rK
- mK
+) 
Agilent, USA 
Escherichia 
coli BL21(DE3) 
F – ompT hsdSB (rB 
– mB 
–) gal dcm (DE3) Invitrogen, Carlsbad, 
CA, USA 
Escherichia 
coli 
Origami(DE3) 
F – ompT hsdSB (rB 
– mB 
–) gal dcm lacY1 ahpC 
gor522::Tn10 (TcR) trxB::kan (DE3) 
Invitrogen, Carlsbad, 
CA, USA 
Escherichia 
coli 
Rosetta(DE3) 
F – ompT hsdSB (rB 
– mB 
–) gal dcm lacY1 (DE3) 
pRARE6 (CmR) 
Invitrogen, Carlsbad, 
CA, USA 
Escherichia 
coli C43 (DE3) 
F – ompT hsdSB (rB 
– mB 
–) gal dcm (DE3)  
(and further uncharacterized mutations) [195] 
University of 
Hohenheim, Stuttgart 
Pichia pastoris 
X-33 
wild-type 
 
Invitrogen, Carlsbad, 
CA, USA 
 
2.1.5 PCR and sequencing primers 
Table 2-3 – PCR and sequencing primers 
PRIMER FUNCTION SEQUENCE 
CKA_I101S_for 
 
QuikChange® primer RBK1 focused 
library (I101S mutation) 
5´- GGGTACCGCTACCAGCCT 
AATTGAAGAG -3´ 
CKA_I101S_rev QuikChange® primer RBK1 focused 
library (I101S mutation) 
5´- CTCTTCAATTAGGCGGTAGCGG
TACCC -3´ 
CKA_I101V_for QuikChange® primer RBK1 focused 
library (I101V mutation) 
5´- GGGTACCGCTACCGTTCTAATT
GAAGAG -3´ 
CKA_I101V_rev 
 
QuikChange® primer RBK1 focused 
library (I101V mutation) 
5´- CTCTTCAATTAGAACGGTAGCG
GTACCC -3´ 
CKA_I101T_for 
 
QuikChange® primer RBK1 focused 
library (I101T mutation) 
5´- GGGTACCGCTACCACCCTAATT
GAAGAG -3´ 
CKA_I101T_rev 
 
QuikChange® primer RBK1 focused 
library (I101T mutation) 
5´- CTCTTCAATTAGGGTGGTAGCG
GTACCC -3´ 
CKA_I113V_for 
 
QuikChange® primer RBK1 focused 
library (I113V mutation) 
5´- GGTGGCCAAAATAGGGTTTTG
ATTGTAGAAGG -3´ 
CKA_I113V _rev 
 
QuikChange® primer RBK1 focused 
library (I113V mutation) 
5´- CCTTCTACAATCAAAACCCTATT
TTGGCCACC -3´ 
CKA_I113T_for 
 
QuikChange® primer RBK1 focused 
library (I113T mutation) 
5´- GGTGGCCAAAATAGGACCTTG
ATTGTAGAAGG -3´ 
CKA_ I113T_rev 
 
QuikChange® primer RBK1 focused 
library (I113T mutation) 
5´- CCTTCTACAATCAAGGTCCTATT
TTGGCCACC -3´ 
Materials & Methods 59 
 
PRIMER FUNCTION SEQUENCE 
CKA_ T279S_for 
 
QuikChange® primer RBK1 focused 
library (T279S mutation) 
5´- GGTTGTTGATACTAGCGGAGCT
GGAGATAC -3´ 
CKA_ T279S_rev 
 
QuikChange® primer RBK1 focused 
library (T279S mutation) 
5´- GTATCTCCAGCTCCGCTAGTAT
CAACAACC -3´ 
CKA_ A319G_for 
 
QuikChange® primer RBK1 focused 
library (A319G mutation) 
5´- CATTCAAAGAAAAGGTGGTGC
TGAAAGCATGC -3´ 
CKA_ A319G _rev 
 
QuikChange® primer RBK1 focused 
library (A319G mutation) 
5´- GCATGCTTTCAGCACCACCTTTT
CTTTGAATG -3´ 
CKA_ A319S_for 
 
QuikChange® primer RBK1 focused 
library (A319S mutation) 
5´- CATTCAAAGAAAAGGTAGCGC
TGAAAGCATGC -3´ 
CKA_ A319S _rev 
 
QuikChange® primer RBK1 focused 
library (A319S mutation) 
5´- GCATGCTTTCAGCGCTACCTTTT
CTTTGAATG -3´ 
CKA_AtDIR6_for PCR amplification of the Atdir6 gene 
cloning into pET22b and pET32a 
5´- TTTCGTAAAACCATTGATCAGA
AAAAACCG -3´ 
CKA_AtDIR6_ 
HindIII_rev 
PCR amplification of the Atdir6 gene 
cloning into pET22b and pET32a 
5´- CCCAAGCTTATAGCATTCATAC
AGTTTAATATCC -3´ 
CKA_RBK1_ 
NdeI_for 
PCR amplification of gene for RBK1 
cloning into pET16b and pJOE 
5´- GGAATTCCATATGGGTATTACA
GTAATAGGTTC -3´ 
CKA_RBK1_ 
BamHI_rev 
PCR amplification of gene for RBK1 
cloning into pET16b 
5´- CGGGATCCTATGCATCTTTCTG 
- 3´ 
CKA_RBK1_ 
HindIII_rev 
PCR amplification of gene for RBK1 
cloning into pJOE 
5´- CCCAAGCTTCTATGCATCTTTCT
GAACATC -3´ 
CKA_pPICZ_Seq Sequencing of pPICZαA constructs 5´- CTGTTCTAACCCCTAC-3´ 
 
CKA_AtDIR6_ 
EcoRI_for 
Control of integration of the Atdir6 
gene in pPICZαA-AtDIR6 
5´- GGAATTCTTCAGAAAGACTATC
GACCAG -3´ 
CKA_AtDIR6_ 
XbaI_rev 
Control of integration of the Atdir6 
gene in pPICZαA-AtDIR6 
5´- GCTCTAGAGCGTAACACTCGTA
CAAC -3´ 
CKA_HiC_ 
EcoRI_for 
Control of integration of Hic gene in 
pPICZαA-HiC 
5´- CGGAATTCGGCGCAATCGAAA
AC -3´ 
CKA_HiC_ 
KpnI_rev 
Control of integration of Hic gene in 
pPICZαA-HiC 
5´- GGGGTACCTATGCGCGGATG -
3´ 
Mutation sites in QuikChange® primers are shown in italic letters. Restriction sites are shown 
in bold letters. 
 
2.2 Molecular- and microbiological methods 
2.2.1 Agarose gel electrophoresis 
Agarose gel electrophoresis was performed to separate DNA by size. Gels with an agarose 
concentration of 1% were run at 120 V for 35 min with 1x TAE buffer (40 mM Tris-acetate, 1 
mM ethylenediaminetetraacetate (EDTA)) as running buffer. For loading the DNA samples, 
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5x loading dye (40% sucrose, 2 g L-1 Orange G) was used. To determine the size of the DNA 
bands, 2.5 µL of a 1 kB DNA ladder (Generuler™ 1 kb DNA ladder, Fermentas, Germany) was 
loaded as a standard. GelRed™ (Biotium, Hayward, CA, USA) was used in a 1x concentration 
directly in the agarose gel to detect DNA under UV light. 
2.2.2 Plasmid DNA preparation 
The Zippy™ Plasmid Miniprep kit (Zymo Research, CA, USA) was used according to the 
manufacturer´s manual to purify recombinant plasmid DNA from E. coli. 5 mL of an E. coli 
overnight culture in LB supplemented with the according antibiotics were used for plasmid 
preparations. Plasmids were eluted with 30 µL of deionized water and analyzed by agarose 
gel electrophoresis. 
2.2.3 DNA restriction digests 
All restriction enzymes and buffers were acquired from and used under recommendations of 
Thermo Scientific (St. Leon-Rot, Germany) and New England Biolabs (Ipswich, MA, USA). 
Agarose gel electrophoresis was used to determine the result of the restriction digests.  
2.2.4 DNA gel extraction and PCR product purification 
The QIAquick® gel extraction kit from Qiagen (Hilden, Germany) was used according to the 
manufacturer´s manual to extract plasmid DNA and DNA fragments from an agarose gel. 
DNA was eluted from the columns using deionized water.  
The QIAquick® PCR purificiation kit from Qiagen (Hilden, Germany) was used according to 
the manufacturer´s manual to purify PCR products after restriction digests. DNA was eluted 
from the columns using deionized water. 
2.2.5 DNA ligation 
T4 DNA ligase obtained from Thermo Scientific (St. Leon-Rot, Germany) was used according 
to the manufacturer´s manual to ligate insert fragments into vectors cut with the 
corresponding restriction enzymes. The concentrations of the digested gene fragments and 
plasmids were measured using a NanoDrop 1000 (Thermo Fisher, MA, USA). For the ligation 
reactions, the insert to plasmid ratio was adjusted to a molar ratio of about three to one. 
The ligation reactions were carried out for about 1 h at room temperature.  
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2.2.6 Polymerase chain reaction 
Polymerase chain reaction was used to either amplify the genes for AtDIR6 (Atdir6) and RBK1 
(Rbk1) from the original vectors with new restriction sites, to control the integration of the 
pPICZαA_AtDIR6 construct into the P. pastoris genomic DNA or for QuikChange® 
mutagenesis to create the focused RBK1 library. The primers used are listed in Table 2-3. 
Amplification of Atdir6 from the original Geneart® (Regensburg, Germany) construct with 
primers CKA_AtDIR6_for and CKA_AtDIR6_HindIII_rev (see Table 2-3) for cloning into pET22b 
and pET32a vectors was performed according to the setup shown in Table 2-4. The PCR 
program used is shown in Table 2-5. The same setup was used for the amplification of Rbk1 
from pRN754 (DSM, Netherlands) with primers CKA_RBK1_NdeI_for and 
CKA_RBK1_BamHI_rev or CKA_RBK1_NdeI_for and CKA_RBK1_HindIII_rev for cloning into 
pET16b or pJOE, respectively (see Table 2-3). 
Table 2-4 – PCR setup for the amplification of the Atdir6 and Rbk1 genes 
VOLUME COMPONENT FINAL CONCENTRATION 
5 µL 10x Pfu buffer with MgSO4 1x 
1 µL dNTP mixture (10 mM) 0.2 mM 
1 µL Template DNA 0.1 ng µL-1 
10 µL Forward primer (1 pmol µL-1) 0.1 pmol µL-1 
10 µL Reverse primer (1 pmol µL-1) 0.1 pmol µL-1 
1 µL Pfu DNA polymerase (2.5 U µL-1) 0.05 U µL-1 
up to 50 µL ddH2O - 
 
Table 2-5 – PCR program for the amplification of the Atdir6 and Rbk1 genes 
CYCLES TEMPERATURE TIME FUNCTION 
1 95°C 2 min Initial denaturation 
35 95°C 
55°C (Atdir6) or 64°C (Rbk1) 
72°C 
0.5 min 
0.5 min 
1.5 min (Atdir6) or 
2.5 min (Rbk1) 
Denaturation 
Annealing 
Extension 
1 72°C 5 min Final extension 
   4°C  hold  
 
Integration of the Atdir6 gene via the respective pPICZαA constructs into the genome of 
P. pastoris was verified by PCR using the following setup. 
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Table 2-6 – PCR setup for the integration control of the Atdir6 gene 
VOLUME COMPONENT FINAL CONCENTRATION 
5 µL 10× Taq Reaction Buffer without MgCl2 1x 
1 µL dNTP mixture (10 mM) 0.2 mM 
1 µL Template DNA - 
10 µL Forward primer (1 pmol µL-1) 0.1 pmol µL-1 
10 µL Reverse primer (1 pmol µL-1) 0.1 pmol µL-1 
1 µL Taq DNA polymerase (5 U µL-1) 0.1 U µL-1 
3 µL MgCl2 (25 mM) 1.5 mM 
up to 50 µL ddH2O - 
The PCR program used is shown in the following table. 
Table 2-7 – PCR program for the integration control of the Atdir6 gene 
CYCLES TEMPERATURE TIME FUNCTION 
1 95°C 5 min Initial denaturation 
30 95°C 
55°C 
70°C 
1 min 
1 min 
1 min 
Denaturation 
Annealing 
Extension 
1 70°C 2 min Final extension 
   4°C  hold  
The PCR products were analyzed on an agarose gel. 
The focused library of RBK1 with single, double, triple, and quadruple amino acid exchanges 
was created by employing the QuikChange® method (Stratagene, CA, USA). For single 
mutants, the entire wild-type plasmid pJOE_RBK1 was synthesized via PCR with primers 
containing the chosen mutation (see Table 2-3). Double, triple, and quadruple mutants were 
subsequently created using the according single, double, and triple mutants as template. The 
mutation is located in the middle of the primers, thus allowing annealing despite the 
mismatch at the mutated positions. Forward and reverse primers, each complementary to 
opposite strands of the vector, were designed as reverse complements to each other. 
Subsequent to the synthesis, the product was treated with DpnI, an endonuclease specific 
for methylated and hemimethylated DNA (target sequence 5´-Gm6ATC-3´). DNA isolated 
from most E. coli strains including DH5α and XL-1 blue is dam methylated and therefore 
susceptible to DpnI digestion. Hence, the wild-type plasmid is digested, while the PCR 
product remains stable. 
Primers (see Table 2-3) were designed with regard to optimal melting temperature and 
E. coli codon usage. The QuikChange® PCR reaction for site-directed mutagenesis was 
performed according to the following setup. 
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Table 2-8 – QuikChange® PCR reaction setup 
VOLUME COMPONENT FINAL CONCENTRATION 
5 µL 10× PfuUltra™ II Reaction Buffer 1x 
1 µL dNTP mixture (10 mM) 0.2 mM 
1 µL Template DNA (50-100 ng) 1-2 ng µL-1 
5 µL 5´ forward primer (1 pmol µL-1) 0.1 pmol µL-1 
5 µL 3´ reverse primer (1 pmol µL-1) 0.1 pmol µL-1 
1 µL PfuUltra™ II Fusion HS DNA Polymerase - 
up to 50 µL ddH2O - 
The PCR program used is shown in the following table. 
Table 2-9 – QuikChange® PCR program 
CYCLES TEMPERATURE TIME FUNCTION 
1 95°C 0.5 min Hot start 
18 95°C 
50°C 
72°C 
0.5 min 
1 min 
4 min 
Denaturation 
Annealing 
Extension 
1 72°C 7 min Final extension 
   4°C  hold  
The PCR program was chosen after recommendations in the QuikChange® manual. Since 
PfuUltra™ II Fusion HS DNA Polymerase with an extension rate of about 2 kb min-1 was used, 
the extension step for the approximately 7.4 kb pJOE_RBK1 was set to 4 min. 
After the QuikChange® PCR, 1 µL DpnI (5 U µL-1) was added to each reaction, mixed, spun 
down briefly, and incubated for 2 h at 37°C. Subsequently, E. coli XL-1 blue cells (100 µL) 
were transformed with 10 µL of each reaction.  
The complete QuikChange® protocol, transformation of E. coli cells, subsequent plasmid 
preparations, and sequence verifications were performed by Dr. Sandra Facey, Melanie 
Allgaier and Silke Bastian (ITB, University of Stuttgart). 
2.2.7 Preparation of competent Escherichia coli cells 
Chemically competent E. coli cells were prepared using standard methods [196]. Briefly, 50 
mL of LB medium was inoculated with 0.5 mL of an E. coli overnight culture (5 mL of LB 
medium inoculated with the respective E. coli strain) and incubated at 37°C and 180 rpm. 
After the OD600 reached approximately 0.5 the culture was chilled on ice for 15 min. 
Afterwards the cells were centrifuged for 10 min at 3,220 g. The pellet was resuspended in 
20 mL TfBI buffer (30 mM potassium acetate, 100 mM rubidium chloride, 10 mM calcium 
chloride, 50 mM manganese chloride, 15% glycerol, adjusted to pH 5.8 with acetic acid and 
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sterile filtered with 0.2 µm filters) and again centrifuged for 10 min at 3,220 g. The pellet 
was now resuspended in 2 mL TfBII buffer (10 mM 3-(N-morpholino)propanesulfonic acid 
(MOPS), 75 mM calcium chloride, 10 mM rubidium chloride, 15% glycerol adjusted to pH 6.5 
with potassium hydroxide and sterile filtered with 0.2 µm filters) and incubated on ice for 15 
min. Aliquots of 200 µL were immediately frozen in liquid nitrogen and stored at -80°C until 
use. 
2.2.8 Heat-shock transformation of competent Escherichia coli cells 
Transformation of competent E. coli cells was performed using standard methods [196]. 
Briefly, competent E. coli cells were thawed on ice. Plasmid (1 µL) for retransformation or 
ligated vector (10 µL) was added to 100 µL of competent cells. The mixtures were gently 
mixed and incubated for 30 min on ice. After a heat-shock for 45 s at 42°C, the cells were 
chilled for 1 min on ice. 500 µL of LB was added and the cells were incubated for 45 min at 
37°C and 180 rpm. The cells were then centrifuged at 20,800 g for 1 min and plated onto LB 
plates with the appropriate antibiotics. The plates were incubated overnight at 37°C.  
2.2.9 Transformation of competent Pichia pastoris cells by electroporation 
Transformation of P. pastoris cells was performed according to the pPICZαA,B,C manual 
(Invitrogen, Carlsbad, CA USA).  P. pastoris X-33 was grown as an overnight culture in 5 mL of 
YPD in a 50 mL conical tube at 30°C. About 0.1-0.5 mL of the overnight culture was used to 
inoculate 200 mL of YPD medium in a 1 L baffled flask. This culture was again grown 
overnight to an OD600 of 1.3-1.5. The cells were then centrifuged at 1500 g for 5 min at 4°C. 
The pellet was resuspended in 200 mL of ice-cold (0°C), sterile water. Centrifugation and 
resuspension were repeated three times. The cells were then resuspended once in 100 mL of 
ice-cold (0°C), once in sterile water, once in 8 mL of ice-cold (0°C) 1 M sorbitol and eventually 
in 0.4 mL of ice-cold (0°C) 1 M sorbitol. Since the cells are not exceedingly stable and cannot 
be stored at -80°C, they were kept on ice and used for transformation immediately.  
80 µL of competent P. pastoris cells were mixed with linearized pPICZαA construct DNA (5-10 
µg) and transferred into an ice-cold (0°C) electroporation cuvette (Biorad, Hercules, CA, 
USA). The cuvette was then incubated on ice for 5 min. Subsequently, the cells were pulsed 
with 1.5 kV, 200 ohm and 25 µF. Immediately 1 mL of ice-cold 1 M sorbitol was added to the 
cuvette to stabilize the cells. The suspension was transferred to 15 mL Falcon tubes and 
incubated at 30°C without shaking for 2 h. The cells were centrifuged and plated on YPDS 
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plates containing 100 µg mL-1 Zeocin™. The plates were incubated for up to 5 d at 30°C. 
Colonies were picked and streaked out for single colonies on fresh YPDS plates containing 
100 µg mL-1 of Zeocin™. 
2.2.10 Isolation of genomic DNA of Pichia pastoris 
To confirm the transformation of P. pastoris X-33 with pPICZαA constructs, genomic DNA of 
P. pastoris was isolated. 10 mL of an overnight culture in YPD were centrifuged at 1500 g and 
4°C for 3 min. The pellet was resuspended in 500 µL of PBS (140 mM sodium chloride, 10 
mM potassium chloride, 6.4 mM disodium hydrogen phosphate, 2 mM potassium 
dihydrogen phosphate) containing 1 mg mL-1 proteinase K. After 20 min incubation at 65°C, 
500 µL of glass beads (mean average of 0.75-1.00 mm) were added. The tubes were then 
shaken for 30 min at 4 °C in a swing mill (MM 2000, Retsch, Germany). Subsequently, the 
glass beads and cell debris were centrifuged for 5 min at 20,800 g and 4°C. The supernatant 
was transferred into a new reaction tube, resuspended in 150 µL of TE (100 mM Tris at pH 
7.5, 10 mM EDTA) with 2% (w/v) SDS and incubated for 5 min at 65°C. Afterwards, 150 µL of 
5 M potassium acetate at pH 6.2 was added and the solution was incubated for 40 min on 
ice. The DNA was precipitated twice with isopropanol. Then, 200 µL of 3 M sodium acetate 
at pH 5.2 and 1 mL of isopropanol were added, incubated for 10 min at -80°C and 
centrifuged for 10 min at 20,800 g and 4°C. The pellet was dried and resuspended in 90 µL of 
deionized water. For the second precipitation, 9 µL 3 M sodium acetate and 90 µL 
isopropanol were added. The DNA was again precipitated at –80°C for 10 min and 
centrifuged as described above. The pellet was washed in 1 mL of 70% (v/v) ethanol. After 
another round of centrifugation, the pellet was dried in a Concentrator 5301 (Eppendorf, 
Hamburg, Germany) for 15 min at 45°C under vacuum. The pellet was finally resuspended in 
100 µL of TE with 400 µg mL-1 RNase A and incubated at 37°C for 30 min to degrade any 
contaminating RNA. 
2.2.11 Sequencing of plasmid constructs 
The sequences of all plasmid constructs were verified by DNA sequencing performed by 
GATC Biotech AG (Köln, Germany). Received sequences were checked with Multalin [197]. 
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2.2.12 Storage of Escherichia coli and Pichia pastoris strains 
For long-term storage, E. coli and P. pastoris strains were stored as glycerol stocks. For 
E. coli, a single colony of each strain was cultured overnight in 5 mL of LB and 750 µL of this 
culture was mixed with 750 µL of 60% sterile glycerol. For P. pastoris, a single colony of each 
strain was cultured overnight in 10 mL of YPD, harvested at 20,800 g, again resuspended in 
750 µL of YPD and mixed with 750 µL of sterile 60% glycerol. Cells were stored at -80°C until 
use.  
2.2.13 Cloning 
2.2.13.1 Humicola insolens cutinase 
The P. pastoris strain transformed with the pPICZαA_HiC construct containing the Humicola 
insolens cutinase gene was already available from a previous work [198]. The hic wild-type 
gene was cloned from pEF-Tu_HiC (kindly provided by Dr. Steffen Maurer, BASF) and 
subcloned into pPICZαA using restriction enzymes EcoRI and KpnI. P. pastoris X-33 was 
transformed as described for AtDIR6 (see 2.2.9). 
2.2.13.2 Arabidopsis thaliana dirigent protein 
The gene for AtDIR6 from Arabidopsis thaliana was obtained as a synthetic gene from 
GeneArt® (Regensburg, Germany) without the N-terminal secretion signal sequence and 
codon-optimized for E. coli and P. pastoris.  
The Atdir6 gene optimized for expression in P. pastoris was subcloned into pPICZαA using 
restriction enzymes EcoRI and XbaI generating the expression plasmid pPICZαA_AtDIR6. The 
open reading frame (ORF) was cloned without a stop codon allowing the fusion of a vector-
encoded C-terminal His6-tag sequence for protein purification. P. pastoris X-33 cells were 
transformed with SacI linearized pPICZαA_AtDIR6 (see 2.2.9) and genomic integration was 
verified (see 2.2.10). Cells were plated on YPDS agar plates containing Zeocin™ (100 µg mL–1) 
and incubated at 30°C for up to 5 d or until colonies were observed. 
The Atdir6 gene optimized for expression in E. coli was subcloned into pET16b and pET28a 
using the restriction enzymes NdeI and BamHI generating the N-terminal His10- 
(pET16b_AtDIR6) or His6-tag fusions (pET28a_AtDIR6), respectively. For generation of the 
pJOE_AtDIR6 construct, restriction enzymes NdeI and HindIII were used. For cloning into 
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pET22b and pET32a, the Atdir6 gene was amplified by PCR from the original GeneArt® 
(Regensburg, Germany) vector (see 2.2.6 and Table 2-3). To generate N-terminal translation 
fusions with a pelB leader (pET22b) and thioredoxin (pET32a), respectively, NcoI was used as 
a restriction site. However, the Atdir6 gene already contained an NcoI restriction site. 
Therefore, a 5´- blunt end ligation was performed. The vectors were cut with NcoI and 
HindIII, while the insert from PCR amplification was only cut with HindIII. The 5´overhang in 
the cut vectors was filled in using the Klenow fragment according to the manufacturer´s 
recommendations (Fermentas, Germany). After purification of vector and insert, the genes 
were ligated into pET22b resulting in a C-terminal His6-tag translational fusion with an N-
terminal pelB leader sequence (pET22b_AtDIR6) and an N-terminal translational fusion with 
thioredoxin-His6 (pET32a_AtDIR6). All sequences were verified by DNA sequencing (GATC 
Biotech AG, Köln, Germany) (see 2.2.11). Chemically competent E. coli strains were 
transformed using standard methods (see 2.2.8). Chaperone expression plasmids pG-Tf2, 
pTf16 and pG-KJE8 (Takara, Japan) were co-transformed with pET16b_AtDIR6. 
2.2.13.3 Saccharomyces cerevisiae ribokinase 
The gene for RBK1 from Saccharomyces cerevisiae was obtained as the construct pRN754 
(DSM, Netherlands). The gene was amplified from this plasmid using primers harboring NdeI 
and HindIII restriction sites. After restriction digest and purification of vectors and insert, the 
insert was ligated into pET16b and pJOE, respectively. RBK1 variants of the focused library 
were prepared with the QuikChange® protocol as described in 2.2.6. All sequences were 
verified by DNA sequencing (GATC Biotech AG, Köln, Germany) (see 2.2.11). Chemically 
competent E. coli strains were transformed using standard methods (see 2.2.8). 
 
2.3 Protein expression and purification 
2.3.1 Expression of AtDIR6 with Escherichia coli 
Expression of AtDIR6 in E. coli was performed in 50 mL of TB medium containing the 
appropriate antibiotics (e.g. 100 µg mL-1 ampicillin or 30 µg mL–1 kanamycin) in 500 mL 
Erlenmeyer flasks without baffles. Cultures were inoculated with overnight cultures of E. coli 
transformants to an OD600 of 0.05 and grown at temperatures ranging from 15°C to 37°C 
using a rotary shaker at 180 rpm. After reaching an OD600 of 0.4-0.6, the cultures were 
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induced with 0.1 mM to 1 mM isopropyl-β-D-thiogalactopyranosid (IPTG) for the pET series 
vector constructs or 0.5% (w/v) L-rhamnose for pJOE_AtDIR6, respectively. Expression of 
chaperones was induced for 4-24 h by the addition of the appropriate inducer (1 mg mL-1 L-
arabinose and/or 2 ng mL-1 tetracyclin) directly after inoculation of the main culture. For 
maintaining chaperone plasmids, 20 µg mL-1 chloramphenicol was added to the medium. For 
purification by fast protein liquid chromatography (FPLC), the E. coli cultures were 
centrifuged at 4°C with 11,000 g for 30 min and the pellet was resuspended in 100 mM 
potassium phosphate buffer at pH 6.0 containing 150 mM KCl. After addition of 0.2 mM of 
the protease inhibitor phenylmethanesulfonylfluoride (PMSF) the cells were disrupted by 
ultrasonification. The cell debris was centrifuged at 4°C with 34,400 g for 1 h and the lysate 
was filtered with 0.2 µm sterile filters before the purification procedure. 
2.3.2 Expression of HiC and AtDIR6 with Pichia pastoris 
For the expression of HiC and AtDIR6 in shaking flasks, selected transformants were 
inoculated in 10 mL of BMGY medium in 50 mL falcon tubes and cultivated at 30°C and 180 
rpm overnight. The precultures were used to inoculate 200 mL of BMMY medium to an 
OD600 of 0.5. Subsequently, the cultures expressing HiC and AtDIR6 were grown at 30°C and 
140 rpm in 1 L Erlenmeyer flasks with baffles for 3 d and 6 d, respectively. Methanol (100%) 
was added daily to a final concentration of 0.5% (v/v) to maintain induction. Cells were 
harvested by centrifugation at 4°C with 1,800 g for 15 min. The supernatants were 
concentrated and buffer exchanged to 100 mM potassium phosphate buffer at pH 6 
containing 150 mM potassium chloride at 4°C with a PALL Minimate™ tangential flow 
filtration capsule (PALL, Port Washington, NY, USA) with a 5 kDa nominal molecular mass 
limit. Further concentration was achieved by ultrafiltration using an Amicon stirred cell 
model 8050 (Merck Millipore, Schwalbach, Germany) with a 5 kDa nominal molecular mass 
limit membrane. 
2.3.3 Fed-batch fermentation of Pichia pastoris expressing AtDIR6 
For fed-batch fermentation, a 50 mL falcon tube with 10 mL of BMGY medium was 
inoculated with a single colony of strain P. pastoris pPICZαA_AtDIR6 and incubated at 30°C at 
180 rpm. After 24 h of growth, this preculture was used to inoculate 200 mL of BMGY 
medium in a 2 L Erlenmeyer flask with baffles and the cells were grown at 30°C and 180 rpm 
for 48 h. Following incubation, the cells were harvested by centrifugation (22°C, 1200 g, 
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5 min), washed with 200 mL of 100 mM potassium phosphate buffer at pH 6.0, centrifuged 
again, and finally resuspended in 20 mL of buffer. Fermentation was performed in a 7.5 L 
reactor (Infors, Bottmingen, Switzerland) containing 4 L basal salt medium (9.1 g L-1 K2SO4, 
7.5 L-1 MgSO4·7 H2O, 4.2 g L
-1 KOH, 0.47 g L-1 CaSO4·2 H2O, 8 mL L
-1  H3PO4 (85%), 50 g L
-1 
glycerol (87%), adjusted to pH 5 with NH4OH (28%)). Additionally, 0.87 mg L
-1 filter sterilized 
D-biotin, 4.35 mg L-1 PTM1 trace salt solution (6 g L
-1 CuSO4·5 H2O, 0.08 g L
-1 NaI, 3 g L-1 
MnSO4·H2O, 0.5 g L
-1 CoCl2, 20 g L
-1 ZnCl2, 0.02 g L
-1 H3BO3, 0.2 g L
-1 Na2MoO4·2 H2O, 65 g L
-1 
FeSO4·7 H2O, 0.2 g L
-1 D-biotin, 30 mL L-1 H2SO4 (6 N)) were added to the medium. The 
bioreactor was inoculated with the washed cells to an OD600 of 0.5 and the growth 
temperature was kept constant at 30°C for 24 h and subsequently shifted to 22°C. The pH 
was maintained at 5.0 using NH4OH (28%) and H3PO4 (10%). The airflow was maintained at 
8 L min-1 and the stirrer speed set to 800 rpm. After depletion of the initial 5% (v/v) glycerol, 
which was indicated by an abrupt increase in dissolved oxygen (DO), 20 mL of 0.6% (v/v) 
PTM1 in methanol was automatically added. During the fermentation process, a threshold of 
30% DO was used for automatic addition of methanol with a 2 h hold-off period before the 
next addition. Methanol consumption was monitored using a balance that was interfaced 
with the IRIS process control system (Infors, Bottmingen, Switzerland). The addition of 
Antifoam 204 (Sigma, Germany) was regulated by an antifoam electrode. Samples for OD600, 
cell wet weight (cww) and cell dry weight (cdw) measurements were taken daily. For OD600, 
samples were diluted appropriately in 0.9% (w/v) NaCl solution. For CWW, 10 mL samples 
were centrifuged (4°C, 1800 g, 5 min) and the pellet was washed once with 10 mL of 0.9% 
(w/v) NaCl solution. The sample was centrifuged again and the pellet was weighed. For CDW, 
10 mL samples were centrifuged (4°C, 1800 g, 5 min) and the pellet was washed once with 
10 mL of 0.9% (w/v) NaCl solution. The sample was centrifuged again and the pellet was 
incubated at 100°C till mass constancy was achieved and subsequently weighed. The 
fermentation with cells expressing AtDIR6 was performed twice and both fermentations 
proceeded comparably and were ended after 13 d. The culture broth was harvested and 
centrifuged (4°C, 1800 g, 15 min). The dirigent protein containing supernatant was filtrated 
by cross-flow filtration (Merck Millipore, Schwalbach, Germany) using a set-up according to 
the manufacturer´s instructions with a silicone membrane with a 10 kDa cut-off value (PALL, 
Port Washington, NY, USA). During this step, the buffer was exchanged to a 100 mM 
potassium phosphate buffer at pH 6 containing 300 mM KCl. 
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2.3.4 Expression of RBK1 with Escherichia coli 
Expression of RBK1 in E. coli was performed in 200 mL of TB medium containing 30 µg mL–1 
kanamycin in 1 L Erlenmeyer flasks without baffles. For maintaining the pRARE plasmid in 
E. coli Rosetta(DE3), 20 µg mL-1 chloramphenicol was added to the medium. Cultures were 
inoculated with overnight cultures of E. coli transformants to an OD600 of 0.05 and grown at 
20°C, 30°C or 37°C using a rotary shaker at 180 rpm. After reaching an OD600 of 0.4-0.6, the 
cultures were induced with 0.1 mM to 0.5 mM IPTG (pET16b_RBK1) or 0.5% (w/v) 
L-rhamnose (pJOE_RBK1), respectively. All RBK1 variants were expressed using pJOE vector 
constructs in E. coli C43(DE3) for 24 h at 30°C. For purification by FPLC, the E. coli cultures 
were centrifuged at 4°C with 11,000 g for 30 min and the pellet was resuspended in 100 mM 
potassium phosphate buffer at pH 7.5 containing 100 mM KCl. After addition of 0.2 mM of 
the protease inhibitor PMSF the cells were disrupted by using a homogenizer (Emulsiflex C5, 
Avestin, Mannheim, Germany). The cell debris was centrifuged at 4°C with 34,400 g for 1 h 
and the lysate was filtered via a 0.2 µm sterile filter before the purification procedure. 
2.3.5 Protein purification of AtDIR6 
The dirigent protein AtDIR6 was purified from concentrated fermentation supernatants and 
E. coli lysates using immobilized metal affinity chromatography (IMAC) on an Äkta Explorer 
FPLC system (GE Healthcare, Little Chalfont, United Kingdom). A Hitrap Chelating HP 5 mL 
column (GE Healthcare, Little Chalfont, United Kingdom) charged with Ni2+ was equilibrated 
with five column volumes (CV) of 100 mM potassium phosphate buffer at pH 6.0 containing 
300 mM KCl (buffer A). Samples of 30 mL were loaded onto the column at a linear flow rate 
of 3 mL min-1. Afterwards, the column was washed with four CV of buffer A containing 20 
mM imidazole. AtDIR6 was eluted from the column with a step gradient using four CV of 
buffer A containing 300 mM imidazole at a flow rate of 5 mL min-1. To remove residual 
protein, the column was washed with two CV of buffer A containing 500 mM imidazole. 
Protein-containing fractions from the elution step were detected by absorption 
measurements at 280 nm, pooled and desalted with PD10 columns (GE Healthcare, Little 
Chalfont, United Kingdom) using buffer A according to manufacturer´s instructions. 
Subsequently, samples were concentrated using Amicon Ultra 4 centrifugal filter units with a 
nominal molecular mass limit of 10 kDa (Merck Millipore, Schwalbach, Germany) to protein 
concentrations ranging from 5-8 mg mL-1.  
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2.3.6 Protein purification of RBK1 
The ribokinase RBK1 and all variants from the focused library were purified from E. coli 
lysates using IMAC on an Äkta Explorer FPLC system. A Hitrap Chelating HP 5 mL column 
charged with Ni2+ was equilibrated with three CV 100 mM potassium phosphate buffer at 
pH 7.5 containing 100 mM KCl (buffer B). Samples of 10 mL were loaded onto the column at 
a linear flow rate of 3 mL min-1. Afterwards, the column was washed with three CV of buffer 
B containing 15 mM imidazole. RBK1 and its variants were eluted from the column with a 
step gradient using four CV of buffer B containing 200 mM imidazole at a flow rate of 
5 mL min-1. To remove residual protein, the column was washed with two CV of buffer B 
containing 500 mM imidazole. Protein-containing fractions from the elution step were 
detected by absorption measurements at 280 nm, pooled and dialyzed against buffer B at 
4°C overnight using SpectraPor dialysis tubings with a nominal molecular mass limit of 6-8 
kDa (Spectrum Labs, Rancho Dominguez, CA, USA). 
2.3.7 Protein quantification 
Protein concentration was determined using the Bradford [199] or BCA assay [200] in a 
micro titer plate format. The absorption at 595 nm or 562 nm, respectively, was measured 
using a Spectramax 340PC micro titer plate reader (Molecular Devices, Sunnyvale, CA, USA). 
Each sample was measured in quadruplicates from individual dilutions and the standard 
deviation was always below 2%. Bovine serum albumin was used to establish standard 
curves. 
2.3.8 SDS-PAGE analysis 
Samples for SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) with cell 
extracts or purified proteins were mixed with 6x sample buffer (200 mM Tris pH 6.8, 600 mM 
dithiothreitol, 30% glycerol, 10% sodium dodecyl sulfate, 0.04% bromphenol blue) in a 1 to 5 
ratio and boiled at 95°C for 5-10 min. For SDS-PAGE analysis of proteins from growing 
cultures aliquots with 5x 108 cells (OD600 of 1 corresponding to 1 x 10
9 cells per mL) were 
centrifuged (14,000 g, 1 min). Cell pellets were resuspended in 50 µl of 2x sample buffer and 
boiled at 95°C for 5-10 min. 10 µl of these samples were applied to SDS-PAGE. Gels were run 
in a Hoefer SE 250 electrophoresis chamber (Hoefer, San Francisco, CA, USA) with SDS-PAGE 
running buffer (20 mM Tris pH 8.3, 190 mM glycine, 0.1% SDS) and stained with Coomassie 
Brilliant Blue R250 (2.5 g L-1 Coomassie Brilliant Blue R250, 30% methanol, 10% acetic acid). 
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Subsequently, gels were destained (30% methanol, 10% acetic acid) and documented on a 
Quantum ST 4 system (Vilber Lourmat, Eberhardzell, Germany).  
Densitometric analysis of SDS gels was performed using the ImageJ 1.45 software [201]. 
Background was substracted with a rolling ball filter (50 pixels). Relative amounts of purified 
protein and impurities as well as glycosylated and deglycosylated AtDIR6 species were 
calculated from band intensities obtained by peak integration. 
2.3.9  Western blot analysis 
For Western blot analysis a Trans-blot SD semi-dry transfer cell (Bio-Rad, Munich, Germany) 
was used for protein transfer onto nitrocellulose membranes (Pall, Port Washington, NY, 
USA). Rabbit polyclonal IgG directed toward AtDIR6 (Eurogentec, Seraing, Belgium) and 
mouse monoclonal IgG directed toward His6-tag (GE Healthcare, Little Chalfont, United 
Kingdom) were used as primary antibodies. Goat anti-mouse IgG-horseradish peroxidase 
(HRP) conjugate (Sigma, Germany) and goat anti-rabbit IgG-HRP conjugate (Sigma, Germany) 
were used as secondary antibodies for detection. All antibodies were used as 1:10,000 
dilutions in 10 mL of Tris-buffered saline with Tween® 20 (TBST, 25 mM Tris·Cl at pH 7.4, 150 
mM NaCl, 0.3 mM KCl, 0.1% Tween® 20) containing 5% non-fat milk powder. For 
visualization, blots were developed using the Amersham ECL Western blot analysis kit (GE 
Healthcare (Amersham Biosciences), Little Chalfont, United Kingdom) and analyzed using a 
Fusion SL image acquisition system (Vilber Lourmat, Eberhardzell, Germany). 
 
2.4 Biochemical characterization of AtDIR6 
2.4.1 Deglycosylation of AtDIR6 
Recombinant AtDIR6 from P. pastoris fermentations was enzymatically deglycosylated with 
PNGase F (New England Biolabs, Ipswich, MA, USA) according to the manufacturer´s 
protocol. To demonstrate that AtDIR6 is post-translationally glycosylated, 20 µg denatured 
AtDIR6 was incubated with 500 U of PNGase F at 37°C for 24 h and analyzed via SDS-PAGE. 
For further deglycosylation, additional 1,000 U of PNGase F were added to the samples, 
incubated for another 48 h, and analyzed via SDS-PAGE. For evaluation of dirigent activity 
after deglycosylation, 1 mg native AtDIR6 was incubated with 2,500 U PNGase F at 30°C for 
up to 24 h. Samples were taken after 0 h, 0.5 h, 1 h, 2 h, 4 h and 24 h of incubation and 
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subjected to SDS-PAGE analysis (5 µg) and dirigent activity assays (51 µg, see below). For 
solubility tests, 1 mg native AtDIR6 was incubated with 2,500 U PNGase F at 30°C for up to 
96 h. Samples were taken after 24 h, 48 h, 72 h and 96 h and centrifuged for 15 min at 
20,800 g and 4°C. Soluble and insoluble fractions were resuspended in appropriate amounts 
of sample buffer and subjected to SDS-PAGE analysis. 
2.4.2 Circular dichroism 
Circular dichroism (CD) was measured with the help of Dr. Uwe Gerken (University of 
Hohenheim, Stuttgart) with a Jasco J-715 spectropolarimeter (Jasco, Tokyo, Japan) using 
quartz cuvettes (Hellma AG, Müllheim, Germany). Protein samples of 1 mg mL-1 AtDIR6 and 
deglycosylated AtDIR6 were dialyzed against 5 mM potassium phosphate buffer (pH 6.0) 
containing 5 mM potassium chloride at 4°C. Samples were diluted to concentrations of 0.07, 
0.04, and 0.02 mg mL-1 for measuring CD spectra or titration with guanidinium hydrochloride 
(GndCl), respectively. 
CD spectra were recorded in the range of 190-260 nm with a scanning speed of 20 nm min-1 
and a step width of 1 nm using a quartz cuvette of 1 mm path length. A response time of 4 s 
and an excitation bandwidth of 2 nm were chosen to improve signal-to-noise ratio. Each 
spectrum was measured in triplicate and background corrected by subtracting a buffer blank 
spectrum. When necessary, the spectra were smoothed with the Savitzky-Golay filter. In 
order to compare spectra from different samples, all spectra were normalized to mean 
residue weight ellipticity (θMRW) [deg cm
2 dmol-1] with  
θMRW(λ) = θmdeg(λ)·MW·(n·c·d·10)
-1 
where θmdeg(λ) is the recorded ellipticity in millidegrees for a given wavelength, MW the 
molecular weight of the protein in Da, d the path length of the cuvette in centimeters, n the 
number of amino acid residues and c the sample concentration in mg mL-1. Calculations of 
the secondary structure were performed with the DICHROWEB server 
(http://dichroweb.cryst.bbk.ac.uk/html/home.shtml) [202,203] using a combination of the 
SP175short dataset [204] with the CDSSTR algorithm [205]. 
For chemical denaturation, AtDIR6 and deglycosylated AtDIR6 was titrated by adding small 
aliquots of 8 M GndCl and denaturation was followed at constant wavelength of 220 nm 
using a quartz cuvette of 5 mm path length (Hellma AG, Müllheim, Germany). Samples were 
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incubated with GndCl aliquots under constant stirring for 5 min at 20°C prior to measuring 
the ellipticity. The response time and excitation bandwith of the spectropolarimeter were 
set to the same parameters as mentioned above.  
All measurements were done in triplicate and the ellipticity values were corrected for 
dilution. 
2.4.3 Mass spectrometric analysis and glycan structure 
Glycosylated and deglycosylated AtDIR6 were subjected to SDS-PAGE analysis and the 
corresponding bands were cut out of the gel. Further steps were performed by Dr. Jens 
Pfannstiel (Proteomics Core Facility, Life Science Center, University of Hohenheim, Stuttgart) 
and are briefly summarized. 
Proteins were in-gel-digested using either trypsin or chymotrypsin (Roche, Penzberg, 
Germany) according to Shevchenko et al. [206]. For chymotryptic digests a modified 
incubation buffer was used (100 mM Tris-HCl, pH 7.6, 10 mM CaCl2). After digestion, the gel 
pieces were extracted with a mixture of 50% of acetonitrile and 50% of 0.1% formic acid 
(v/v) for 15 min. The supernatant was collected and the gel pieces were covered with 5% 
formic acid for 15 min before the same volume of acetonitrile was added. After incubation 
for 10 min the supernatant was collected. The pooled supernatants were then dried in a 
vacuum centrifuge and stored at -20°C. Dried samples were dissolved in 0.1% formic acid. 
Characterization of intact AtDIR6 and identification of AtDIR6 glycosylation sites by mass 
spectrometry was performed as described by Cedzich et al. [207]. 
2.4.4 Dirigent activity assay 
For assay of dirigent activity, recombinant AtDIR6 was used in the oxidative coupling of 
coniferyl alcohol catalyzed by Trametes versicolor laccase (Sigma, Germany) with molecular 
oxygen. The standard reaction condition consisted of 4 mM coniferyl alcohol, 5.7 µM 
laccase, and 4.2 µM AtDIR6 in 100 mM potassium phosphate buffer at pH 6 containing 
300 mM KCl. The reactions were incubated at 30°C with constant shaking at 500 rpm for 
15 min. Subsequently, substrate and products were extracted three times with 250 µl of 
ethyl acetate. The solvent was evaporated at 40°C for 1 h using a GeneVac EZ 2 plus 
evaporator (GeneVac, Gardiner, NY, USA). The residue was resuspended in 50 µl of 50% 
acetonitrile containing 0.01% formic acid and analyzed by high-performance liquid 
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chromatography (HPLC) (see below). In further experimental setups, concentration of 
coniferyl alcohol, AtDIR6 or laccase were varied in a range from 1-7 mM, 0-53 µM, and 
0.1-23 µM, respectively. Dirigent activity assays for each sample were done in triplicates. 
For comparison with the plant derived AtDIR6, molar concentrations of AtDIR6 from 
P. pastoris fermentations were calculated based on the molecular mass of the active 
homodimer, which slightly differs between plant- and Pichia-derived AtDIR6 due to the 
C-terminal His-tag. The molecular mass of the P. pastoris derived, His-tagged AtDIR6 and the 
untagged, native AtDIR6 homodimer as derived from S. peruvianum is 41.5 kDa and 
36.1 kDa, respectively. Although Pickel (2010) used the molecular mass of the glycosylated 
AtDIR6 homodimer expressed in S. peruvianum (40.8 kDa) for calculation of molar 
concentrations in the dirigent activity assay, here the molecular mass of the unglycoslated 
forms was used for the calculations to be able to compare AtDIR6 derived from both systems 
since the degree of glycosylation and therefore contribution to the molecular mass differs. 
2.4.5 HPLC analytics 
Reaction products from dirigent assays were first subjected to RP-HPLC in order to 
fractionate the pinoresinol peak. The analysis was carried out on an Agilent 1200 series HPLC 
system (Agilent, Santa Clara, CA, USA) equipped with an Agilent HPLC Zorbax Eclipse 
XDB-C18 column (150x4.6 mm, 5 µm particle size, Agilent, USA). A gradient of 10-40% 
acetonitrile containing 0.1% formic acid with a flow rate of 1 ml min-1 was used for eluation 
(10-27% from 0-20 min, 40% from 20-26 min, 10% from 26-35 min). A diode array detector 
(DAD; 1260 infinity diode array detector; Agilent, Santa Clara, CA, USA) was used for 
detection at 280 nm and 200-320 nm. The pinoresinol peak was fractionated and the solvent 
evaporated at 40°C for 1.5 h in a GeneVac EZ 2 plus evaporator (GenVac, Ipswich, United 
Kingdom). The residue was resuspended in 50 µl of chiral solvent (ethanol and hexane in a 
1:1 ratio, 0.1% formic acid). The enantiomeric composition of pinoresinol was analyzed by 
chiral HPLC using a Daicel Chiralpak IB column (150x4.6 mm, 5 µm particle size, Daicel Chiral 
Technologies, Illkirch, France) run isocratically in chiral solvent at 0.7 ml min-1 on an Agilent 
1200 series HPLC system with DAD. The enantiomeric excess of (-)-pinoresinol was 
calculated by integration of the peak areas of both enantiomers. Pure (+)-pinoresinol 
(ArboNova, Turku, Finland) was used as standard for RP-HPLC and chiral HPLC. 
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2.4.6 Analytical gel filtration 
Native molecular mass (MM) of AtDIR6 was determined by analytical gel filtration on a 
XK-16/100 Sephacryl S-200 HR column (GE Healthcare, Little Chalfont, United Kingdom) with 
an Äkta Explorer FPLC system (GE Healthcare, Little Chalfont, United Kingdom). The column 
(total bed volume Vt of 183 mL) was packed according to the manufacturer´s 
recommendations (maximum pressure 0.28 MPa), washed with 3 CV of deionized water and 
equilibrated with 3 CV of buffer C (100 mM potassium phosphate buffer pH 6, 100 mM NaCl) 
at a flow rate of 1.0 mL min-1. An AtDIR6 sample was buffer exchanged to buffer C using 
Amicon Ultra 4 centrifugal filter units with a nominal molecular mass limit of 10 kDa (Merck 
Millipore, Schwalbach, Germany). Three samples with a volume of purified AtDIR6 of 0.5 mL 
each and a concentration of about 10 mg mL-1 were applied in analytical gel filtration. The 
column void volume V0 was determined using blue dextran as the excluded solute. A gel 
filtration standard (Bio-Rad gel filtration standard kit, Bio-Rad, Munich, Germany) was run 
three times through the column and a calibration curve was generated by semi-logarithmic 
plotting of molecular mass (MM) versus the gel phase distribution coefficient (Kav). The Kav 
value of AtDIR6 was used to calculate its molecular mass using the established calibration 
curve. The Kav value was calculated according to the following formula, where Ve is the 
elution volume of the protein, V0 the column void volume and Vt the total bed volume [208]: 
    
     
     
 
 
2.5 Biochemical characterization and structure elucidation of RBK1 
2.5.1 Kinase activity assay 
Kinase activity was determined using a coupled NADH assay monitoring the oxidation of 
NADH to NAD+ at 340 nm (ε = 6,220 M–1 cm-1) (modified from [142]). In this assay, the ATP 
consumed in the kinase reaction is regenerated by the phoshphorylation of ADP to ATP 
catalyzed by pyruvate kinase using phosphoenolpyruvate. The generated pyruvate is then 
reduced to lactate by lactate dehydrogenase under oxidation of NADH (see Figure 2-1).  
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Figure 2-1 – Kinase activity assay. In the first step, ribokinase phosphorylates D-ribose to D-ribose-5-phosphate 
consuming the co-substrate ATP. In the coupled enzyme reactions, pyruvate kinase phosphorylates the 
generated ADP from the first step consuming phosphoenolpyruvate and yielding pyruvate. The pyruvate is then 
reduced to lactate in the last step of the coupled NADH assay by lactate dehydrogenase. The NADH oxidation in 
the last step can be measured spectrophotometrically at 340 nm. 
 
One unit of enzymatic activity was defined as the amount of free, soluble ribokinase that 
phosphorylated 1 µmol sugar substrate in 1 min at room temperature. Since the coupling to 
the NADH consumption is in a stoichiometric ratio, the reaction rate of the kinase 
corresponds to the reaction rate of the NADH oxidation in the coupled NADH assay. The 
basic setup of the assay included 10 mM sugar substrate, 1 mM ATP, 0.6 mM 
phosphoenolpyruvate, 0.5 mM NADH, 10 µl pyruvate kinase/lactate dehydrogenase mixture 
(Sigma Germany, 600-1,000 U and 9,000-14,000 U, respectively) and 30 nM to 5 µM RBK1 in 
a 1 mL reaction scale unless otherwise stated. The reaction was monitored 
spectrophotometrically in cuvettes using an Ultrospec 3100 pro spectrophotometer (GE 
Healthcare (Amersham Biosciences), Little Chalfont, United Kingdom). 
The reaction was optimized for the wild-type RBK1 in respect to magnesium, potassium and 
phosphate concentrations as well as pH value using different buffer compositions. 
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A temperature profile of the RBK1 activity at increased temperatures was recorded. 
Therefore, the enzyme was incubated at the respective temperature for 5 min in the 
reaction mixture prior to starting the reaction by substrate addition. All measurements at 
varying temperatures were performed in 100 mM potassium phosphate buffer at pH 6.0 
including 2.5 mM magnesium chloride. 
For analysis of enzyme stability, aliquots of wild-type RBK1 (5.5 mg mL-1) were incubated at 
22°C and 30°C for up to 24 h and at -20°C and 4°C for up to 8 weeks. Aliquots were tested at 
several time points and the enzyme was appropriately diluted prior to determination of 
activity versus D-ribose. All measurements for stability analysis were performed in 75 mM 
triethanolamine buffer at pH 7.5 including 5 mM potassium phosphate and 5 mM 
magnesium chloride. 
RBK1 variants from the focused library were initially screened for increased specific activity 
with 10 mM D-ribose and 50 mM D-xylose as substrates in 75 mM triethanolamine buffer at 
pH 7.5 including 5 mM potassium phosphate and 5 mM magnesium chloride. Selected 
variants were analyzed for their substrate specificity towards D-glucose, D-fructose, 
D-arabinose, L-arabinose, D-lyxose, D-erythrose, D-threose (50 mM each) and 
2-deoxy-D-ribose (10 mM) in 100 mM potassium phosphate buffer at pH 6 including 2.5 mM 
magnesium chloride. 
For kinetic data, activity of wild-type RBK1 and variants towards D-ribose were measured at 
concentrations from 0.1 µM to 20 mM D-ribose. Furthermore, kinetic data with varying 
concentrations of the co-substrate ATP (0.05 µM to 5 mM), D-xylose (1 mM to 500 mM), 
D-glucose (0.01 mM to 100 mM) and 2-deoxy-D-ribose (1 mM to 500 mM) were collected. 
For the Km determination of ATP, the concentration of D-ribose was held constant at 10 mM 
D-ribose. For the Km determination of D-ribose, 2-deoxy-D-ribose, D-xylose and D-glucose, the 
concentration of ATP was held constant at 1 mM. All measurements for kinetic data were 
performed in 100 mM potassium phosphate buffer at pH 6.0 including 2.5 mM magnesium 
chloride. Apparent kinetic constants Km and kcat were calculated using Origin Pro 8.5 from 
the non-linear regression of the Michaelis-Menten plots. 
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For 2-deoxy-D-ribose, D-xylose and D-glucose, the data was fitted to the equation:  
   
       
(      )
 
The Michaelis-Menten model basically describes an enzyme-catalyzed reaction with the 
conversion of a single substrate into a product. However, it can also describe the rate of a 
multi-substrate reaction as long as the dependency of only one substrate is studied and the 
other substrate is kept constant at a saturating concentration [209]. Here, v0 is the initial 
velocity, vmax the maximal velocity for infinite substrate concentrations, Km the Michaelis-
Menten constant and [S] the substrate concentration. 
For ATP and D-ribose, the data was fitted to the following equation: 
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This equation describes the rate of a reaction with substrate inhibition at higher substrate 
concentrations due to a second substrate molecule acting as an uncompetitive inhibitor 
binding to the enzyme-substrate complex. Here, Kiu is the inhibitory constant for the 
uncompetitive competition. 
2.5.2 Biotransformations with RBK1 
RBK1 wild-type and variants were employed in biotransformations with D-ribose, D-xylose 
and D-glucose. The basic setup was in a 0.5 mL scale including 5 mM sugar substrate, 2 mM 
ATP and 30 nM to 3 µM enzyme in 100 mM potassium phosphate buffer at pH 6.0 with 2.5 
mM magnesium chloride. The samples were incubated at 30°C for 10 min to 60 min at 750 
rpm in a Thermomixer comfort (Eppendorf, Hamburg, Germany). Aliquots of 100 µL were 
taken after addition of the enzyme and after 10 min to 60 min. The reactions were stopped 
by addition of 6 µL sulfuric acid (1 M) and spun down briefly at 20,800 g. The samples (100 
µL) were transferred into glass vials and analyzed by HPLC. 
The dependency of RBK1 activity on mono- and divalent cations was analyzed in 
biotransformations with D-ribose. For monovalent cation dependency, biotransformations 
were performed in 100 mM Tris buffer at pH 6.0 with 2.5 mM magnesium chloride. 
Monovalent cations tested were potassium, sodium, ammonium, cesium, lithium, rubidium 
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(each as the respective chloride salt) at a concentration of 100 mM. Additionally, the 
reaction was performed without monovalent cations. Here, 1 µM RBK1 wild-type, which was 
purified by size exclusion chromatography (see 2.5.4) and buffer exchanged to 10 mM Tris at 
pH 7.5 was used in these reactions. Samples were taken after 0 min and 45 min and 
processed as described above. 
For divalent cation dependency, biotransformations with ribose were performed in 100 mM 
potassium phosphate buffer at pH 6.0. Divalent cations tested were magnesium, manganese 
and calcium (each as the respective chloride salt) at a concentration of 2.5 mM. Additionally, 
the reaction was performed without divalent cations. In all cases, 30 nM RBK1 wild-type 
from IMAC purification was used. Samples were taken after 0 min and 10 min and processed 
as described above. 
Further biotransformations with D-ribose were performed with varying concentrations of the 
pentavalent anion phosphate in 100 mM Tris pH 6.0 with 2.5 mM magnesium chloride. Here, 
potassium phosphate was used and the potassium concentration was always 100 mM by 
addition of potassium chloride. Samples were taken after 0 min and 10 min and processed as 
described above. 
2.5.3 HPLC and LC/MS analytics 
The analysis of biotransformations with RBK1 was carried out on an Agilent 1200 series HPLC 
system (Agilent, Santa Clara, CA, USA) equipped with an Aminex HPX-87H column (300 x 
7.8 mm, 9 µm particle size, Bio-Rad, Munich, Germany). Eluation was achieved with 5 mM 
sulfuric acid as solvent run in an isocratic mode at 0.5 or 0.7 mL min-1 flow rate for 25 or 15 
min, respectively, at 60°C. The injection volume was 10 µL. A refractive index detector (RID; 
1260 infinity refractive index detector; Agilent, Santa Clara, CA, USA) was used for detection 
of substrates and products. Additionally, a DAD (1260 infinity diode array detector; Agilent, 
Santa Clara, CA, USA) was used for detection of ATP and ADP at 254 nm. All substrates and 
products were validated by their retention time in comparison to standard substances. The 
conversion of substrates and generation of products was calculated by integration of the 
peak areas from detection with RID and DAD in comparison to standard curves. Standards 
were measured and standard curves were generated for D-ribose, D-xylose and D-glucose 
(2.6 mM to 5.4 mM, refractive index detection) as well as ATP and ADP (0.4 mM to 2.4 mM, 
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diode array detection). All standard curves showed excellent linearity with r2 values of 
minimum 0.99. 
The reaction products D-ribose-5-phosphate, D-xylose-5-phosphate, and D-glucose-6-
phosphate were qualitatively validated by analysis of the biotransformations by mass 
spectrometry using an LC/MS system (Agilent 1260 Infinity series with a 6130 quadrupole 
MS system). Biotransformations for LC/MS analysis were performed in the MS compatible 
buffer ammonium acetate at pH 5.8 with 2.5 mM magnesium chloride and 20 mM potassium 
chloride. Fractionation was achieved using an Aminex HPX-87H column with 0.1% formic 
acid as solvent at a flow rate of 0.7 mL min-1 for 15 min at 60°C. The injection volume was 
10 µL. Besides detection of ATP and ADP at 254 nm by DAD, a mass spectrometer (MSD) was 
used as detector of reaction products. The following ESI (electrospray ionization) parameters 
were used: The drying gas temperature was set to 350°C, the drying gas flow to 10.0 L min-1, 
the nebulizer pressure to 35 psig, the capillary voltage to +/- 3000 V and the fragmentor 
voltage to 70 eV. Mass spectrometric data was acquired in positive and negative scan mode 
from m/z 100 to 300. Additionally, negative SIM mode was used to aquire data of the 
reaction products D-ribose-5-phosphate (229 m/z), D-xylose-5-phosphate (229 m/z) and 
D-glucose-6-phosphate (259 m/z). The retention times and mass spectra of the substrates 
and reaction products were compared to standard substances.  
2.5.4 Size exclusion chromatography 
Further purification of IMAC purified RBK1 for crystallization and native molecular mass 
determination was performed by size exclusion chromatography (SEC) on a XK-16/100 
Sephacryl S-200 HR column (GE Healthcare, Little Chalfont, United Kingdom) with an Äkta 
Explorer FPLC system (GE Healthcare, Little Chalfont, United Kingdom). The column (total 
bed volume Vt of 183 mL) was packed according to the manufacturer´s recommendations 
(maximum pressure 0.28 MPa) and validated using an aceton standard. Therefore, the 
column was washed with 3 CV of deionized water. An acetone sample (200 µL, 2%) was 
injected and the column was run at a flow rate of 1.0 mL/min. For a measure of column 
efficiency, the number of theoretical plates (N) was calculated with the following formula, 
where Ve is the peak elution volume (in mL), W1/2 the peakwidth at half peak height (in mL) 
and L the total bed height (in mm) [208]: 
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Additionally, the peak symmetry As was calculated where a is the first half peak width at 10% 
peak height and b the second half peak width at 10% peak height: 
   
 
 
 
For the Sephacryl S-200 HR resin applied for this column these values should be N > 9,000 
and As = 0.80 - 1.50. 
For purification, the column was equilibrated with 3 CV of buffer D (20 mM Tris pH 7.5, 150 
mM sodium chloride) at a flow rate of 1.0 mL min-1. An RBK1 sample was buffer exchanged 
to buffer D using Amicon Ultra 4 centrifugal filter units with a nominal molecular mass limit 
of 10 kDa (Merck Millipore, Schwalbach, Germany). Three samples with a volume of purified 
RBK1 of 2 mL each and a concentration of about 8.5 mg mL-1 were applied in gel filtration 
chromatography. Protein containing fractions detected with UV at 280 nm were collected.  
Furthermore, the native molecular mass of RBK1 was determined by analytical gel filtration 
using the same column. The Kav value of RBK1 was compared to the values of standard 
proteins as described for AtDIR6 in 2.4.6. 
2.5.5 Crystallization of RBK1 
For crystallization screening, RBK1 samples from SEC purification were buffer exchanged to 
10mM Tris buffer at pH 7.5 and concentrated to 10 mg mL-1 and 20 mg mL-1 using Amicon 
Ultra 4 centrifugal filter units with a nominal molecular mass limit of 10 kDa (Merck 
Millipore, Schwalbach, Germany). Samples were then filtrated using centrifugal filter units 
with a pore size of 0.22 µm (Merck Millipore, Schwalbach, Germany) and stored for 
shipment at 4°C. An initial crystallization screening was performed by Dr. Jürgen Kopp at the 
Protein crystallization platform of the “Biochemie-Zentrum der Universität Heidelberg” 
(University of Heidelberg, Germany). Prior to crystallization, RBK1 was mixed with 10 mM D-
ribose and 10 mM AMP-PNP as ligands. A liquid handling system was used to dispense sitting 
drops of 384 non redundant conditions and plates were incubated at 18°C. Several 
conditions yielded protein crystals suitable for diffraction studies. Additionally, the 
“Optimizer and Additive” screen was performed to obtain crystals of higher quality. Based 
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on the results from the initial screening, a home-made fine screen was performed at the 
University of Hohenheim, Stuttgart, with PEG3350 concentrations varying between 18 to 
23% containing 200 mM or 400 mM potassium citrate, potassium fluoride, or potassium 
sulfate, respectively. RBK1 was incubated using the sitting drop method at a final 
concentration of 3.3 mg mL-1 with 5 mM AMP-PNP and 25 mM D-ribose or D-xylose at 18°C. 
Additionally, the protein was incubated in the apo form without substrates.  
For data collection, crystals were mounted on cryoloops and flash-frozen in liquid nitrogen. 
Native datasets were recorded at 100 K using a rotation angle of 0.15° per image on a 
Pilatus 6M detector at beamline ID29 of the European Synchrotron Radiation Facility (ESRF) 
in Grenoble, France (Dr. Daniele de Sanctis, ESRF, and Dr. Domenico Lupo, University of 
Hohenheim). 
 
2.6 Biochemical characterization and biotechnological use of Humicola 
insolens cutinase 
2.6.1 Cutinase activity assay 
Cutinase activity was determined using para-nitrophenyl (pNP) esters of butyrate, octanoate 
and palmitate. Activity was measured by absorbance increase at 410 nm (ε = 13,200 M–1 
cm-1) due to free para-nitrophenol using an Ultrospec 3100 pro spectrophotometer (GE 
Healthcare (Amersham Biosciences), Little Chalfont, United Kingdom). The assay consisted of 
800 µL Tris buffer (100 mM Tris pH 7.5 with 0.5% Triton X-100 and 0.1% gum arabic), 100 µL 
substrate (2.5 mM pNP ester in 100% DMSO) and 100 µL cutinase solution. One unit of 
enzymatic activity was defined as the amount of free, soluble cutinase that releases 1 µmol 
of para-nitrophenol in 1 min at room temperature. For kinetic data, activity of HiC towards 
pNP esters was measured at concentrations of 10 µM to 10 mM for pNPP and of 10 µM to 
2 mM for pNPB and pNPO, respectively. Apparent kinetic constants KM and kcat were 
calculated using Origin 8.0 from the non-linear regression of the Michaelis-Menten plots. 
Standard deviations were calculated from at least three individual measurements and were 
below 6.2%.  
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Figure 2-2 – Cutinase activity measurement with the para-nitrophenol assay. Hydrolysis of para-nitrophenyl 
ester yields fatty acid and free para-nitrophenol leading to an absorbance increase at 410 nm. 
2.6.2 Immobilization of HiC 
HiC was immobilized onto microporous resin Diaion HP20 (average particle size 440 µm, 
30 nm pore radius) with an enzyme loading of 1% (w/w) or 4.5 µmol HiC. The resin was 
degreased using ethanol (100%) and dried under vacuum for 24 h at room temperature prior 
to use. Three mg of HiC were diluted in immobilization buffer (50 mM potassium phosphate 
buffer pH 7.8 containing 25% ethanol) to a final concentration of 0.25 mg mL–1. Afterwards, 
300 mg Diaion HP20 was added and the solution was incubated at 4°C for 24 h under 
constant agitation. Subsequently, the immobilisate was recovered by filtration, washed 
twice with 15 mL of potassium phosphate buffer (50 mM, pH 7.8) and dried in a desiccator 
over silica gel for 72 h at room temperature to achieve a low water activity aw towards 0. The 
immobilisate was stored at 4°C. 
2.6.3 Transesterification reactions with HiC 
In the standard reaction setup methyl acrylate (300 µL, 10.3 M) as donor of the acrylic group 
and sole solvent, 6-mercapto-1-hexanol (20 µL, 275 mM) and 10 mg immobilisate (1% (w/w) 
enzyme loading; 4.5 µmol HiC) were applied. Reactions were carried out in screw-capped 
glass vials under constant shaking (700 rpm) at a temperature of 40°C and a water 
concentration of 0.025% (w/w) for up to 24 h. The influence of the radical inhibitor butylated 
hydroxytoluol (BHT) was tested by adding BHT (3-15% (w/w) acrylic ester, 0.14-0.71 M) to 
the standard reaction. For the substrate specificity in transesterifications, methyl propionate 
was additionally used as acyl donor. 
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2.6.4 GC/MS analysis 
Samples (50 µL) from transesterifications were centrifuged for 1 min at 20,800 g, diluted in 
1 mL diethyl ether dried over MgSO4 (anhydrous) and analyzed by GC/MS measurements. 
GC/MS analysis was carried out on a Shimadzu GCMS-QP2010 (equipped with a 
FS-Supreme-5 column length 30 m, internal diameter 0.25 mm) using helium as carrier gas. 
The following GC program was used: 70°C for 1 min, 15°C min–1 to 280°C, 30°C min–1 to 
310°C. Standard curves for substrates were generated and conversion of mercaptoalcohols 
was calculated from the peak area ratios of mercaptoalcohols and products. 
Transesterification products were identified by their characteristic MS fragmentation 
patterns. 
2.6.5 Product purification and identification by NMR and FT-IR 
For the identification of the main product (6-mercaptohexyl acrylic ester) by nuclear 
magnetic resonance (NMR) and FT-IR (Fourier transform infrared) spectroscopy an upscaled 
reaction was performed. Methylacrylate (3 mL, 10.3 M) was incubated with 200 µL of 
6-mercapto-1-hexanol (275 mM), 50 mg HiC immobilisate and 0.025% (w/w) water at 40°C 
for 24 h using a reflux condenser. 6-mercaptohexyl acrylic ester was purified using silica 
column chromatography with a mobile phase of hexane and diethyl ether in a 10 to 4 ratio. 
To determine the product containing fractions, TLC was performed with the same mobile 
phase and potassium permanganate solution was used to visualize the compounds. The 
solvent from product containing fractions was evaporated using a Rotavapor R-200 
evaporator (Büchi, Essen, Germany) and the substance was dissolved in deuterated 
chloroform containing 1% (v/v) tetramethylsilane (TMS) for NMR measurements. The 
structure was confirmed by 1H (500 mHz) and 13C (125 MHz) NMR measurements and FT-IR 
The NMR measurements were performed by the service unit of the Institute of Organic 
Chemistry (University of Stuttgart) and the spectra were interpreted with the help of 
Dr. Holger Beuttler (Institute of Technical Biochemistry, University of Stuttgart). 
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3. Results 
3.1 Optimized expression of the dirigent protein AtDIR6 in Pichia pastoris 
and impact of glycosylation on protein structure and function 
Recently, the expression and initial characterization of the dirigent protein (DIR) AtDIR6 from 
Arabidopsis thaliana was reported [109]. In the presence of laccase and molecular oxygen, 
this protein was shown to exhibit a novel dirigent activity, mediating the formation of (-)-
pinoresinol from coniferyl alcohol. Although a hypothesis based on detailed biochemical 
studies of FiDIR1 was proposed, the exact reaction mechanism is still elusive 
[95,104,111,112]. Up to now, all characterized DIRs were either extracted from plant 
material or expressed in systems based on higher organisms such as plant and insect cell 
cultures, yielding only up to 200 µg per L of culture [95,105,108,109]. Initial trials with E. coli 
as expression host resulted only in insoluble expression and the formation of inclusion 
bodies [210]. 
The aim of this case study was the heterologous expression of the dirigent protein AtDIR6 in 
biotechnologically established expression hosts like Escherichia coli (E. coli) or Pichia pastoris 
(P. pastoris) to obtain high yields of the protein for further characterization or possible 
biotechnological use. Furthermore, the biochemical characterization especially with respect 
to the dirigent activity of AtDIR6 and the impact of glycosylation on protein structure, 
solubility and function was investigated. 
3.1.1 Heterologous expression of AtDIR6 with Escherichia coli 
In a recent study, it has been shown that AtDIR6 could not be expressed in soluble form 
using a pET21a construct under the control of the IPTG inducible T7 promoter in E. coli 
BL21(DE3) or Rosetta-gami B(DE3) [210]. Neither lowering expression temperature from 
30°C to 4°C nor refolding of purified, insoluble AtDIR6 yielded soluble protein. It was 
hypothesized that the glycosylation might influence the soluble expression and possibly also 
the aggregation propensity of the protein. A more systematic evaluation regarding E. coli as 
a heterologous expression system was necessary to exclude E. coli as a viable alternative for 
the expression of dirigent proteins. Therefore, several strategies for a soluble expression in 
E. coli were tested. 
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Since the synthetic Atdir6 gene was optimized for E. coli in terms of codon usage, E. coli 
strains like Rosetta (Merck, Darmstadt, Germany), which can substitute for rare tRNAs [211], 
were not required. Initial expressions were performed using the standard E. coli BL21(DE3) 
expression strain as well as the BL21(DE3) derivatives C41(DE3) and C43(DE3) [195] at a 
temperature of 37°C. In these initial experiments, the formation of a band at about 19 kDa 
was observed during SDS-PAGE analysis (see Figure 3-1) and identified as AtDIR6 by Western 
blot analysis using the primary AtDIR6 or His6-tag antibodies (data not shown). AtDIR6 was 
therefore readily expressed in E. coli BL21(DE3) (see Figure 3-1a) as well as C41(DE3) and 
C43(DE3) (data not shown) strains either as N-terminal His10 or C-terminal His6 fusion protein 
using the pET16b or pET28a constructs, respectively. However, in all attempts, AtDIR6 could 
only be found in the insoluble fraction after cell lysis. 
 
Figure 3-1 – Comparison of the expression of AtDIR6 in E. coli BL21(DE3) and Origami B(DE3) hosts by SDS-
PAGE analysis. (a) Expression of AtDIR6 with E. coli BL21(DE3) at 37°C. Control: pET16b vector control without 
Atdir6 gene; pET16b: expression with pET16b_AtDIR6 construct; pET28a: expression with pET28a_AtDIR6 
construct. The white arrows indicate the protein band at about 19 kDa identified as AtDIR6 by Western blot 
analysis (data not shown). (b) Expression of AtDIR6 with E. coli BL21(DE3) and Origami B(DE3). Origami B: 
expression with E. coli Origami B(DE3) pET16b_AtDIR6; pET22b: expression with E. coli BL21(DE3) 
pET22b_AtDIR6; pET32a: expression with E. coli BL21(DE3) pET32a_AtDIR6. The white arrows indicate the 
protein identified as AtDIR6 by Western blot analysis (data not shown). The black arrow indicates the 
thioredoxin-AtDIR6 fusion protein at about 38 kDa. Lane abbreviations: Soluble: soluble protein fraction after 
cell lysis; total: total protein fraction from expression culture; insoluble: insoluble (pellet) fraction after cell 
lysis. 15 µg of total protein was loaded in each lane. Lanes M represent molecular size markers. Molecular size 
is indicated in kDa in lanes M. 
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Variation of expression parameters such as inducer concentration (0.01 mM to 1 mM IPTG) 
or temperature (15°C to 37°C) did not result in increased solubility of AtDIR6. To rule out 
problems with the strong T7 promoter used in the pET series vectors, AtDIR6 was expressed 
with E. coli BL21(DE3) using a rhamnose-inducible pJOE construct under the control of the 
rhamnose promoter [212–214]. However, no detectable change in expression strength or 
solubility was found (data not shown).  
As already described in the introduction, a homology model of AtDIR6 based on the crystal 
structure of an allene oxide cyclase was recently established indicating a possible disulfide 
bond connecting the N- and C terminus, which was then verified by mass-spectrometric data 
[110]. To facilitate the formation of this disulfide bond during expression with E. coli, AtDIR6 
was expressed as pET22b construct in BL21(DE3) or as pET16b construct in Origami B(DE3). 
While the pET22b construct allowed targeting of the protein into the periplasm in a Sec-
dependent fashion via the PelB leader to provide an oxidative environment for disulfide 
bond formation, Origami B(DE3) already provides an oxidative cytoplasm due to various 
mutations. Again, AtDIR6 was strongly expressed, but not found in the soluble fraction (see 
Figure 3-1b). 
Another possibility to enhance soluble protein production is to fuse the target protein to 
other, highly soluble proteins like maltose binding protein or thioredoxin (Trx) [42–44]. Using 
a pET32a construct, AtDIR6 was expressed as C-terminal fusion to Trx-His6 in E. 
coli BL21(DE3) and Origami B(DE3). A band at about 38 kDa corresponding to the expected 
size of the fusion protein was observed. Despite the high solubility of Trx alone, the Trx-
AtDIR6 fusion was found in the insoluble fraction (see Figure 3-1b). Western blot analysis 
verified that not even small amounts of the fusion protein were obtained as soluble protein 
(data not shown).  
To explore the effect of increased chaperone activity in E. coli on the expression and correct 
folding of AtDIR6, some of the commercially available Takara chaperone plasmids (Clontech, 
USA) were used (see Figure S 6, Figure S 7 and Figure S 8). Directly after inoculation, E. coli 
Origami B(DE3) cultures were induced with the appropriate inducer for co-expression of 
chaperones DnaK-DnaJ-GrpE and/or GroES-GroEL, GroES-GroEL-TF or TF alone from pG-KJE8, 
pG-Tf2 or pTf16, respectively. Chaperone expression, especially for GroEL (about 60 kDa) and 
TF (about 48 kDa), was visible from SDS-PAGE analysis. Depending on the expression 
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parameters, AtDIR6 expression was weak and often only visible in Western blot analysis 
(data not shown). Figure 3-2 shows the results of the SDS-PAGE and Western blot analysis 
from the co-expression of DnaK-DnaJ-GrpE from pG-KJE8 and AtDIR6 from the pET16b 
construct. Here, the co-expression of chaperones did result in soluble AtDIR6 for the first 
time as verified by Western blot analysis, albeit only in very low amounts not clearly visible 
in the SDS-PAGE analysis (see Figure 3-2a). In order to gain substantial amounts of AtDIR6 
expressed in E. coli for further biochemical characterization, a larger cultivation, expression, 
and purification procedure was performed. E. coli Origami B(DE3) cultures were inoculated 
to an OD600 of 0.05, induced with 0.5 mM IPTG at an OD600 of about 0.5 after 2 d, and 
harvested at an OD600 of about 3 after 6 d. Cells were lysed and directly purified with Ni-NTA 
chromatography. Lysate from 1 L cell culture yielded approximately 40 µg AtDIR6 after Ni-
NTA chromatography. In addition to these low amounts of soluble form, the protein was still 
only partially pure as seen in Figure 3-2b.  
 
Figure 3-2 – Expression of AtDIR6 in E. coli Origami B(DE3) with the co-expression of chaperones DnaK, DnaJ 
and GrpE and purification of AtDIR6. (a) Expression of AtDIR6 was analyzed by SDS-PAGE and Western 
blotting. Lanes total and soluble represent the total protein fraction from expression cultures and the soluble 
protein fraction after cell lysis, respectively. Fifteen micrograms of total protein was loaded in each lane. (b) 
Purification of AtDIR6 by Ni-NTA chromatography. For SDS-PAGE analysis (lane 1), 5 µg of purified AtDIR6 was 
used. For Western blot analysis (lane 2), 0.2 µg of purified AtDIR6 was used. For the control, 5 µg of total 
protein with insoluble AtDIR6 from a previous expression was used. Lane abbreviations: Lanes M represent a 
size marker. Protein bands are marked with their respective molecular weight in kilodaltons (kDa). The white 
arrows indicate the protein band at about 19 kDa identified as AtDIR6 by Western blot analysis. 
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3.1.2 High yield fed-batch fermentation of AtDIR6 with Pichia pastoris 
Due to the problems with the expression in E. coli, P. pastoris was investigated as an 
alternative expression host. Dirigent proteins were found to be N-glycosylated in planta 
[105] as well as in insect [108] and plant cell expression hosts [109,110] at two N-
glycosylation sites. Thus, the most obvious advantage with P. pastoris is the ability for 
glycosylation of recombinant proteins, although this glycosylation might vary strongly from 
the original pattern in the natural organism [36].  
Initial experiments were performed in Erlenmeyer flasks at 30°C and 180 rpm up to 6 d. The 
gene of AtDIR6 was fused to the alpha-mating factor pre-pro leader sequence (α-MF) from 
Saccharomyces cerevisiae in the pPICZαA construct. This allows the secretion of the dirigent 
protein into the medium. After concentration of the supernatant, several bands could be 
identified by SDS-PAGE analysis (Figure 3-3a). Surprisingly, none of these bands was 
detected at the size of unglycosylated AtDIR6 of about 21 kDa when expressed from the 
pPICZαA_AtDIR6 construct in P. pastoris. However, the band at about 33 kDa was identified 
as AtDIR6 by Western blot analysis using anti-AtDIR6 primary antibodies (Figure 3-3a). 
Additionally, an indistinct signal at about 15 kDa was visible. 
 
Figure 3-3 – SDS-PAGE and Western blot analysis of the AtDIR6 expression, fermentation and purification 
(modified from [215]). (a) SDS-PAGE (1) and Western blot analysis (2) of purified AtDIR6. For SDS-PAGE analysis 
(lane 1), 15 µg of concentrated supernatant was used. For Western blot analysis (lane 2), 1 µg of concentrated 
supernatant was used. The asterisks indicate the indistinct signal in the lower molecular weight range. (b) SDS-
PAGE of fermentation supernatants from P. pastoris cells expressing AtDIR6 after 6, 9 and 13 days. 15 µg of 
total protein was loaded in each lane. (c) SDS-PAGE (1) and Western blot analysis (2) of purified AtDIR6. For 
SDS-PAGE analysis (lane 1), 10 µg of purified AtDIR6 was used. For Western blot analysis (lane 2), 0.5 µg of 
purified AtDIR6 was used. Lane abbreviations: Lanes M represent a size marker. Protein bands are marked with 
their respective molecular weight in kilodaltons (kDa). The white arrows indicate the protein band identified as 
AtDIR6 by Western blot analysis. 
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For higher yields of AtDIR6, high cell density fed-batch fermentation of the AtDIR6 
expressing P. pastoris strain was performed as duplicates. To accumulate cell mass before 
induction of protein expression, the cells grew at 30°C on the initial 5% (v/v) glycerol for the 
first 28 h to an OD600 over 100 during the batch phase. Then the process was switched to 
fed-batch with the addition of methanol, which was performed at 22°C to increase the level 
of dissolved oxygen as this is the main restraint of the growth of P. pastoris at high cell 
densities. Both fermentations proceeded comparably and the process is shown for the 
second fermentation in Figure 3-4. Before harvest, the cells reached a final OD600 of 
approximately 500 and cell wet weight as well as cell dry weight increased up to 414 g L-1 
and 115 g L-1, respectively, and were therefore in good correlation with the OD600 [215]. 
 
Figure 3-4 – Fed-batch fermentation process of AtDIR6 with Pichia pastoris (adapted from [215]). Samples 
were taken at various time points and analyzed for the OD600 (black circles), cell dry weight (grey squares), and 
cell wet weight (light grey triangles). The dotted line represents the shift from the batch to the fed-batch 
process. The dashed lines represent sampling of 0.5 L fermentation broth for protein expression analysis and 
addition of new media. Standard deviations of OD600 were calculated from three individual samples. 
 
For evaluation of the increase in AtDIR6 yield during the fermentation process, 500 mL 
samples were taken after 6 d and 9 d. The fermenter was replenished with 500 mL fresh 
medium at these points. After 13 d, the fed-batch fermentation processes were finished with 
a final volume of 5.1 L and 4.9 L. After centrifugation, the volume of the supernatants 
amounted to 3.9 and 3.4 L, respectively. Since AtDIR6 was secreted into the supernatant, a 
concentration via a cross-flow filtration unit with a 10kDa molecular weight limit membrane 
was performed as the first downstream processing step. During this, the buffer was 
exchanged to a 100 mM potassium phosphate buffer at pH 6 containing 300 mM KCl. 
Subsequently, the protein content of the retentate was analyzed by SDS-PAGE. Comparably 
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to the shaking flask experiment, a distinct band was observed around 33 kDa (white arrow; 
Figure 3-3b) after 9 d and 13 d of fermentation. The protein was purified by immobilized 
metal affinity chromatography (IMAC) and verified as AtDIR6 by Western blot analysis with 
primary anti-AtDIR6 antibodies (Figure 3-3c). 
Besides the major band around 33 kDa, the fermentation resulted also in impurities in the 
lower molecular range as seen before in the expression in shaking flasks. Additionally, a 
smear between 35 and 40 kDa was visible on both the SDS gel and the Western blot. Based 
on the quantification of overall band intensities by densitometric analysis of the SDS gels of 
purified AtDIR6 samples, a purity of 90% and yield of 47 mg L-1 were calculated for the 
33 kDa protein from the fermentation process [215]. 
3.1.3 Characterization of the glycan structure and enzymatic deglycosylation 
Since the apparent molecular mass estimated from SDS-PAGE analysis (about 33 kDa) was 
higher than the calculated size for the P. pastoris derived AtDIR6 (21 kDa), it was 
investigated whether this is due to glycosylation of AtDIR6 in P. pastoris. In a first attempt, a 
sample of AtDIR6 was analyzed with MALDI-TOF-MS analysis (Dr. Jens Pfannstiel, Proteomics 
Core Facility, Life Science Center, University of Hohenheim) and the molecular mass of 
AtDIR6 was determined as 24.6 kDa, which is significantly lower than the 33 kDa estimated 
from the SDS-PAGE analysis, but still higher than the calculated size (see Figure 3-5) [215]. 
 
Figure 3-5 – MALDI-TOF mass spectrum of AtDIR6 isolated from Pichia pastoris (modified from [215], 
supplementary information). Approximately 10 pmol of the protein were applied to a stainless steel target 
after C4-ZipTip purification. The mass spectrum was recorded in the linear detection mode with external 
calibration. Singly and doubly charged molecule ions are indicated. The average mass observed for the singly 
charged molecule ion (24.6 kDa) is considerably larger than the calculated average mass for the singly charged 
non-glycosylated AtDIR6 protein. 
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In this regard, the possibility of glycosylation of AtDIR6 was further investigated by using a 
deglycosylation approach. For this, AtDIR6 was incubated with PNGase F under denaturing 
conditions to enzymatically remove possible N-glycans. A shift in the molecular mass of the 
protein indicated the presence of an N-linked glycan structure (Figure 3-6). Two distinct 
bands at about 25 kDa and 21 kDa were formed after 24 h of incubation with sizes 
comparable to glycosylated AtDIR6 derived from cell cultures of S. peruvianum. During 
further incubation with additional PNGaseF for another 48 h (72 h total incubation) no 
significant changes in the protein pattern was observed, indicating the formation of two 
discrete protein species, which likely differed in the glycosylation pattern [215]. 
 
Figure 3-6 – SDS-PAGE analysis of AtDIR6 samples after deglycosylation (adapted from [215]). PNGase F 24 h: 
24 h deglycosylation with 500 U PNGase F; PNGase F 72 h: 72 h deglycosylation with additional 1000 U PNGase 
F added after 24 h of incubation. The bands at 36 kDa represent PNGase F; Control: Negative control under the 
same buffer conditions but lacking PNGase F; AtDIR6 Pichia: AtDIR6 produced by P. pastoris cells; AtDIR6 Plant: 
AtDIR6 produced by cell cultures of Solanum periuvanum. The black arrow indicates native AtDIR6 derived from 
P. pastoris fermentations (33 kDa), the grey arrow indicates glycosylated AtDIR6 derived from cell cultures of 
Solanum peruvianum (22 kDa) and the white arrows indicate deglycosylated AtDIR6 species (25 kDa and 21 
kDa). Lane M represents a size marker. 
 
In order to investigate possible differences in the glycosylation pattern of the two observed 
protein species, samples from untreated AtDIR6 and the two distinct deglycosylated AtDIR6 
species were prepared for analysis via MALDI-TOF and LC-ESI-MS (Dr. Jens Pfannstiel, 
Proteomics Core Facility, Life Science Center, University of Hohenheim). In this analysis, two 
N-glycosylation sites at position N30 and N94 could be identified. These sites correspond to 
the N-glycosylation sites N59 and N123 in the plant derived AtDIR6 with the N-terminal 
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secretion signal peptide [110]. Both sites exhibited a high mannose type glycan chain with a 
mass of about 2 kDa for each structure (Hexose9GlcNAc2), which is typical for P. pastoris 
(Figure 3-7, Figure S 11, Figure S 12 and Figure S 13). Different isoforms with nine to thirteen 
hexose residues at both sites were found by ESI-MS/MS (data not shown). In the peptide 
mass fingerprint (PMF) of the 25 kDa band a deglycosylated peptide including N30 was 
identified, whereas the position at N94 remained glycosylated (Figure 3-7b). In contrast, in 
the PMF of the 21 kDa band deglycosylated peptides for both sites, N30 and N94, were 
identified (Figure 3-7c) [215]. 
 
Figure 3-7 – MALDI-TOF peptide mass fingerprints (PMF) of tryptic digests from glycosylated and PNGase F 
treated AtDIR6 isolated from Pichia pastoris (adapted from [215]). PMF spectra of glycosylated AtDIR6 (a), the 
25 kDa species (b) and the 21 kDa species (c) were recorded in the reflector mode with external calibration. 
AtDIR6 glycopeptides including the N30 and N94 glycosylation sites are marked by hashes, the corresponding 
deglycosylated peptides are marked by an asterisk and a filled square, respectively (b, c). Zoomed views of the 
PMF’s showing the glycosylated and deglycosylated peptides are given in supplementary figures Figure S 11 
and Figure S 12a-c. The identity of the glycopeptides and the corresponding deglycosylated peptides was 
verified by MS/MS analysis (see Figure S 13a-d). The figure was prepared by Dr. Jens Pfannstiel (Proteomics 
Core Facility, Life Science Center, University of Hohenheim). 
 
Results 95 
 
In correspondence with the proposed reaction mechanism for dirigent proteins, AtDIR6 was 
shown to be a native homodimer when derived from a plant cell expression system 
[109,110]. To estimate the native molecular size, analytical gel filtration was performed. 
Here, AtDIR6 exhibited a Kav value of 0.182, which corresponded to a molecular mass of 97.7 
± 0.1 kDa (Figure 3-8). However, this indicated a homotetrameric structure for native AtDIR6 
produced in P. pastoris based on the molecular mass of 24.6 kDa obtained by MALDI-TOF-MS 
analysis [215]. 
 
Figure 3-8 – Analytical gel filtration of AtDIR6 isolated from Pichia pastoris (modified from [215]). Analytical 
gel filtration was performed on a XK16/100 column (GE Healthcare, England) packed with Sephacryl S-200. The 
column was calibrated with γ-globulin (GG, 158 kDa), ovalbumin (OA, 44 kDa), myoglobin (MG, 17 kDa) and 
vitamin B12 (VB, 1.35 kDa). The Kav was determined three times for 500 µg purified AtDIR6 and the log10(MM) 
was derived by comparison with the standard proteins. 
 
3.1.4 Dirigent activity of AtDIR6 
It has already been shown that AtDIR6, like other dirigent proteins, does not possess 
catalytic activity for the initiation of the phenoxy radical coupling, but can increase overall 
pinoresinol formation and lead to an enantiomeric excess of (-)-pinoresinol in 
biotransformations of coniferyl alcohol with an oxidizing agent such as laccases [95,109]. To 
validate these results and the functionality of the P. pastoris produced AtDIR6, the purified 
protein was employed in laccase-catalyzed bioconversions of coniferyl alcohol (1), which 
were analyzed with RP-HPLC (Figure 3-9a). The collected pinoresinol fraction was 
subsequently separated into (+)- and (-)-pinoresinol using chiral HPLC (Figure 3-9b). As 
expected no products were formed in the presence of AtDIR6 without laccase (Figure 3-9a, 
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solid line). In contrast, RP-HPLC analysis of biotransformations with Trametes versicolor 
laccase showed the formation of erythro/threo-(±)-guaiacylglycerol 8-O-4´-coniferyl alcohol 
ether (4a and 4b), (±)-dehydrodiconiferyl alcohol (5) and (±)-pinoresinol (3) (Figure 3-9a, 
dotted line). In the presence of dirigent proteins, quantitative formation of products (4) and 
(5) was slightly decreased, while formation of (3) was favoured (Figure 3-9a, dashed line). 
 
Figure 3-9 – Reversed phase and chiral HPLC analysis of biotransformations with AtDIR6 isolated from Pichia 
pastoris. (a) Reversed phase HPLC analysis of biotransformations of coniferyl alcohol with AtDIR6 (solid line), 
laccase (dotted line) or AtDIR6 and laccase (dashed line). No products are formed in biotransformations with 
only AtDIR6, however the product composition of biotransformations with laccase is shifted to pinoresinol 
formation in the presence of AtDIR6. Concentrations of coniferyl alcohol, AtDIR6 and laccase were 4 mM, 8.5 
µM and 5.7 µM, respectively. 1: coniferyl alcohol; 3: (±)-pinoresinol 4a/4b: erythro/threo-(±)-guaiacylglycerol 8-
O-4´-coniferyl alcohol ether; 5: (±)-dehydrodiconiferyl alcohol. (b) Chiral HPLC analysis of the pinoresinol 
fraction from RP-HPLC analysis without AtDIR6 (dotted line) and with 25 µM AtDIR6 (solid line). (-)-3: (-)-
pinoresinol; (+)-3: (+)-pinoresinol. The figure was created from the original chromatograms using GIMP2.0 
software. 
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Chiral HPLC analysis of the pinoresinol fraction from RP-HPLC showed an increased 
enantiomeric excess of (-)-pinoresinol validating the functionality of AtDIR6 from P. pastoris 
(Figure 3-9b). 
The enantiomeric excess of (-)-pinoresinol was further evaluated as a function of AtDIR6, 
coniferyl alcohol, and laccase concentrations and the results were compared to the dirigent 
activity of AtDIR6 derived from cell cultures of S. peruvianum. It was found that the 
enantiomeric excess of (-)-pinoresinol increased with higher concentrations of the dirigent 
protein (Figure 3-10a). At 83 µM, which corresponds to two mole percent of AtDIR6 per 
mole of coniferyl alcohol, an enantiomeric excess of 89.0 ± 0.5% was reached. Although 
AtDIR6 from P. pastoris fermentations exhibited the typical high mannose type glycan 
structure and varied therefore strongly from the plant specific glycosylation pattern, AtDIR6 
from S. peruvianum and P. pastoris showed comparable activities, of 59.4 ± 1.5% and 
53.6 ± 1.6% at 8.5 µM, respectively [215]. 
 
Figure 3-10 – Enantiomeric excess of (-)-pinoresinol as a function of the (a) AtDIR6, (b) coniferyl alcohol, and 
(c) laccase concentration (modified from [215]). Black squares: AtDIR6 derived from P. pastoris; grey circle: 
AtDIR6 derived from S. peruvianum. (a) Concentrations of coniferyl alcohol and laccase were kept constant at 4 
mM and 5.7 µM, respectively. (b) Concentrations of AtDIR6 and laccase were kept constant at 4.2 µM and 5.7 
µM, respectively. (c) Concentrations of AtDIR6 and coniferyl alcohol were kept constant at 8.5 µM and 4 mM, 
respectively. The standard deviations did not exceed 2.6% enantiomeric excess in (a), 2.2% in (b) and 1.6% in 
(c), respectively. 
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In contrast, increasing the coniferyl alcohol or laccase concentrations led to a decrease in 
enantiomeric excess of (-)-pinoresinol. An increase in coniferyl alcohol concentration from 1 
to 6 mM, resulted in a marked reduction in enantiomeric excess from 66.1 ± 1.0% to 
27.1 ± 2.2% (Figure 3-10b). Altering the laccase concentration from 0.11 to 22.9 µM resulted 
in a similar, but less prominent effect on the enantiomeric excess, which decreased from 
56.4 ± 0.7% to 47.6 ± 0.4%, respectively (Figure 3-10c) [215]. 
3.1.5 Dirigent activity of deglycosylated AtDIR6 
Since glycosylation can have not only an influence on folding or stability of proteins, but also 
on the bioactivity [30], the relevance of glycosylation for dirigent activity was evaluated. 
Therefore, AtDIR6 was enzymatically deglycosylated with PNGase F and samples from 
different time intervals were subjected to SDS-PAGE analysis and dirigent activity assays 
(Figure 3-11). From these experiments it could be shown that the dirigent activity was stable 
with 81.0 ± 0.8% of the initial activity remaining after 24 h when AtDIR6 was incubated in the 
absence of PNGase F (Figure 3-11b).  
 
Figure 3-11 – SDS-PAGE and dirigent activity analysis of deglycosylated AtDIR6 derived from P. pastoris 
(adapted from [215]). (a) SDS-PAGE analysis of enzymatic deglycosylation of AtDIR6 over time. The black arrow 
indicates glycosylated AtDIR6 from P. pastoris (33 kDa) and the white arrows indicate deglycosylated AtDIR6 
species (25 kDa and 21 kDa). (b) Enantiomeric excess of (-)-pinoresinol as a function of AtDIR6 from incubations 
with (black circles) or without (black squares) PNGase F at different time intervals. The percentage of fully 
glycosylated AtDIR6 at a given timepoint (grey triangles) from PNGase F incubations were calculated by 
densitometry. Standard deviations are shown for the densitometric analysis of three independent experiments. 
 
In contrast, the enantiomeric excess considerably decreased over time when AtDIR6 was 
incubated in the presence of PNGaseF, with 3.4% remaining after 24 h corresponding to a 
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90% loss of activity. The loss of activity over time corresponded well with the disappearance 
of the fully glycosylated AtDIR6 band at 33 kDa, which showed a 97.9 ± 1.7% reduction after 
24 h quantified by densitometric analysis (Figure 3-11a) [215]. 
To further characterize, whether loss of function of deglycosylated AtDIR6 was due to 
reduced solubility of the protein, stability and solubility of AtDIR6 during incubations for up 
to 96 h at 30°C were investigated. SDS-PAGE analysis of the soluble and insoluble protein 
fractions verified that fully glycosylated AtDIR6 was stable during 96 h of incubation (see 
Figure 3-12). In contrast, a gradual loss of soluble protein was identified for deglycosylated 
AtDIR6 [215]. 
 
Figure 3-12 – Solubility of deglycosylated AtDIR6 isolated from Pichia pastoris during long-term incubations 
(adapted from [215]). Soluble: soluble AtDIR6 fractions; insoluble: insoluble AtDIR6 fraction after 96 h 
incubation at 30°C; control: soluble fraction of the fully glycosylated AtDIR6 after 96 h incubation at 30°C. The 
black arrow indicates glycosylated AtDIR6 derived from P. pastoris (33 kDa) and the white arrows indicate 
deglycosylated AtDIR6 species (25 kDa and 21 kDa). Lane M represents a size marker. 
 
3.1.6 Changes in protein structure induced by deglycosylation of AtDIR6 
As loss of function is often accompanied by an alteration in the structural composition of 
proteins, samples of AtDIR6 were analyzed by circular dichroism (CD) spectroscopy in the 
far-UV range (190-260 nm). The spectrum of fully glycosylated AtDIR6 revealed a single 
minimum at 220 nm, indicating a high content of β structures, and a characteristic shoulder 
around 200 nm (Figure 3-13a). By deconvolution of the spectrum, a secondary structure 
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composition of 9% α-helices, 34% β-sheets, 25% turns and 31% unordered elements was 
found. After deglycosylation of AtDIR6, a significant change in the CD spectrum was 
observed. The 220 nm minimum and the wavelength characterized by a mean residue 
weight ellipticity of 0 deg cm2 dmole-1 were shifted by about 4 nm to 216 nm. Furthermore, 
the intensity of the positive band decreased by almost two thirds from 27500 to 11400 deg 
cm2 dmole-1. However, deconvolution of the spectrum also revealed that the fractions of 
structural elements were not altered significantly with 10% α-helices, 32% β-sheets, 24% 
turns and 32% unordered elements for deglycosylated AtDIR6 [215]. 
For a further evaluation of the effect of deglycosylation on protein structure, glycosylated 
and deglycosylated AtDIR6 was exposed to chemical denaturation by guanidinium 
hydrochloride (GndCl) and related changes in ellipticity at 220 nm were analyzed (Figure 
3-13b). At low concentrations of GndCl, the fully glycosylated AtDIR6 showed a slight 
decrease in ellipticity at 220 nm followed by a strong increase up to concentrations of about 
1 M GndCl. In contrast, deglycosylated AtDIR6 showed a slow and gradual increase in 
ellipticity at 220 nm over the entire concentration range. Above 1.33 M GndCl, both, 
glycosylated and deglycosylated AtDIR6, showed identical behavior with a slow increase in 
ellipticity [215]. 
 
Figure 3-13 – CD spectroscopy of glycosylated and deglycosylated AtDIR6 derived from P. pastoris (modified 
from [215]). (a) Far-UV spectrum of fully glycosylated (black) or deglycosylated AtDIR6 (grey). Identical 
concentrations of glycosylated and deglycosylated AtDIR6 were used (0.07 mg mL
-1
). (b) Chemical denaturation 
followed by CD spectroscopy at 220 nm of fully glycosylated glycosylated (black) or deglycosylated AtDIR6 
(grey). Identical concentrations of glycosylated and deglycosylated AtDIR6 were used (0.04 mg mL
-1
). 
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3.2 Enzyme engineering of Saccharomyces cerevisiae ribokinase  
3.2.1 A novel D-xylose metabolizing pathway 
Ribokinases catalyze the phosphorylation of D-ribose to D-ribose-5-phosphate with ATP as 
co-substrate [130]. They are ubiquitous among prokaryotes and eukaryotes, highly 
conserved due to their central role in pentose-phosphate metabolism, and show high 
substrate specificity towards D-ribose [129,131]. Ribokinase from E. coli was shown to be 
able to weakly accept D-xylose as substrate yielding D-xylose-5-phosphate [146]. 
While Saccharomyces cerevisiae (S. cerevisiae) is able to ferment hexoses like D-glucose, it 
cannot utilize pentoses like D-xylose and D-arabinose, which are the main constituents from 
hemicellulose in lignocellulosic feedstocks [25]. However, S. cerevisiae can ferment the D-
xylose isomer D-xylulose by phosphorylation to D-xylulose-5-phosphate and funneling of this 
intermediate into the pentose phosphate pathway. Metabolic engineering of S. cerevisiae 
strains by implementing pathways for the isomerization of D-xylose to D-xylulose have been 
reported (see Figure 3-14), however they lack the fermentation rate and ethanol yield 
necessary for an industrial process. 
In this case study, a novel D-xylose metabolizing pathway was proposed. This would include 
the action of a ribokinase engineered to phosphorylate D-xylose to D-xylose-5-phosphate 
with a specific activity comparable to the natural activity towards D-ribose (see Figure 3-14). 
In a second step, the novel intermediate D-xylose-5-phosphate could be converted to D-
xylulose-5-phosphate, which is an intermediate of the pentose phosphate pathway, e.g. by 
the action of an engineered ribose-5-phosphate-isomerase from S. cerevisiae [25]. Since the 
novel pathway should be implemented by metabolic engineering into S. cerevisiae in further 
studies, the homologous ribokinase candidate RBK1 from S. cerevisiae itself was chosen for 
the enzyme engineering approach. For the enzyme engineering of RBK1 in regard to the 
alteration of the substrate specificity, a rational design approach was chosen.  
The rationale for the novel pathway was devised in an industrial cooperation with DSM 
(Heerlen, The Netherlands) for developing novel D-xylose metabolizing S. cerevisiae strains 
for the production of second generation biofuels from lignocellulosic feedstocks. 
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Figure 3-14 – Metabolically engineered pathways for D-xylose metabolism and novel pathway. In the 
implemented pathways, D-xylose is isomerized to D-xylulose by xylose isomerase (XI) or converted to D-xylulose 
by the action of xylose reductase (XR) and xylitol dehydrogenase (XDH) via xylitol. S. cerevisiae can convert D-
xylulose to D-xylulose-5-phosphate by the action of xylulokinase (XuK). In the proposed, novel pathway, an 
engineered RBK1 variant phosphorylates D-xylose to yield D-xylose-5-phosphate. The novel intermediate could 
then be isomerized to D-xylulose-5-phosphate by an engineered variant of ribose-5-phosphate-isomerase 
(RpiA). In all cases, D-xylulose-5-phosphate is funneled into the pentose phosphate pathway. 
 
3.2.2 Homology modelling and smart library design 
RBK1 from S. cerevisiae shows 30.7% identity and 48.9% similarity in the amino acid 
sequence to the ribokinase from E. coli [143]. In addition, members of the ribokinase family 
were found to be structurally highly similar [129]. Based on the crystal structure of the E. coli 
ribokinase (PDB code: 1RKD) [135], a homology model was designed by the bioinformatics 
group of the Institute of Technical Biochemistry of the University of Stuttgart (Jannik 
Vollmer) (see Figure 3-15a). The crystal structure of the E. coli ribokinase includes D-ribose 
bound in the active site. Based on the position of D-ribose in its cyclic α-furanose form, 
residues were identified, which are in direct contact and are likely to contribute to substrate 
binding. These residues included isoleucine at position 101 (I101) and 113 (I113), threonine 
at position 279 (T279), and alanine at position 319 (A319) in the yeast RBK1. D-ribose is 
bound in a manner that the more hydrophobic side of the sugar ring faces towards the 
hydrophobic isoleucines, which are situated in the lid domain [135]. While the two residues 
aspartate 12 (D12) and asparagine 42 (N42) are also in direct proximity and were shown to 
interact with the hydroxyl groups on the other side of the sugar via hydrogen bonds, both 
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are strictly conserved. While D12 is involved in interactions with the protein backbone, the 
catalytic base aspartate 283 is supported by N42. 
 
Figure 3-15 – Homology model of the yeast RBK1 protein. (a) Overlay of the homology model of RBK1 (grey) 
and the E. coli ribokinase protein structure (cyan) used as template for homology modeling (PDB: 1RKD). The 
ADP analogue and α-D-furanoribose bound in the E. coli structure are shown in the standard atomic colors and 
red, respectively. (b) A zoomed view of the substrate binding site of the homology model. The sites I101, I113, 
T279, and A319 chosen for mutagenesis are represented as orange sticks. The ADP analogue is again shown 
colored according to the standard atomic colors. The bound α-D-furanoribose is exchanged by an α-D-
furanoxylose (red) with the altered C3 hydroxyl group indicated by an asterisk.  
 
In D-xylose, the hydroxyl group at carbon atom three (C3-OH) faces in the other direction. 
Based on the assumption that D-xylose binds in the same manner as D-ribose, the C3-OH 
group would face mainly towards I101 and I113, while T279 and A319 are in close proximity 
(see Figure 3-15b). Examination of a family alignment of 200 ribokinase sequences with over 
25% sequence identity showed that the four identified residues are able to tolerate 
mutations, as some minor amino acid variants were observed at these positions (René de 
Jong, DSM, The Netherlands) (data not shown). 
Based on these results, a small focused library of RBK1 variants was designed with the aim to 
generate several active enzyme variants, while at the same time creating diversity in 
hydrogen bonding patterns for alternative sugars to bind in the active site. For all amino acid 
exchanges, the family alignment showed that these variations can be tolerated in other 
ribokinase sequences.  
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Table 3-1 – Variants of the focused library. 
Single Double Triple Quadruple 
I101S I101S I113T I101S I113T T279S I101S I113T T279S A319G 
I101V I101S I113V I101S I113T A319G I101S I113T T279S A319S 
I101T I101S T279S I101S I113T A319S I101S I113V T279S A319G 
I113T I101S A319G I101S I113V T279S I101S I113V T279S A319S 
I113V I101S A319S I101S I113V A319G I101T I113T T279S A319G 
T279S I101T I113T I101S I113V A319S I101T I113T T279S A319S 
A319G I101T I113V I101S T279S A319G I101T I113V T279S A319G 
A319S I101T T279S I101S T279S A319S I101T I113V T279S A319S 
 I101T A319G I101T I113T T279S I101V I113T T279S A319G 
 I101T A319S I101T I113T A319G I101V I113T T279S A319S 
 I101V I113T I101T I113T A319S I101V I113V T279S A319G 
 I101V I113V I101T I113V T279S I101V I113V T279S A319S 
 I101V T279S I101T I113V A319G  
 I101V A319G I101T I113V A319S  
 I101V A319S I101T T279S A319G  
 I113T T279S I101T T279S A319S  
 I113T A319G I101V I113T T279S  
 I113T A319S I101V I113T A319G  
 I113V T279S I101V I113T A319S  
 I113V A319G I101V I113V T279S  
 I113V A319S I101V I113V A319G  
 T279S A319G I101V I113V A319S  
 T279S A319S I101V T279S A319G  
  I101V T279S A319S  
  I113T T279S A319G  
  I113T T279S A319S  
  I113V T279S A319G  
  I113V T279S A319S  
8 variants 23 variants 28 variants 12 variants 
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The focused library is based on a combinatorial approach of single, double, triple, and 
quadruple variants. For this, the hydrophobic I101 and I113 were changed to the similar 
valine. The rationale for this was to accommodate the altered position of the C3-OH group 
potentially pointing in this direction for D-xylose as well as allowing larger sugar substrates 
more space in the active site. Additionally, I101 was changed to two small, polar residues, 
serine and threonine, and I113 was changed to threonine. These changes might facilitate 
hydrogen bonds with hydroxyl groups facing towards these residues. In the case of T279, 
only minor variations were suggested by the family alignment. This residue was changed to 
the smaller serine, again allowing more space to accommodate larger substrates or 
stereoisomeric changes in the substrates. For A319, the same rationale was applied for a 
change to glycine, while more operational freedom suggested by the family alignment also 
allowed a change to serine, which might again facilitate hydrogen bonding. By combination 
of the original amino acids at all positions with these new variations, a small focused library 
of 72 combinatorial variants (including wild-type RBK1) with single, double, triple, and 
quadruple mutations was established (see Table 3-1). 
3.2.3 Expression and purification of RBK1 
Since the E. coli ribokinase protein was successfully expressed using a pET vector construct in 
the E. coli BL21(DE3) derivative ER2566 (New England Biolabs) [146], expression of the S. 
cerevisiae RBK1 protein was initially investigated with a pET16b vector construct expressing 
RBK1 as N-terminal His10 fusions. Strains used were the common BL21(DE3) expression 
strain, the derivative C43(DE3) [195] and Rosetta(DE3) since the rbk1 gene was not codon 
optimized for E. coli. Expression in BL21(DE3) and Rosetta(DE3) at 37°C did not result in an 
easily distinguishable band at about 38 kDa in SDS-PAGE analysis (see Figure 3-16a). Faint 
bands at the expected size of RBK1 were visible in Western blot analysis with anti-His 
antibodies supporting weak expression strength, however no signals were observed in the 
soluble fraction (lanes S, Figure 3-16a). Interestingly, a signal was already observed for the 
sample before inducing with 0.5 mM IPTG (lanes 0, Figure 3-16a). This indicated that the 
repression of the T7 promoter was not completely tight as verified by Western blot analysis. 
In contrast, expression with C43(DE3) resulted in strong expression of RBK1 as analyzed by 
SDS-PAGE and verified by Western blot analysis (see Figure 3-16b). Soluble protein 
expression as indicated by Western blot analysis was achieved at a low temperature of 20°C. 
At this temperature, the E. coli cells grew slowly and produced only low protein yields of 
Results 106 
 
RBK1. Expression at a higher temperature (37°C) did not lead to soluble protein and the 
Western blot analysis also showed signals in the lower molecular range indicating protein 
degradation. Variation of inducer concentration (0.01 mM to 1 mM IPTG), expression 
temperature (30°C) or expression time (2 h to 24 h) could not improve the soluble 
expression of RBK1 using the pET16b_RBK1 vector construct harboring the rbk1 gene (data 
not shown). 
 
Figure 3-16 – Comparison of the expression of RBK1 in E. coli BL21(DE3), Rosetta(DE3) and C43(DE3) hosts by 
SDS-PAGE and Western blot analysis. (a) Expression of RBK1 in E. coli BL21(DE3) and Rosetta(DE3) at 37°C. (b) 
Expression of RBK1 in E. coli C43(DE3) at 20°C and 37°C. Lane abbreviations: Lanes 0 or 3, 6 and 24 show total 
cell protein fractions before or after IPTG induction, respectively. Lanes S and IS show the soluble protein 
fraction after cell lysis and the insoluble (pellet) fraction after cell lysis, respectively. Lanes M1 and M2 represent 
molecular size markers. Protein bands are marked with their respective molecular weight in kilodaltons (kDa). 
15 µg of total protein was loaded in each lane. The white arrows indicate the protein bands identified as RBK1 
by SDS-PAGE and Western blot analysis. 
 
Expression in C43(DE3) using a pJOE vector construct (Dr. Joseph Altenbuchner, Institute for 
Industrial Genetics, University of Stuttgart) [212–214] with the rbk1 gene under the control 
of the rhamnose promoter resulted in high yields of soluble protein when expressed for 24 h 
at 30°C with 0.5% rhamnose as inducer. Still, a large percentage of recombinantly expressed 
RBK1 was found in the insoluble fraction (see Figure 3-17a).  
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For further characterization of RBK1, the C-terminally His6-tagged protein was purified by 
immobilized metal affinity chromatography (IMAC) and again verified by Western blot 
analysis with anti-His antibodies (data not shown). After elution with 200 mM imidazole, the 
RBK1 containing fraction was dialyzed against 100 mM potassium phosphate buffer at pH 7.5 
containing 100 mM KCl. After determination of the protein concentration (approximately 8-
10 mg mL-1), the sample was subjected to SDS-PAGE analysis (see Figure 3-17b). The 
expression with the pJOE vector construct harboring the rbk1 gene in E. coli C43(DE3) 
resulted in an almost pure protein (> 95% purity as assessed by densitometric analysis of SDS 
gels, data not shown) after one purification step (IMAC) and gave excellent yields of 150-200 
mg purified protein per litre cell culture. Only minor protein impurities were faintly visible in 
the 70-85 kDa and 15-20 kDa range. 
 
Figure 3-17 – Expression and purification of RBK1 from E. coli C43(D3) cells. (a) Expression of RBK1 in E. coli 
C43(DE3) at 30°C. (b) Purification of RBK1 by IMAC. Lane abbreviations: Lanes M1 and M2 represent molecular 
size markers. Protein bands are marked with their respective molecular weight in kilodaltons (kDa). The white 
arrows indicate the protein bands identified as RBK1 by SDS-PAGE. For unpurified samples, 15 µg of total 
protein was loaded in each lane. For purified RBK1, 5 µg protein was loaded in each lane. Lanes 0 or 3, 6 and 24 
show total cell protein fractions before or after rhamnose induction, respectively. Lanes S and IS show the 
soluble protein fraction after cell lysis and the insoluble (pellet) fraction after cell lysis, respectively. Lanes L, F, 
E and SEC show the soluble protein fraction used for the IMAC purification, the flow-through of the IMAC 
purification, the RBK1 containing eluate fraction after the IMAC purification and the RBK1 containing eluate 
fraction after size exclusion chromatography, respectively. 
 
A subsequent purification step was included using size exclusion chromatography (SEC) to 
prepare the protein for crystallization experiments (see 3.2.7). Therefore, a XK-16/100 
column was packed with Sephacryl S-200 HR resin (GE Healthcare, Little Chalfont, United 
Kingdom). The column efficiency was validated by an acetone standard. The minimum 
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specifications for a self-packed column with this kind of resin are theoretical plates N > 9,000 
and an asymmetry factor As = 0.8 - 1.5. The column (183 mL CV) showed excellent values 
with N = 14,600 and As = 1.1 supporting an effective polishing step. The pooled RBK1 protein 
fractions from IMAC purification were buffer exchanged to 20 mM Tris at pH 7.0 with 150 
mM NaCl, applied to the SEC column in three 2 mL samples (8.5 mg mL-1) and run with the 
same buffer at 1.0 mL min-1 flow rate. The major protein containing fractions were pooled 
(see Figure 3-18b), buffer exchanged to 10 mM Tris pH 7.5 and concentrated to 10 mg mL-1 
and 20 mg mL-1, respectively, using Amicon Ultra 4 centrifugal filter units with a nominal 
molecular mass limit of 10 kDa (Merck Millipore, Schwalbach, Germany). Although the RBK1 
samples were almost pure after IMAC (> 95% purity), it was possible to remove the minor 
impurities in the 70-85 kDa and 15-20 kDa range leaving an apparently pure RBK1 after SEC 
(see Figure 3-17b).  
Analysis of the elution time of RBK1 samples during size exclusion 
chromatography/analytical gel filtration in comparison to standard proteins resulted in a Kav 
value of 0.223 for RBK1 corresponding to a molecular mass of 75.7 kDa (see Figure 3-18a). 
This would indicate a dimeric structure for native RBK1 from S. cerevisiae produced in E. coli 
based on the molecular mass of 37.7 kDa calculated from the amino acid sequence. 
 
Figure 3-18 – Gel filtration purification of RBK1. (a) Analytical gel filtration was performed on a XK16/100 
column (GE Healthcare, England) packed with Sephacryl S-200. The column was calibrated with γ-globulin (GG, 
158 kDa), ovalbumin (OA, 44 kDa), myoglobin (MG, 17 kDa) and vitamin B12 (VB, 1.35 kDa). The Kav was 
determined three times for 1 mg purified RBK1 and the log10(MM) was derived by comparison with the 
standard proteins. (b) Chromatogram of a size exclusion purification of RBK1. The shaded fractions were 
pooled. The figure was created from the original chromatogram using the GIMP2.0 software. 
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After the expression system for the RBK1 wild-type was established, all sequence verified 
Quikchange™ mutants of the focused RBK1 library were expressed with the pJOE vector 
constructs in E. coli C43(DE3) induced with 0.5% rhamnose at an OD600 of 0.5 for 24 h at 30°C 
in a 200 mL scale in 1 L unbaffled shaking flasks. All variants showed strong expression 
comparable to the RBK1 wild-type in SDS-PAGE analysis (data not shown). The C-terminally 
His6-tagged RBK1 variants were purified with IMAC using the setup established for the wild-
type. Typical yields of 30-40 mg from 200 mL culture in a 4 mL fraction (7-10 mg mL-1) of 
purified protein were achieved. The purity of all variants was comparable to the RBK1 wild-
type (> 95% purity as assessed by densitometric analysis of SDS gels, data not shown) (see 
Figure 3-19). 
In respect to the oligomerization state assessed by analytical gel filtration, RBK1 variants 
I101V and I113V, which were also purified for crystallization studies, showed Kav values 
similar to the wild-type and therefore indicated a dimeric native structure as well (data not 
shown). 
 
Results 110 
 
 
Figure 3-19 – SDS-PAGE analysis of the purified RBK1 variants. 15 µg purified RBK1 variants were loaded in 
each lane. Abbreviations for quadruple mutants stand for the amino acid exchanges (in one letter code) in the 
order of positions I101(S/T/V), I113(T/V), T279(S) and A319(G/S). WT: RBK1 wild-type. 
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3.2.4 Biochemical characterization of RBK1  
For a valid comparison of the RBK1 wild-type and mutants from the focused library, an 
intense biochemical characterization of RBK1 was performed. Therefore, the activity was 
assessed by a coupled NADH assay. Additionaly, substrate conversion and product formation 
during biotransformations were analyzed by HPLC. Furthermore, the stability as well as the 
ion and pH requirements of the enzyme were investigated and kinetic data of the 
bi-substrate reaction with the natural substrates and additional substrates were collected. 
3.2.4.1 Activity and stability 
Purified RBK1 from S. cerevisiae was strongly dependent on ion concentrations as already 
described for ribokinase from E. coli [146,152,154]  and other organisms [143]. With a 
turnover number kcat of 82.3 ± 0.3 s
-1 the highest activity versus D-ribose at 22°C was 
measured in 100 mM potassium phosphate (KPi) buffer at pH 6.0 with 2.5 mM magnesium 
chloride (MgCl2). When measured at 37°C, the turnover number reached 165.0 ± 4.3 s
-1, 
which is comparable to the highest measured rate of ribokinase from E. coli at 37°C (130 s-1) 
[146]. At higher temperatures, activity increased up to 401.7 ± 16.2 s-1 at 65°C, however 
when incubated for 10 min at 65°C prior to the measurement, already about 50% of the 
activity was lost. 
The stability of RBK1 was evaluated using the coupled NADH assay to assure a conclusive 
comparison in regard to activity between the wild-type and variants from the focused 
library. Therefore, a short-term stability under conditions used in the coupled NADH assay 
and biotransformations and a long-term stability under storage conditions was assessed. For 
incubation at 30°C and 22°C, the enzyme lost only about 3% and 1%, respectively, of its 
activity in 2 h. After 24 h, the residual activities were still 78.9 ± 2.0% and 99.3 ± 2.4%, 
respectively. Especially for the biotransformations with RBK1 at 30°C, the high stability of the 
enzyme should guarantee comparable results. For long-term stability at 4°C and -20°C, 
residual activities were 74.7 ± 1.6% and 97.2 ± 3.8%, respectively, after eight weeks of 
storage. Again, the high stability of the enzyme proved unproblematic for the production 
and evaluation of the focused library variants of RBK1. 
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3.2.4.2 Optimization of ion concentrations and pH 
Since the ribokinase from E. coli showed strong dependence on adequate mono, di- and 
pentavalent ion concentrations [146,152,154], optimized parameters regarding the 
concentration of potassium, magnesium and phosphate ions as well as pH were examined 
for the purified RBK1 from S. cerevisiae. Changes in pH and ion concentrations could 
influence the activity of the two coupling enzymes, pyruvate kinase and lactate 
dehydrogrenase, which are used in the coupled NADH assay (see 2.5.1). Therefore, in all 
experiments it was verified that the coupling reactions catalyzed by pyruvate kinase and 
lactate dehydrogenase did not represent the rate limiting steps. Initial activities were 
measured in 75 mM triethanolamine (TEA) buffer at pH 7.5 containing 5 mM KPi and 5 mM 
MgCl2 and resulted in a kcat of only 27.8 ± 0.9 s
-1 (versus 82.3 ± 0.3 s-1 in 100 mM KPi buffer at 
pH 6.0 with 2.5 mM MgCl2). By optimization of the ion concentrations and pH to 100 mM KPi 
buffer at pH 6.0 with 2.5 mM MgCl2, it was possible to improve the turnover number by a 
factor of three.  
Bacterial and mammalian ribokinases were shown to be affected by pentavalent ions 
increasing both the velocity and affinity of the enzyme for D-ribose [143,154]. For RBK1, an 
increase in activity from 7.6 ± 0.1 s-1 to 53.4 ± 0.9 s-1 at 0 mM up to 85 mM inorganic 
phosphate (Pi), respectively, was found (see Figure 3-20a). Higher concentrations of Pi 
resulted in a decreased activity, however also higher concentrations of potassium might 
influence the activity. Measurements were performed in KPi buffer at pH 7.5 with 5 mM 
MgCl2 and potassium chloride (KCl) up to a final concentration of 100 mM potassium. These 
non-optimized parameters reflect the difference to the maximum activity with 100 mM KPi 
buffer at pH 6.0 with 2.5 mM MgCl2 (82.3 ± 0.3 s
-1). Relative activities under 2% were 
reported for mammalian and bacterial ribokinases without inorganic phosphate in the 
reaction buffer [143,154]. The relative activity of about 14% without inorganic phosphate 
found in the coupled NADH assay for RBK1 is likely due to the activating effect of 
phosphoenolpyruvate (PEP) present in the coupled NADH assay reaction buffer, which was 
already described by Maj and Gupta [154]. Doubling the standard concentration of PEP at 
low phosphate concentrations had a measurable effect. However, at high Pi concentrations 
the enzyme was already fully activated by Pi and no further activation via PEP was 
measurable (data not shown). 
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The best activity with different magnesium concentrations was found at 2.5 mM MgCl2 (see 
Figure 3-20a), which is in the same range as for the concentrations used with bacterial (5 
mM) and mammalian (2 mM) ribokinases [146,154]. 
In contrast to the E. coli ribokinase whose highest activities were at a pH of 8 to 9 [146], the 
evaluation of the optimum pH value resulted in the highest activity of RBK1 at pH 6.0 while 
the enzyme showed high activity in a rather broad pH spectrum (see Figure 3-20b). Below pH 
6.0, the activity decreased rather fast with less than 60% residual activity at pH 4.5, while at 
pH 9.0 still over 75% residual activity was measurable. 
 
Figure 3-20 – Optimization of magnesium and phosphate concentrations and pH value for RBK1 activity. (a) 
Grey circles: relative activity as a function of the phosphate (Pi) concentration; black squares: relative activity as 
a function of magnesium (Mg
2+
) concentration. Standard deviations from three independent samples are 
shown and were always below 3%. (b) Relative activity as a function of the pH value. Standard deviations from 
three independent samples are shown and were always below 2%. 
 
3.2.4.3 Biotransformations and analytics via HPLC 
In addition to the indirect measurement of the RBK1 activity by the coupled NADH assay, 
biotransformations of sugar substrates with RBK1 and subsequent analysis by HPLC and 
LC/MS were performed. This setup had the advantage of allowing further characterization of 
the ion requirements of RBK1 since no other enzymatic steps and cofactors are involved. 
Furthermore, this allowed the direct detection of the phosphorylated reaction products e.g. 
D-ribose-5-phosphate. 
Since the sugar substrates and phosphorylated sugar products are not detectable with a 
diode array detector (DAD; 1260 infinity diode array detector; Agilent, Santa Clara, CA, USA), 
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a refractive index detector (RID; 1260 infinity refractive index detector; Agilent, Santa Clara, 
CA, USA) was used with an Agilent 1200 series HPLC system. This however limited the used 
method to an isocratic flow, because a gradient would lead to a severe baseline drift in the 
refraction index. For a complete separation of all reaction substrates and products, namely 
ribose, D-ribose-5-phosphate, ATP and ADP, several methods and columns for polar 
substances were tested.  While there was no satisfying separation of substrates and 
products achieved with an Polaris NH2 column (4.6x150 mm, 5 µm particle size, Agilent, 
Santa Clara, CA, USA) (data not shown), ribose and D-ribose-5-phosphate could be fully 
separated on a TSKgel Amide-80 column (4.6x250 mm, 3 µm particle size, Tosoh, Tokyo, 
Japan) with 65% acetonitrile in 0.1% formic acid as solvent at 1.0 mL min-1 flow rate and 
30°C. However, the ATP and ADP peaks showed strong peak fronting and overlapped 
completely precluding any quantification via DAD at 254 nm. Furthermore, the peak 
produced from 50 mM sulfuric acid from quenching of the biotransformations overlapped 
with ribose and D-ribose-5-phosphate preventing routine quantification of these compounds 
with the RID as well (see Figure 3-21a). A separation of all compounds was achieved using an 
Aminex HPX-87H (7.8x300 mm, 9 µm particle size, Bio-Rad, Munich, Germany) with 5 mM 
sulfuric acid as solvent at 0.5 mL min-1 flow rate and 60°C. This column was further used for 
standard operation. 
For the calculation of conversion, standard curves for ribose, D-ribose-5-phosphate, ATP and 
ADP were generated. In the basic setup with 5 mM ribose, 2 mM ATP and 30 nM RBK1 in 100 
mM KPi buffer at pH 6 with 2.5 mM MgCl2, 1.51 ± 0.01 mM ribose were converted in 10 min 
at 30°C and 750 rpm (Thermomixer comfort, Eppendorf, Germany) (see Figure 3-21b). A high 
correlation with the conversion of ATP (1.55 ± 0.01 mM) and the formation of ADP (1.52 ± 
0.03 mM) was found. 
Since the D-ribose-5-phosphate peak detected with the RID overlapped with the ATP peak 
and the sulfate peak from quenching of the biotransformations, it was not used for routine 
quantification. However, biotransformations, which were not stopped with sulfuric acid, 
showed that a complete conversion of 1.97 ± 0.08 mM D-ribose and 1.99 ± 0.10 mM ATP 
correlated with the formation of 1.93 ± 0.05 mM D-ribose-5-phosphate. Due to the high 
correlation of conversion of substrates and formation of products, routinely only the 
conversion of ribose and ATP were quantified.  
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Figure 3-21 – HPLC analysis of biotransformations. (a) Chromatograms of various standards using an Amide-80 
column (Tosoh, Tokyo, Japan) column. Black line: 50 mM potassium phosphate buffer at pH 6.0 with 50 mM 
sulfuric acid; grey line: 10 mM D-ribose; dashed line (long dashes): 10 mM D-ribose-5-phosphate; dotted line: 10 
mM ATP; dashed line (short dashes): 10 mM ADP. (b) Chromatograms of biotransformations of D-ribose and 
ATP with RBK1 analyzed with an Aminex HPX-87H (column). 10 mM D-ribose (peak 5, retention time of 13.8 
min) and 9 mM ATP (peak 3, retention time of 8.9 min) were incubated for 10 min at 30°C. Peak 1: 50 mM 
sulfuric acid (retention time of 7.9 min); peak 2: D-ribose-5-phosphate (retention time of 8.4 min; peak 4: 50 
mM potassium phosphate at pH 6.0 (retention time of 10.8 min); black line: biotransformation after 0 min; 
dotted line: biotransformation after 5 min; grey line: biotransformation after 10 min. Formation of ADP 
(Retention time of 22.5 min) is not shown. 
 
For comparison of the enzyme activity of RBK1 in the coupled NADH assay and 
biotransformations, the conversion in the basic setup was evaluated as a function of time 
(see Figure 3-22a). In the first 4 min an initial, maximum conversion rate of about 200 µM 
min-1 for 30 nM of RBK1 was reached. After this, the conversion rate decreased until the 
limiting substrate ATP was depleted. This reduce in conversion rate was likely due to a 
combination of product inhibition and substrate shortage. To avoid a rate limiting effect like 
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this, a conversion of 0.8 mM was not exceeded in the basic setup for further comparative 
evaluations. The initial conversion rate corresponds well with the activity measured in the 
coupled NADH assay at 30°C. A kcat of 110.3 ± 2.5 s
-1 matches a conversion of 199 ± 5 µM 
min-1 for 30 nM enzyme indicating a normal behavior of RBK1 in the coupled NADH assay 
(see also Table 3-3). 
 
Figure 3-22 – Conversion rate as a function of time and potassium cation concentration. (a) Conversion rate 
as a function of time. D-ribose (5 mM) and ATP (2 mM) were converted with 30 nM RBK1 at 30°C and 750 rpm. 
Standard deviations are shown for 3 individual samples. (b) Relative conversion of D-ribose at different 
potassium ion concentrations. Ribose (5 mM) and ATP (2 mM) were converted with 1 µM RBK1 in 45 min at 
30°C and 750 rpm. Standard deviations are shown for three individual samples. 
 
The evaluation of the potassium concentration needed for full activation of RBK1 was 
performed with biotransformations and subsequent HPLC analysis. The coupled NADH assay 
was not used for this analysis due to several reasons. Since no potassium phosphate could 
be used, overall activities were rather low as the activation of RBK1 by phosphate was 
missing. The use of sodium phosphate was avoided as well, since at this point it was not 
clear whether sodium would activate RBK1 on its own. The resulting low conversions were 
easier to measure with biotransformations over a longer time-span. Furthermore, the 
coupling enzyme pyruvate kinase in the coupled NADH assay is dependent on potassium, 
which would preclude a control without any potassium. The biotransformations with RBK1 
were performed in 100 mM Tris buffer at pH 6.0 with 2.5 mM MgCl2. Further, 1 µM RBK1, 
which was buffer exchanged to 10 mM Tris at pH 7.5, was used in these reactions. This had 
two reasons, one being the need to circumvent contamination of the buffer with potassium 
from the enzyme preparation after IMAC purification. Secondly, the high amount of enzyme 
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was necessary since no Pi was present in the reaction. As has been shown, the conversion of 
ribose dropped to about 3% without Pi. Although 2mM ATP available as disodium salt 
contaminated the buffer with 4 mM sodium, the negative control showed almost no 
conversion (0.02 ± 0.01 mM). Comparable to the results for the ribokinase from E. coli 
[146,152], a jump-like increase in relative conversion from 2.2 ± 0.6% to 62.2 ± 0.3% was 
found with an increase of the potassium concentration from 0 mM to 0.5 mM. The highest 
conversion was measured at 100 mM potassium ion concentration and no further influence 
on conversion rate was found up to 250 mM (see Figure 3-22b). 
As seen in the phosphate screening with the coupled NADH assay, PEP can also function as 
activator comparable to Pi. RBK1 showed only 3.4 ± 0.8% conversion in biotransformations 
without Pi relative to a maximum conversion when the enzyme was fully activated by 
100 mM Pi in 100 mM Tris buffer at pH 6.0 with 100 mM KCl and 2.5 mM MgCl2. This is 
comparable to the results for bacterial and mammalian ribokinases [143,154]. 
It was reported that other mono- and divalent cations can facilitate the activation of 
bacterial ribokinases. Therefore, in addition to potassium, the influence of the monovalent 
cations ammonium, cesium, lithium, rubidium and sodium was tested. As full activation of 
RBK1 was observed with 100 mM potassium, all other monovalent cations were used as the 
respective chloride salts at a concentration of 100 mM in 100 mM Tris buffer at pH 6.0 with 
2.5 mM MgCl2. While all monovalent cations activated RBK1 to some degree, only rubidium 
almost reached the level of potassium (see Figure 3-23a). 
For the influence of divalent ions, magnesium, manganese and calcium were tested. Since 
the optimum concentration of magnesium was found to be 2.5 mM, manganese and calcium 
were tested with 2.5 mM as well. While conversion with calcium was nearly negligible, 
manganese was comparable to magnesium (see Figure 3-23b).  
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Figure 3-23 – Activation of RBK1 by different mono- and divalent cations. (a) Relative conversion for the 
activation of RBK1 by different monovalent cations.  -: negative control without monovalent ions. Standard 
deviations are shown for three individual samples. (b) Relative conversion for the activation by different 
divalent cations. -: negative control without divalent ions.   
 
3.2.5 Evaluation of the focused library 
The small focused library of the RBK1 variants, which was established by evaluation of the 
tolerated variations based on a family alignment (René de Jong, DSM) and rational design 
based on the homology model of the S. cerevisiae ribokinase RBK1 (Jannik Vollmer, Institute 
of Technical Biochemistry, University of Stuttgart), was screened for an altered substrate 
spectrum compared to the wild-type enzyme. Therefore, a variety of sugars with four to six 
carbon atoms (C4 to C6) and stereoisomeric differences in the C2 or C3 hydroxyl group 
position were chosen. Of special interest was the change in activity towards the D-ribose 
epimer D-xylose, which differs in the position of the hydroxyl group at the C3 atom, since the 
initial aim of the project was the phosphorylation of this sugar for a novel D-xylose 
metabolizing pathway in yeast. 
3.2.5.1 Initial screening 
All variants from the focused library were initially screened under the same conditions (75 
mM triethanolamine buffer at pH 7.5 including 5 mM potassium phosphate and 5 mM 
MgCl2) using the coupled NADH assay at 22°C. Hereby, the activity of RBK1 was evaluated 
either with 10 mM D-ribose or 50 mM D-xylose. It was found that all triple and quadruple 
mutant variants did not show any activity or less than 1% relative to wild-type activity 
towards both substrates. Also, the mutations I101T and I113T in the double variants resulted 
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in a complete loss of activity. For the I101S mutation, only the double variants I101S/I113V 
and I101S/T279S still showed activity towards D-xylose (see Figure 3-24b). However, the 
activity was reduced to 72.6 ± 1.6% and 56.9 ± 3.9%, respectively, compared to the wild-type 
activity. While all the double variants with a I101V and I113V mutation (except with a I101S, 
I101T or I113T mutation in combination) still showed activity towards D-ribose and D-xylose, 
only the double variant I101V/I113V showed higher activity than the wild-type towards D-
ribose (116.3 ± 1.8%). From the eight single mutation variants, all showed at least some 
activity towards D-ribose and D-xylose. Especially the more conservative mutations I101V, 
I113V and A319G, but also A319S showed higher activity than the wildtype towards D-ribose 
(see Figure 3-24a). For the activitiy versus D-ribose, the best performing single variant was 
I113V. It showed an relative activity of 173.3 ± 2.4%.  
From all the variants, only the single variant I101V showed marginally higher activity towards 
D-xylose than the wild-type (113.2 ± 3.7%). Therefore, the targeted increase in activity 
towards D-xylose in the order of two magnitudes could not be achieved with the focused 
library. Furthermore, the aim to generate as many active variants as possible was also not 
achieved, since 72% of the variants exihibited completely abolished or strongly diminished 
activity towards D-ribose and D-xylose. 
 
Figure 3-24 – Initial activity screening of the RBK1 focused library towards (a) 10 mM D-ribose and (b) 50 mM 
D-xylose. The ten best variants are shown in comparison to the wild-type (WT). Standard deviations are shown 
for at least three individual samples and were calculated from standard deviations in the activity assay and 
concentration measurements. 
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3.2.5.2 Phosphate dependency 
The best performing mutants from the initial screen were further characterized. 
Interestingly, under conditions optimized for the wild-type (100 mM KPi at pH 6.0 with 2.5 
mM MgCl2) the increase in activity towards 10 mM D-ribose, especially of the I113V variant, 
could not be reproduced. Instead, an activity comparable to the wild-type activity was found 
(80.8 ± 1.1 s-1 versus 82.3 ±0.3 s
-1 for the wild-type). A more detailed screen at various Pi 
concentrations showed that the variant I113V reached its maximum screened activity 
already at 50 mM Pi (84.9 ± 0.4 s
-1) and was almost fully activated at 5 mM and 25 mM Pi 
(78.0% and 97.9%, respectively, of the maximum activity) (see Figure 3-25a). This behavior 
was also found for the variants I101V, A319G and A319S, although to a lesser degree starting 
at 25 mM Pi (70.6%, 92.0%
 and 92.4%, respectively). In contrast, the wild-type needed 100 
mM Pi for the maximum screened activity and only reached 46.4% relative activity at 5 mM 
Pi. Also, while variants I113V, A319G and A319S reached the maximum screened activity at 
50 mM Pi (84.9 ± 0.4 s
-1
, 78.5 ± 2.2 s
-1 and 88.2 ± 3.0 s-1, respectively), the wild-type and 
variant 101V reached it at 100 mM Pi (82.3 ±1.2 s
-1 and 85.6 ± 3.8 s-1, respectively). As the 
enzymes where diluted 100 to 300 times in the corresponding buffer, buffer effects from the 
enzyme preparations were unlikely. Still, to preclude any effects from this, different enzyme 
preparations from each variant were tested. 
 
Figure 3-25 – Phosphate dependency of RBK1 wild-type and I113V variant. (a) Turnover number kcat as a 
function of Pi concentration. Standard deviations are shown for three individual samples. Dark grey columns: 
RBK1 wild-type; light grey columns: RBK1 I113V variant. (b) Relative conversion as a function of Pi 
concentration. Standard deviations are shown for three individual samples. Dark grey columns: RBK1 wild-type; 
light grey columns: RBK1 I113V variant. 
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Since PEP present in the coupled NADH assay can facilitate activation of RBK1 in a similar 
manner as Pi, the wild-type and I113V mutant were also evaluated in biotransformations 
with different Pi concentrations. A similar behavior was found verifying the results from the 
coupled NADH assay (see Figure 3-25b). Lacking the activating effect of PEP in the 
biotransformations, a lower relative conversion was found at 0 mM Pi when compared to 
the coupled NADH assay. 
3.2.5.3 Substrate spectrum of the focused library variants 
While human ribokinase and ribokinase from E. coli are both highly specific for the 
phosphorylation of D-ribose, they accept a number of other sugar substrates with 
differences in the C2 or C3 functional group (e.g. replacement of the hydroxyl group by a 
proton, altering the conformation from ribo to arabino or xylo) or chain length (tetroses or 
hexoses) [143,146]. These include for example 2-deoxy-D-ribose, D-arabinose, D-xylose and D-
fructose. However, in all cases higher Km values indicated lower substrate affinities and the 
total turnover numbers kcat were about two orders of magnitude lower compared to D-ribose 
(about one order of magnitude for the E. coli ribokinase towards 2-deoxy-D-ribose). The 
focused library of RBK1 was established to aim for a shift in the substrate specificity 
especially towards the C3 epimer D-xylose. While the initial screening of the focused library 
indicated only a minor increase in activity towards D-xylose, a verification of these results 
with biotransformations and HPLC as well as LC/MS analytics was performed.  
While 2-deoxy-D-ribose was tested at 10 mM concentration, all further sugar substrates 
were tested at a concentration of 50 mM in 100 mM KPi buffer including 2.5 mM MgCl2. The 
wild-type showed high substrate specificity for D-ribose and only minor activities towards 
other sugar substrates (see Table 3-2). Although RBK1 from S. cerevisiae accepted similar 
sugar substrates including D-xylose, D-arabinose, D-erythrose and 2-deoxy-D-ribose, the 
activity towards these substrates was still one to two orders of magnitude lower compared 
to the E. coli ribokinase [146]. Interestingly, from the selected variants tested with these 
sugar substrates, several showed an increased activity. The I101V variant showed an 
increased activity towards 2-deoxy-D-ribose (0.57 ± 0.00 s-1). Furthermore, while the wild-
type showed no detectable activity with D-glucose, D-fructose, D-arabinose, D-lyxose and D-
threose, the variants I101S/I113V and I101S/T279S exhibited low activity with these 
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substrates with the highest increase in activity towards D-glucose (0.33 ± 0.00 s-1 and 0.16 ± 
0.00 s-1, respectively). For D-xylose, the results from the initial screening regarding the I101V 
variant could be verified with the conditions optimized for the RBK1 wild-type. The I101V 
variant showed an activity of 0.24 ± 0.00 s-1 at 50 mM D-xylose, which was approximately 
twice the activity of the wild-type (0.11 ± 0.00 s-1) (see Table 3-2). Still, the highest turnover 
numbers were not reached for both until a concentration of 300 mM D-xylose (0.76 ± 0.00 s-1 
and 0.38± 0.00 s-1, respectively) (see also 3.2.6).  
 
Table 3-2 – Substrate spectrum of RBK1 wild-type and variants. D-ribose and 2-deoxy-D-ribose were used at a 
concentration of 10 mM, all other sugars at 50 mM. Standard deviations are shown for at least three individual 
samples. -: no activity detected. 
Substrate 
kcat [s-1] 
Wild-type I101V I101S/I113V I101S/T279S 
D-ribose 82.6 ± 1.2 75.8 ± 2.3 1.45 ± 0.04 1.29 ± 0.03 
2-deoxy-D-ribose 0.29 ± 0.00 0.57 ± 0.00 - 0.14 ± 0.00 
D-xylose 0.11 ± 0.00 0.24 ± 0.00 0.10 ± 0.00 0.08 ± 0.00 
D-lyxose - - 0.06 ± 0.00 0.04 ± 0.00 
D-arabinose 0.02 ± 0.00 0.07 ± 0.00 0.05 ± 0.00 0.05 ± 0.00 
L-arabinose - - 0.07 ± 0.00 0.06 ± 0.00 
D-glucose - - 0.33 ± 0.00 0.16 ± 0.00 
D-fructose - - 0.07 ± 0.00 0.06 ± 0.00 
D-erythrose 0.04 ± 0.00 - 0.10 ± 0.00 0.09 ± 0.00 
D-threose - - 0.07 ± 0.00 0.07 ± 0.00 
 
For validation of the results from the coupled NADH assay, biotransformations of D-xylose 
and D-glucose with RBK1 were performed. Here, D-xylose and D-glucose showed different 
retention times (11.9 min and 11.2 min, respectively) in the standard HPLC analytic than D-
ribose (13.8 min) and were also identified with standards. 
With 500 mM D-xylose an initial conversion rate of about 165 µM min-1 and 80 µM min-1 for 
3 µM of the I101V variant and wild-type, respectively, was found at 30°C. This corresponds 
to a turnover number kcat of 0.93 and 0.45, respectively, validating the rates from the 
coupled NADH assay (0.98 ± 0.05 and 0.44 ± 0.02, respectively) at 30°C (see Table 3-3). The 
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variants I101S/I113V and I101S/T279S were tested at a D-glucose concentration of 10 mM 
since preliminary tests indicated saturation with substrate already at this concentration. 
Initial conversion rates of 65 µM min-1 and 30 µM min-1 were found corresponding to the 
rates calculated with the coupled NADH assay (0.38 ± 0.06 and 0.20 ± 0.03, respectively.  
Table 3-3 – Comparison of the reaction rates from the coupled NADH assay and initial conversion rates from 
biotransformations with selected RBK1 variants and various substrates. 
a 
Activity and initial conversion rates 
were measured at 30°C. 
b
 Initial conversion rates of D-ribose are shown for 30 nM enzyme. 
c
 Conversion rates 
towards D-xylose and D-glucose are shown for 1 µM enzyme. 
Substrate RBK1 variant 
rate 
[s-1]a 
conversion 
[µM min-1]a 
D-ribose 
Wild-type 110.3 ± 2.5 200 b 
I113V 106.2 ± 4.5 195 b 
D-xylose 
Wild-type 0.44 ± 0.02 80 c 
I101V 0.98 ± 0.05 165 c 
D-glucose 
I101S/I113V 0.38 ± 0.06 65 c 
I101S/T279S 0.20 ± 0.03 30 c 
 
A qualitative verification of the phosphorylated sugar products was performed with LC/MS 
analysis. Therefore, the compounds were determined on an Agilent 1260 Infinity series LC 
system equipped with an Aminex HPX-87H column (Bio-Rad, Munich, Germany) and 
detected with a DAD and MSD. All retention times and mass spectra were verified with 
standard substrates. The sugar substrates D-ribose, D-xylose and D-glucose were detected as 
[M+NH4
+]+ and [M+K+]+ ions in positive scan mode and [M+Cl-]-, [M-H++HCO2H]
- and [M-H+]- 
ions in negative scan mode (see Figure 3-26 and Table 3-4). Here, the dominant ions in 
positive scan mode were the ammonia adducts [M+NH4
+]+ with relative abundancies of  over 
95% for all substrates. The dominant ions in negative scan mode were the formic acid 
adducts, also with relative abundancies over 95%. The co-substrate ATP and the 
phosphorylated products were only detected as [M-H+]- ions in negative scan mode (see 
Table 3-4 and Figure 3-26) with relative abundancies over 95%. For all biotransformations 
with the sugar substrates D-ribose, D-xylose and D-glucose, negative controls without enzyme 
did show the respective substrate ions, but did not show the respective product ions (data 
not shown). A qualitative detection and increase of the integrated total ion chromatogram 
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(TIC) signals of product ions and decrease of the TIC signals of substrate ions were found in 
samples from biotransformations with enzyme (data not shown). 
 
 
Figure 3-26 – Mass spectra from LC/MS analysis. (a) Mass spectrum of D-glucose in positive scan mode. (b) 
Mass spectra of D-xylose in positive scan mode. (c) Mass spectra of D-glucose in negative scan mode. (d) Mass 
spectra of D-xylose in negative scan mode. (e) Mass spectra of D-glucose-6-phosphate in negative scan mode. 
(f) Mass spectra of D-xylose-5-phosphate in negative scan mode. The figures were created from the original 
mass spectra using GIMP2.0 software. 
 
 
 
 
 
 
Results 125 
 
Table 3-4 – Adducts and ions of reaction substrates and products formed during LC/MS analysis. 
Substrates/ 
Products 
Retention 
time (min) 
Adducts/ions formed (m/z) 
[M+NH4+]+ [M+K+]+ [M+Cl-]- [M-H++HCO2H]- [M-H+]- 
ATP 5.3 - - - - 506 
D-ribose 8.9 168 189 185/187 195 149 
D-xylose 7.9 168 189 185/187 195 149 
D-glucose 7.4 198 219 215/217 225 179 
D-ribose-5-P 5.0 - - - - 229 
D-xylose-5-P 4.9 - - - - 229 
D-glucose-6-P 4.3 - - - - 259 
 
3.2.6 Kinetic data of RBK1 
Since the rational design approach with the focused library of RBK1 variants concentrated on 
the sugar substrate binding site, not only an alteration in the maximum velocity of the 
enzyme, but also in the substrate affinity was to be expected. Therefore, kinetic data of the 
wild-type and selected variants for the natural substrates D-ribose and ATP as well as for 2-
deoxy-D-ribose, D-xylose and D-glucose were collected. When possible, the wild-type was 
compared to the best performing mutant versus the various substrates.  
While the maximum activity of the RBK1 wild-type and the I113V variant at high phosphate 
concentrations (100 mM KPi at pH 6.0 including 2.5 mM MgCl2) were comparable (82.3 ± 1.2 
s-1 and 80.8 ± 1.1 s-1, respectively), the Km for D-ribose increased significantly from 0.89 ± 
0.02 mM for the wild-type to 2.47 ± 0.05 mM for the I113V variant at a constant ATP 
concentration of 1.0 mM (see Table 3-5 and Figure 3-27a). This resulted in a decrease of the 
catalytic efficiency for the variant by a factor of about three. Concomitantly, the increase in 
the Km value was also reflected in the higher inhibition constant Kiu. However, the lower 
substrate inhibition did not lead to significantly higher activity at high D-ribose 
concentrations over 15 mM, but resulted in a stable activity around 80.0 ± 1.9 s-1. For a 
detailed assessment of the kinetic data regarding this bi-substrate, enzymatic reaction, the 
influence of the ATP concentration at a constant D-ribose concentration (10 mM) was 
investigated as well. Here, no significant change in the Km value was found (see Table 3-5 
and Figure 3-27b). 
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Figure 3-27 – Michaelis-Menten kinetics of RBK1 wild-type and I113V variant with D-ribose (a) and ATP (b). 
Black squares: experimental values for the RBK1 wild-type; grey circles: experimental values for the RBK1 I113V 
variant; black line: non-linear regression calculation of the Michaelis-Menten kinetics for the RBK1 wild-type; 
grey line: non-linear regression calculation of the Michaelis-Menten kinetics for the RBK1 I113V variant. 
Standard deviations are shown and calculated from at least three samples. 
 
Since the I101V variant performed slightly better than the wild-type towards D-xylose in the 
initial screening, the kinetic data for both were collected. All measurements were performed 
in the optimized buffer (100 mM KPi at pH 6.0 including 2.5 mM MgCl2) and showed no 
significant change in the Km values (170 ± 2 mM versus 148 ± 2 mM for the wild-type) (see 
Table 3-5). Still, the I101V variant performed better than the wild-type. The kcat value at 500 
mM D-xylose was 0.77 ± 0.00 s-1 and 0.38 ± 0.01 s-1 for the I101V variant and the wild-type, 
respectively.  
Comparable to D-xylose, a slight increase in activity towards 2-deoxy-D-ribose was seen for 
the I101V variant in the screening at 50 mM substrate concentration (5.2 ± 0.2 s-1 versus 4.1 
± 0.3 s-1). However, in contrast to D-xylose, kinetic data showed that the I101V variant 
actually has a better substrate affinity with a Km value of 163 ± 17 mM compared to the wild-
type (275 ± 58 mM) (see Table 3-5). This is about two orders of magnitude higher compared 
to the Km value of the wild-type towards D-ribose (0.89 ± 0.02 mM). 
In the evaluation of the substrate spectrum of the focused library, variants I101S/I113V and 
I101S/T279S showed activity towards substrates that were not phosphorylated by the wild-
type, e.g. D-glucose and D-fructose. The variant I101S/I113V was further investigated with D-
glucose as substrate. Here, a Km of 0.72± 0.01 mM was found, which is in the range of the 
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affinity for the natural substrate D-ribose (see Table 3-5). Since the wild-type enzyme did not 
show a measurable activity towards D-glucose, no kinetic data could be collected. 
Table 3-5 – Kinetic data with RBK1 wild-type and selected variants with various substrates. The kcat values 
shown are the highest measured rates in the standard setup. The Km and Kiu values are theoretical values 
calculated from the non-linear regression of the kinetic data collected. The r
2
 values of the fit of the non-linear 
regression to the experimental values were always at least 0.97. N/A: no values available. 
Substrate RBK1 variant 
kcat 
[s-1] 
Km 
[mM] 
Kiu 
[mM] 
kcat/Km 
[s-1 mM-1] 
ATP 
Wild-type 74.5 ± 0.7 0.079 ± 0.000 7.06 ± 0.39 945.7 ±4.3 
I113V 76.0 ± 1.0 0.088 ± 0.001 4.52 ±0.07 862.0 ± 0.2 
D-ribose 
Wild-type 82.6 ± 1.2 0.89 ± 1.2 33.9 ± 3.1 92.3 ±1.1 
I113V 79.5 ± 2.1 2.47 ± 0.05 416.5 ±1.5 32.2 ± 0.3 
D-xylose 
Wild-type 0.38 ± 0.0 148 ± 2 N/A 0.002 
I101V 0.77 ± 0.0 162 ± 2 N/A 0.005 
2-deoxy-D-
ribose 
Wild-type 4.1 ± 0.3  275 ± 58 N/A 0.015 
I101V 5.2 ± 0.2 163 ± 17 N/A 0.032 
D-glucose 
Wild-type 0.00 ± 0.00 N/A N/A N/A 
I101S/I113V 0.35 ± 0.0 0.72 ± 0.01 N/A 0.49 ± 0.00 
 
3.2.7 Crystallization and x-ray diffraction of RBK1 
In order to gain structural information of the yeast ribokinase RBK1, the protein was 
expressed and purified for crystallization trials (see 3.2.3). The apparently pure protein was 
concentrated, filtrated and mixed with the substrates D-ribose, D-xylose, or AMP-PNP when 
necessary. The protein was crystallized in an initial screening at the Biochemiezentrum, 
University Heidelberg (Dr. Jürgen Kopp). Further optimization of crystals was performed 
using the “Optimizer and Additive” screen. Based on the initial screening, a home-made fine 
screen was performed at the University of Hohenheim, Stuttgart. Crystals of apparently good 
quality appeared already after a few hours in the different screens. Various crystals from the 
initial and the fine screening were analyzed at the European Synchrotron Radiation Facility 
(ESRF) in Grenoble, France. Data of well diffracting crystals were collected and processed 
(Dr. Daniele de Sanctis, ESRF, Grenoble, and Dr. Domenico Lupo, University of Hohenheim, 
Stuttgart). The best data were obtained from crystals grown from the initial screen (0.18 M 
ammonium citrate and 20% (w/v) PEG 3350 at pH 7) and the fine screen (0.2 M potassium 
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citrate and 20% (w/v) PEG 3350) with AMP-PNP and D-xylose or D-ribose as ligands, 
respectively. The data are summarized in Table 3-6. However, it was not possible to solve the 
structure using molecular replacement based on the available data so far [216]. 
Table 3-6 – Data collection during x-ray diffraction for RBK1. 
Data collection RBK1 (fine screen) RBK1 (initial screen) 
Space group C222 I121 
Cell parameters 
Axis a, b and c (in Å) 
Angles α, β and γ (in °) 
 
78.435; 168.5; 58.949 
90.00; 90.00; 90.00 
 
123.26; 79.806; 160.75 
90.00; 90.40; 90.00 
Beamline ESRF ID 29 ESRF ID 29 
Wavelenght (Å) 1.06124 1.06124 
Resolution (Å)* 48-2.8 (2.9-2.8) 49-2.3 (2.4-2.3) 
Completeness (%)* 99.5 (99.1) 98.5 (97.3) 
Rsym (%)* 4.5 (79.0) 7.5 (52.0) 
I/σ* 18.0 (1.6) 6.0 (1.5) 
Reflections 
(Total/Unique) 
45,334/10,068 214,572/68,932 
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3.3 Thiol-functionalization of acrylic ester monomers catalyzed by 
immobilized Humicola insolens cutinase 
Functionalized acrylic monomers are important precursors for refined polymers used in 
various industrial applications. Enzymatic processes with biocatalysts like lipases have been 
for the production of polymers with thiol and acrylate functional groups have already been 
established [217]. Cutinases have been evaluated for and applied in various reactions like 
the polyester synthesis and lactone ring-opening polymerizations [179,180].  
In this case study, the cutinase from the ascomycete Humicola insolens (HiC) was evaluated 
as a novel biocatalyst for the synthesis of functionalized acrylic esters by transesterification. 
In the first stage of the project [198], the expression and immobilization of the enzyme on a 
microporous resin was optimized. Initial transesterification reactions with the model 
substrates 6-mercapto-1-hexanol and methylacrylate were performed (see Figure 3-28a) and 
the influences of water concentration and by-product inhibition as well as the temperature 
optimum were evaluated. For a comprehensive analysis, the substrate spectrum (see Figure 
3-28b) and the influence of a radical inhibitor on by-product formation were investigated in 
the present study. Furthermore, the scope of this work involved the purification and 
identification of the main product as well as kinetics of HiC in hydrolysis reactions. 
 
Figure 3-28 – Transesterification of methyl acrylate and 6-mercapto-1-hexanol by HiC (a) and further 
substrates tested (b). (4) methanol, (5) methyl-3-(6-hydroxyhexylthio)propanoate, and (6) 6-(3-methoxy-3-
oxopropylthio)hexyl acrylate. 
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3.3.1 Preparation of immobilized Humicola insolens cutinase 
Expression of HiC was performed with a P. pastoris strain, which had earlier been 
transformed with the pPICZαA_HiC construct [198]. The expression in shaking flasks resulted 
in volumetric yields of secreted HiC of up to 200 mg L-1 with a purity of over 90% without any 
purification steps (see Figure 3-29). 
 
Figure 3-29 – Expression of HiC from P. pastoris and analysis with SDS-PAGE. The white arrow indicates the 
molecular size of the HiC protein band at about 22 kDa. Lane M represents a molecular size marker. Ten µg of 
total protein were loaded. 
 
For the use of HiC in transesterification reactions in organic media or substrate, the enzyme 
was immobilized on the polystyrenic, microporous resin Diaion HP20 [218]. After incubation 
of the resin with the enzyme, filtration and drying for 72 h at room temperature under 
vacuum to achieve a water activity towards zero, the immobilisate was stored at 4°C until 
further use. 
3.3.2 Kinetic data of Humicola insolens cutinase 
Before HiC was used in transesterification reactions for the thiol-functionalization of acrylic 
esters a comprehensive biochemical characterization of HiC was performed also collecting 
kinetic data with various para-nitrophenyl (pNP) esters. Here, HiC showed a preference for 
shorter chain substrates (C4 and C8) with higher substrate affinity and turnover numbers 
(see Table 3-7) [219]. This was comparable to literature data on other cutinases from e.g. 
Fusarium solani pisi and Alternaria brassicicola [220–222] 
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Table 3-7 – Kinetic parameters of HiC. 
Substrates 
kcat 
[s-1] 
Km 
[µM] 
kcat/Km 
[s-1 mM-1] 
pNP-butyrate (C4) 191 ± 6 454 ± 29 0.42 
pNP-octanoate (C8) 187 ± 24 207 ± 24 0.90 
pNP-palmitate (C18:1) 18 ± 1 2246 ± 347 0.0082 
 
3.3.3 Transesterification reactions and substrate specificity 
For comparison with earlier results [198,219] and to validate the functionality of the newly 
prepared batch of immobilized HiC, 10 mg of the immobilisate were used in a 
transesterification reaction under previously optimized conditions (methyl acrylate (300 µL, 
10.3 M), 6-mercapto-1-hexanol (20 µL, 275 mM), 0.025% (w/w) deionized water, 40°C, 700 
rpm, 6 h). The formation of 83.9 ± 0.9% 6-mercaptohexyl acrylic ester corresponded well 
with earlier results (84.1 ± 1.7%) validating the functional expression, reproducible 
immobilization of HiC on Diaion HP20, and activity in transesterification reactions [198,219]. 
Based on the results from earlier experiments regarding the substrate specificity of HiC, it 
was found that the sterically less demanding methyl acrylate (1) was favored over methyl 
methacrylate (8) as acyl donor in transesterifications with 6-mercapto-1-hexanol (2) and 4-
mercapto-1-butanol (7) [198,219] (see Figure 3-28 and Table 3-8). To further evaluate the 
influence of the predominantly flat substrate geometry of the acrylate, transesterifications 
were additionally performed with methyl propionate. While transesterifications of methyl 
acrylate (1) with 6-mercapto-1-hexanol (2) yielded 84.1 ± 1.7% main product after 6 h at 
40°C, the transesterification with methyl propionate resulted in 93.2 ± 0.2% product already 
after 2 h. No Michael-addition products were found in this reaction, which is likely since 
methyl propionate lacks the acrylic double bond. 
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Table 3-8 – Substrate specificity of HiC in transesterification with various acyl donors and acceptors (adapted 
from [219]. Reactions were performed with 10 mg immobilisate and 0.025% (w/w) deionized water at 40°C for 
6 h for transesterifications of methyl acrylate (1), 24 h for methyl methacrylate (8) and 2 h for methyl 
propionate (9). -: not detected. 
 
Ratio substrate to products [%]  
1+2a 1+7 b 8+2 c 8+7 d 9+2 e 
Mercaptoalcohol 15.2 ± 1.6 21.3 ± 0.8 55.5 ± 0.3 50.0 ± 1.5 6.8 ± 0.2 
Acrylic ester 84.1 ± 1.7 76.3 ± 0.9 43.6 ± 0.1 48.0 ± 1.1 93.2 ± 0.2 
Michael-addition #1 f - - 0.9 ± 0.2 2.0 ± 0.3 - 
Michael addition #2 f 0.6 ± 0.1 2.4 ± 0.0 - - - 
a
 Transesterifications of methyl acrylate (1) with 6-mercapto-1-hexanol (2) 
b
 Transesterifications of methyl acrylate (1) with 4-mercapto-1-butanol (7) 
c
 Transesterifications of methyl methacrylate (8) with 6-mercapto-1-hexanol (2) 
d
 Transesterifications of methyl methacrylate (8) with 4-mercapto-1-butanol (7) 
e
 Transesterifications of methyl propionate (9) with 6-mercapto-1-hexanol (2) 
f
 Michael addition #1 and #2 refers to product (5) and (6) and corresponding Michael-addition products formed 
in transesterification of (1) + (7), (8) + (2), and (8) + (7), respectively. 
 
3.3.4 Influence of a radical inhibitor on transesterifications 
For a further optimization of the transesterification of methyl acrylate with 6-mercapto-1-
hexanol, the influence of the radical inhibitor butylated hydroxytoluol (BHT) on the 
formation of by-products and overall conversion was studied. The addition of 3% (w/w) BHT 
enhanced the overall conversion in diisopropyl ether as solvent at equimolar concentrations 
of substrates (150 µM) from 5.9 ± 1.1% to 38.9 ± 2.1% 6-mercaptohexyl acrylic ester. When 
used in the standard setup in methyl acrylate as the sole solvent, BHT reduced the formation 
of the Michael-addition product (6) at concentrations of 0.14 to 0.71 M (3 to 15% (w/w 
acrylic ester)), but also increasingly lowered the conversion of the main product (75.5 ± 0.4% 
6-mercaptohexyl acrylic ester with 0.71 M BHT. 
3.3.5 Product purification and identification by NMR and FT-IR 
For the identification of the main product via nuclear magnetic resonance (NMR) 
spectroscopy and Fourier transform infrared spectroscopy (FT-IR), a large scale 
transesterification reaction was performed to gain the necessary amount of product. 
Analysis by GC/MS showed that in the large scale batch, no Michael-addition products were 
detected, which might contaminate the main product. The product was then purified with 
silica column chromatography and the structure of the compound was confirmed by 1H and 
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13C NMR (see Figure 3-30). Thereby, the acrylic ester was confirmed as the exclusive product 
leaving the thiol group as the reactive, functional end group. 
 
 
Figure 3-30 – Structure elucidation of 6-mercaptohexyl acrylic ester by NMR and FT-IR. (a) 13C NMR spectrum 
of 6-mercaptohexyl acrylic ester. C-atoms are marked in the spectrum and in the (b) corresponding structure. 
(c) 1H NMR spectrum 6-mercaptohexyl acrylic ester. Chemical shifts are marked in the structure on the right. 
(d) FT-IR spectrum of 6-mercaptohexyl acrylic ester. Chemical shifts (NMR) and wavenumbers (FT-IR): 13C NMR 
(125 MHz, CDCl3): δ = 23 (C-9), 24 (C-6), 27 (C-7), 28 (C-5), 33 (C-8), 63 (C-4), 128 (C-1), 130 (C-2), 165 (C-3) 
ppm. 1H NMR (500 MHz, CDCl3): δ = 1.2-1-6 (m, 9 H), 2.4 (dt, J = 7.5 Hz, J = 10.5 Hz, 2 H), 4.1 (t, J = 6.7, 2 H), 5.8 
(dd, J =1.3 Hz, J = 10.5 Hz, 1 H), 6.0 (dd, J = 10.5 Hz, J = 17.2 Hz, 1 H), 6.3 (dd, J = 1.3, J = 17.2, 1 H) ppm. FT-IR: 
2936 (w), 2860 (w), 2562 (w, S-H), 2255 (w), 1961 (w), 1717 (m), 1637 (w), 1464 (w), 1409 (w), 1280 (w), 1197 
(m), 1061 (w), 984 (w). 
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4. Discussion 
4.1 Optimized expression of the dirigent protein AtDIR6 in Pichia pastoris 
and impact of glycosylation on protein structure and function 
In this case study, the goal was to improve the heterologous expression of the dirigent 
protein AtDIR6 from Arabidopsis thaliana (A. thaliana) by using expression hosts such as 
Escherichia coli (E. coli) or Pichia pastoris (P. pastoris) to serve as an example for selected, 
critical challenges in the production of biocatalysts. The dirigent protein AtDIR6 derived from 
a high yield fed-batch fermentation process with P. pastoris was studied in regard to the 
impact of its glycosylation on protein structure, solubility, and function. This exemplifies 
some challenges in the second step of establishing a biocatalytic process, the 
characterization of the protein or biocatalyst. 
4.1.1 Recombinant protein production of AtDIR6 
The biotechnologically interesting dirigent proteins were so far only produced with insect 
and cell culture expression systems such as Spodoptera frugiperda Sf9 cells (with the 
baculovirus expression system using Autographa californica multiple nuclear polyhedrosis 
virus) or Solanum peruvianum cells [95,105,108,109]. These heterologous expression 
systems, which are also applied in biotechnology and offer some advantages compared to 
bacterial expression systems, generally result in low overall yields of the target protein 
[38,39].  
For a high yield production of AtDIR6, E. coli was chosen as the primary expression host. 
Critical challenges in the expression of this eukaryotic protein in a bacterial expression 
system were particularly the correct formation of post-translational modifications, which 
might be necessary for the soluble expression, structural integrity, and function of the 
protein. First indications for a certain difficulty to express AtDIR6 in soluble form were made 
in a previous study using a standard pET expression vector and E. coli expression strain [210]. 
In the same study, refolding of the insoluble AtDIR6 failed.  
For a comprehensive evaluation, several strategies, which addressed different problems in 
the use of E. coli as a heterologous expression system, were tested in the scope of this work. 
The focus here was on allowing a soluble expression, and not refolding of the protein from 
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inclusion bodies, since this was already shown to be ineffective [210]. This included 
strategies to allow a correct formation of the putative disulfide bond in AtDIR6, which was 
verified only recently [110]. While attempts to introduce a functional glycosylation pathways 
into E. coli have been made [37], this technology is not yet ready for common use and the 
organism is naturally not able to add glycan structures to proteins. Glycosylation has been 
shown to be important for the soluble expression, stability and/or bioactivity of many, 
especially eukaryotic, proteins [30]. Therefore, several basic and more advanced strategies, 
which have been shown to be advantageous in facilitating a soluble expression of a target 
protein, have been pursued. 
The Atdir6 gene was synthesized and codon-optimized to enhance expression in E. coli [223]. 
Although solving the problem with rare codons by using synthetic, codon-optimized genes 
was shown to improve soluble expression of eukaryotic proteins [41], initial attempts to 
express AtDIR6 in a soluble form failed. Neither lowering the cultivation temperature nor the 
variation of inducer concentration, expression time or promoter system, which possibly 
could all reduce the stress on the folding machinery of the cell, resulted in a soluble 
expression of AtDIR6. In some cases, purification tags like the common His6-tag result in a 
decreased solubility of the target protein and variation of the position (N- or C-terminal) or 
deletion can have an advantageous effect [53,224]. However, expression of AtDIR6 without 
His6-tag from the rhamnose-inducible, very tight expression vector pJOE did not lead to 
soluble protein. Since the homology model of AtDIR6 [110] indicated that the N- and C-
terminus are not buried in the core of the enzyme, a disruption of the structure by the His6-
tag is unlikely. Therefore, the presence or absence of the His6-tag did not seem to have an 
effect on the soluble expression of AtDIR6.  
The E. coli BL21 derivatives C41 and C43 contain a mutation in the T7 polymerase promoter 
region and additional, uncharacterized mutations shown to be advantageous for toxicity 
issues and plasmid stability in the expression of recombinant proteins [195,225]. Several 
cytosolic and membrane proteins from bacterial and eukaryotic origin only expressed in low 
yields or as inclusion bodies in BL21 could be expressed successfully using these strains. 
AtDIR6 was still found in inclusion bodies when expressed in C41 or C43. These results, taken 
together with the results from the previously mentioned, basic strategies to improve soluble 
expression, indicated an important role of the post-translational modifications. 
Discussion 136 
 
Therefore, two strategies to allow the formation of correct disulfide bonds were tested. 
AtDIR6 includes two cysteines near the N- and C-terminus and it was recently shown that 
these form a disulfide bond in the native protein, which was suggested to be structurally 
relevant [110]. While the expression of soluble proteins featuring correct disulfide bonds in 
the cytoplasm of E. coli can be hampered by the oxidative milieu, this problem can be solved 
by localizing the target protein into the periplasm. The latter features enzymes involved in 
the protein quality control like oxidoreductases and isomerases, which allow the correct 
formation of disulfide bonds [46]. Furthermore, special E. coli strains like Origami B have 
mutations in the thioredoxin reductase (trxB) and glutathione reductase (gor) genes, which 
strongly enhance disulfide bond formation in the E. coli cytoplasm. These strategies did not 
solve the problem of AtDIR6 forming inclusion bodies. While an important effect of the 
disulfide bond on the structural stability of AtDIR6 cannot be excluded, its formation was not 
enough to allow a soluble expression. 
Proteins, which are prone to aggregation during heterologous overexpression can be often 
produced soluble by a translational fusion to highly soluble proteins such as thioredoxin or 
maltose-binding protein [42,43]. Fusion of AtDIR6 to the former resulted in an insoluble 
protein species indicating a strong aggregation propensity of AtDIR6 expressed in E. coli. 
Also, the combination of this strategy with the expression in E. coli Origami B(DE3) did not 
result in soluble protein. 
The majority of proteins in the E. coli cytoplasm, especially large multi-domain and 
overexpressed proteins, do not fold correctly on their own, but require the assistance of 
folding modulators [31]. Folding modulators include molecular chaperones, which favor 
productive folding by shielding interactive surfaces from each other and from the solvent as 
well as folding catalysts accelerating rate-limiting steps, such as the isomerization of 
peptidyl-prolyl bonds and reshuffling of disulfide bonds. The correct folding and soluble 
expression of many recombinant proteins was successfully improved by co-expression of the 
well-studied DnaK/DnaJ/GrpE or GroES/GroEL chaperone systems as well as the E. coli 
trigger factor TF [45]. Indeed, AtDIR6 was found in the soluble form during a co-expression 
of DnaK/DnaJ/GrpE in E. coli Origami B(DE3) at a low temperature. The protein could be 
purified by Ni-NTA chromatography, however only low yields (about 40 µg L-1) and purity 
were achieved. This was most likely connected to the disadvantageous expression conditions 
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at 15°C and co-expression of chaperones leading to a strongly reduced growth rate. 
However, other expression conditions during co-expression of chaperones, e.g. higher 
temperatures did not yield soluble protein. Importantly, the partially purified AtDIR6 
exhibited aggregation during storage. Therefore, this aggregation-prone behaviour indicated 
a further problem with AtDIR6, which was potentially correctly folded during the expression 
by the aid of the molecular chaperones.  
Based on these data and compared to results from the expression in insect and cell cultures, 
in which N-glycosylation of proteins is possible [95,105,108,109], it was hypothesized that 
this post-translational modification might be the critical issue in failing to express AtDIR6 in a 
soluble form in E. coli. This conclusion led to the evaluation of P. pastoris as potential 
expression host. 
The rationale for using P. pastoris cells in recombinant protein production is mainly based on 
the simple production and secretion into the supernatant via gene-fusions to the alpha-
mating factor pre-pro leader sequence (α-MF) from Saccharomyces cerevisiae and the ability 
of yeast cells to efficiently glycosylate recombinant proteins, although the glycosylation 
clearly varies from the pattern found in the originating organism [36]. Furthermore, this host 
is widely used for ultra-high cell density and high yield fermentations [35].  
Based on initial results in shaking flasks, a fed-batch fermentation process was established 
yielding 47 mg L-1 AtDIR6. This corresponds to an overall yield of about 160 mg AtDIR6 from 
only one fermentation procedure over 13 days. Compared to plant-based expression 
systems using transfected S. peruvianum cell lines, where only about 200 µg L-1 of purified 
protein could be obtained, this represents a more than 250-fold increase in recombinant 
protein production. In addition to these high yields, the ease of molecular manipulation and 
cheap fermentation procedure distinguish P. pastoris as the superior expression host for the 
production of dirigent proteins compared to all previously reported expression systems 
[95,105,109]. 
4.1.2 Characterization of AtDIR6  
The positive results with P. pastoris as expression host for AtDIR6 compared to the failure of 
producing stable protein in E. coli again strongly indicated an important role of the 
glycosylation in this regard. Therefore, a biochemical characterization of AtDIR6 was 
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performed and the impact of its glycosylation on protein structure and function was 
evaluated. 
First of all, to verify the basic suitability of P. pastoris as an expression host for the 
production of dirigent proteins, the dirigent activity of AtDIR6 was confirmed by activity 
assays.  For this, a combination of reversed-phase and chiral HPLC methods were used, 
which were modified from Pickel et al. (2010) [109]. While it was shown that the overall 
pinoresinol formation was increased in the presence of AtDIR6 derived from P. pastoris, only 
the increase in the enantiomeric excess (ee%) of (-)-pinoresinol was routinely quantified. 
This increase in ee% is defined as dirigent activity. AtDIR6 from P. pastoris exhibited 90% of 
the dirigent activity when compared to the protein derived from S. peruvianum. This slight 
difference in activity may be attributed to a somewhat lower purity and possible 
degradation products assessed by densitometric analysis of the SDS-PAGE gels as compared 
to the S. peruvianum preparation.  
The obtained bioconversion data validate previous work on dirigent proteins, in which higher 
ee-values were observed with increasing amounts of AtDIR6 and decreasing coniferyl alcohol 
concentrations [109]. The ee% increased from 14.1 ± 2.6% to 89.0 ± 0.5% in the presence of 
4 mM coniferyl alcohol and 1 µM or 89 µM AtDIR6, respectively. When comparing to an 
industrial process, 89 µM AtDIR6 would correspond to two mole percent catalyst per mole 
substrate indicating a high efficiency of the dirigent protein in formation of the product 
enantiomer. These results are in agreement with the mode of action of dirigent proteins as 
proposed by Lewis and coworkers, according to which the guided coupling of protein-bound 
coniferyl alcohol radicals (CA*) competes with unselective coupling of free radicals in 
solution (as shown in Figure 1-4a) [104,112]. Furthermore, the effective concentration of 
CA* depends not only on the concentration of dirigent protein and coniferyl alcohol, but also 
on the concentration of the oxidizing agent. Therefore, as expected, experiments with lower 
laccase concentrations lead to higher enantiomeric access, which demonstrates that 
selective coupling is favored at low levels of CA*. 
While AtDIR6 produced by P. pastoris and S. peruvianum appeared to be functionally 
equivalent, there are subtle differences, which can most likely be attributed to differences in 
the glycosylation in the two expression hosts. Molecular mass analysis by MALDI-TOF-MS 
revealed a mass of 24.6 kDa for the fully glycosylated AtDIR6 produced by P. pastoris. This 
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varied significantly from the mass of 33 kDa estimated by SDS-PAGE analysis. The 
discrepancy can be explained by the fact that varying conformations of the sugar moieties 
can alter the interactions with the electrophoresis gel or extent of SDS binding, which finally 
results in an electrophoretic behavior which does not reflect the correct size of the 
corresponding protein [226]. Results from analytical gel filtration indicated a homo-
tetrameric structure of the protein derived from P. pastoris fermentations with a size of 
about 98 kDa. In contrast, a homo-dimeric structure was shown for AtDIR6 expressed in S. 
peruvianum and for FiDIR1 purified from Forsythia intermedia stem tissue [109,111]. 
Interestingly, in the first report of dirigent proteins, Davin et al. (1997) [95] proposed a 
homo-trimeric structure for FiDIR1 with a molecular weight estimation of 78 kDa from 
analytical gel filtration for the native protein based on an observed band at 26 kDa in SDS-
PAGE analysis. More recent MALDI-TOF analysis of FiDIR1 verified the actual size of a 
monomer to be 21 to 23 kDa, which again would hint to a homo-tetrameric structure instead 
of the earlier proposed structure of a homotrimer (Davin and Lewis 2000). Although there is 
no final clarification found in the corresponding literature to this discrepancy of the earlier 
studies and the later established homo-dimeric structure and reaction mode, this indicates a 
possible dependence of the oligmerization state on other factors. As the oligomerization 
state may depend on the purification conditions used, the different glycosylation pattern of 
the expression host, and/or on the handling of the protein during the analysis, the 
observation of a tetrameric structure for AtDIR6 derived from P. pastoris is not necessarily in 
conflict with the proposed homodimer as the functional unit of a dirigent protein. Most 
importantly, even if the oligomerization states of the protein preparations from P. pastoris 
and S. peruvianum are different, the function of the protein is not impaired as shown by the 
bioconversions with AtDIR6 from both sources.  
Analysis of the N-glycosylation revealed a high mannose type glycan structure (Hex9GlcNAc2; 
about 2 kDa) typical for P. pastoris at the two N-glycosylation sites N30 and N94. These sites 
correspond to N59 and N123 reported as glycosylation sites in the plant-derived AtDIR6 
(numbering including the signal peptide) [110]. ESI-MS/MS measurements showed that 
different isoforms with 9-13 hexose residues exist. This heterologous glycosylation can 
explain the broad peaks in the MALDI-TOF chromatogram as well as the smear above the 
major band at 33 kDa in the SDS-PAGE analysis. In contrast to proteins produced by P. 
pastoris, plant-derived AtDIR6 has paucimannosidic type glycans, which hinders efficient 
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deglycosylation with most of the commercially available enzymes due to the presence of 
fucose residues at the core of the glycan structure [114]. Consequently, the impact of AtDIR6 
glycosylation on structure, solubility, and function of the protein remained untested so far. 
With the option to enzymatically deglycosylate AtDIR6 from P. pastoris, it was possible to 
evaluate the influence of the glycosylation on the native structure and function of the 
protein. 
Interestingly, treatment of AtDIR6 from P. pastoris with the enzyme peptide-N-glycosidase F 
(PNGaseF) resulted not only in the formation of one lower molecular weight band as 
expected, but of two major bands at 25 kDa and 21 kDa. MALDI-TOF and ESI-MS/MS analysis 
revealed that the higher band was quantitatively deglycosylated at only one N-glycosylation 
site (N30), while the lower band was deglycosylated at both sites (N30 and N94). The 
molecular mass of the partially deglycosylated protein (about 23 kDa) still did not 
correspond with the molecular mass assessed by SDS-PAGE analysis (25 kDa). This could 
again be addressed to the remaining glycan influencing the electrophoretic behavior as 
discussed earlier. In contrast, the calculated mass of 21 kDa for the fully deglycosylated 
protein species corresponded well with its mobility during SDS-PAGE analysis. 
Despite the fact that PNGase treatment of native AtDIR6 did result in a heterogeneous 
population of partially and fully deglycosylated proteins, it was still possible to address the 
relevance of glycosylation for dirigent activity. Samples of AtDIR6 taken during the enzymatic 
deglycosylation were directly employed in laccase-catalyzed biotransformations of coniferyl 
alcohol. A clear correlation was found between the loss of dirigent activity and the 
disappearance of fully glycosylated protein. After 24 h of deglycosylation, 90% of the initial 
dirigent activity was lost, which corresponded well with the disappearance of 97.9 ± 1.7% of 
the fully glycosylated AtDIR6. Importantly, a negative control of AtDIR6 incubated under the 
same conditions without PNGase F still showed 81.0 ± 0.8% of the initial dirigent activity 
after 24 h validating the important effect of the glycosylation on the function of the protein. 
Interestingly, purified and soluble AtDIR6 from the E. coli expression with chaperones did not 
show any dirigent activity (0.1 ± 0.2% enantiomeric excess) in bioconversions (data not 
shown). Since the unglycosylated AtDIR6 from E. coli showed aggregation over time (see 
3.1.1), it was used in activity assays directly after a purification procedure before complete 
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aggregation. Taken together, this species behaved comparably to the deglycosylated AtDIR6 
species derived from P. pastoris. 
A proper glycosylation of AtDIR6 may thus be necessary for the binding and orientation of 
CA* to maximize the probability for the specific 8,8´-coupling event yielding (-)-pinoresinol. 
Alternatively, glycosylation may affect the tertiary structure with an indirect effect on 
dirigent activity. To test this assumption, CD spectroscopy was performed with glycosylated 
and deglycosylated AtDIR6. CD spectroscopy is a powerful and easy to use methodology to 
assess protein secondary structure information without the need for a crystal structure of 
the protein [203]. Based on reference databases, the obtained CD spectra can be 
deconvoluted, which allows an estimation of the secondary structure composition [204]. 
This analysis revealed that the composition in the glycosylated and degylcosylated forms of 
AtDIR6 from P. pastoris is almost identical. It can therefore be assumed that both proteins 
adopt the same overall -barrel structure as proposed for AtDIR6 from S. peruvianum [110]. 
However, despite the similarity in secondary structure composition, differences in the shape 
of the CD spectra hinted at conformational differences between the deglycosylated and 
glycosylated forms of the protein. This was further supported by the diverse behavior in 
chemical denaturation experiments. While deglycosylated AtDIR6 exhibited a gradual 
increase in ellipticity value at 220 nm, glycosylated AtDIR6 showed a two-phase behavior 
with a strong increase in ellipticity during low concentrations of guanidinium hydrochloride 
indicating a more pronounced change in tertiary structure. Concluding, the results obtained 
by CD spectroscopy indicated a change in tertiary structure concomitant with a loss in 
stability upon deglycosylation of AtDIR6.  
Based on the data indicating structural changes upon deglycosylation, it was hypothesized 
that these changes in tertiary structure could also explain the partial deglycosylation 
observed under native conditions. Intramolecular conformation changes upon 
deglycosylation at position N30 of AtDIR6 could be made accountable for a steric hindrance 
of PNGase F on the glycan at position N94. However, longer incubation of AtDIR6 with 
freshly added PNGase F under denaturated conditions did not support this hypothesis. Thus, 
the reason for incomplete deglycosylation is still unknown and needs to be further 
investigated.  
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In addition to changes in tertiary structure, the deglycosylated protein mixture also exhibited 
a significant reduction in long-term solubility compared to the fully glycosylated protein, 
indicating increased protein aggregation over time. This phenomenon again correlates with 
the results obtained from the expression of AtDIR6 in E. coli, where the obtained, 
unglycosylated protein is not functional and also shows aggregation over time. 
From these results, it can be concluded that only fully glycosylated AtDIR6 is functional and 
already the removal of the glycan structure at site N30 induces conformational changes in 
the monomer structure, which are sufficient for the complete loss in dirigent activity. 
Whether loss of function is solely due to changes in the protein structure or coupled to 
higher oligomerization (n>4) preceding the aggregation or a combination thereof remains to 
be determined. 
4.1.3 Outlook 
A high yield fed-batch fermentation process for AtDIR6 was established and the importance 
of the protein glycosylation for the structure, solubility, and function of the protein was 
confirmed. With the availability of recombinant protein, a crystal structure could be solved 
aiming at a better understanding of the reaction mechanism and the molecular basis for 
enantioselectivity in dirigent proteins. In this regard, a co-crystallization of a stable, radical 
substrate analogue would be interesting to identify residues involved in substrate binding 
and conferring enantioselectivity. Crystallization studies based on protein obtained from S. 
peruvianum and P. pastoris will be conducted by the group of Prof. Schaller (University of 
Hohenheim, Germany). Mutation of the N-glycosylation sites or alteration of the glycan 
pattern using special yeast strains manufactured for glycoengineering could further help in 
understanding whether the glycans have a direct influence on the activity of the dirigent 
protein, are imperative for correct folding during expression, effect the solubility of the 
protein, or a combination thereof. Furthermore, high protein yields also allow a more 
extensive biochemical characterization of AtDIR6. This could include an evaluation of the 
optimum of important parameters such as temperature or the pH value. Also, a more 
detailed characterization of the kinetics involved in the radical coupling process directed by 
dirigent proteins might be useful for high space-time yields and low by-product formation in 
possible biotechnological applications. Rational design based on the newly established 
homology model [110] could already be useful for studies aiming at an alteration of the 
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substrate spectrum of dirigent proteins for possible biocatalytic applications such as 
enzymatic steps in the enantioselective synthesis of natural products. In this regard, the 
evaluation and optimization of protein stability by enzyme engineering or immobilization 
techniques would be important for the biotechnological use of dirigent proteins. 
 
4.2 Enzyme engineering of Saccharomyces cerevisiae ribokinase  
In this case study, the aim was to produce the ribokinase RBK1 from Saccharomyces 
cerevisiae (S. cerevisiae) and alter its substrate spectrum to serve as an example for selected, 
critical challenges in the production, characterization, enzyme engineering, and application 
of biocatalysts. A small focused, library of RBK1 variants was established by rational design 
based on a homology model of the protein with the focus to alter the substrate spectrum to 
D-xylose, which might allow a novel pathway for the production of second generation 
biofuels. RBK1 wild-type and its variants were derived from a high yield, heterologous 
expression in E. coli and characterized for conditions optimized for activity and the substrate 
spectrum. For a better understanding of the substrate binding, RBK1 was prepared for 
crystallization and the solution of the structure was attempted. 
4.2.1 Recombinant protein production of RBK1 
While the first biochemical characterization of a ribokinase was already performed in 1956 
[140], the first recombinant overexpression of a ribokinase was performed for the E. coli 
ribokinase 30 years later [142]. In 1998, the crystal structure of this protein was solved up to 
a resolution of 1.8 Å [135]. For this, the protein was overexpressed in an E. coli strain with a 
non-functional ribose operon and purified to near homogeneity [144]. Typical yields of about 
8 mg purified protein per litre cell culture after three purification steps including ammonium 
sulfate precipitation and ion-exchange chromatography were achieved. Park et al. reported 
the first recombinant expression of a eukaryotic (human) ribokinase using a pET vector 
construct in E. coli BL21(DE3) as a heterologous host [143]. While ribokinase genes were also 
found in plants and fungi [141,150], the production of RBK1 from S. cerevisiae in this study is 
the first report of a functional, recombinant expression of a fungal ribokinase. 
Based on the positive results for the human ribokinase, overexpression of RBK1 was initially 
tested with E. coli BL21(DE3) and a pET16b construct. However, the expression was very 
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weak and the low amounts of produced protein were not soluble. The use of the 
Rosetta(DE3) strain featuring rare tRNAs, which might help with the codon bias for the rbk1 
gene, which was not codon optimized for the use in E. coli, did not alter this result. Since 
overexpression of an enzyme involved in the central metabolism like RBK1 might be 
problematic for the expression host, the E. coli strain C43(DE3) [195], which is often used for 
the expression of problematic and toxic proteins, was evaluated as well. Here, strong, yet 
insoluble expression at 37°C and weak, soluble expression at 20°C was observed. The failure 
to express RBK1 soluble in high yields in a system comparable to the one used for human 
ribokinase might be related to the fact that human ribokinase actually shares higher 
sequence identity with homologs from bacterial and protist species, and not with fungal and 
plant species [143]. 
For the characterization and crystallization of RBK1, a robust expression system with high 
yields was necessary. Therefore, further options were evaluated. Expression of RBK1 was 
performed using a pJOE vector construct with the rbk1 gene under the control of the tight 
rhamnose promoter in C43(DE3) [212–214]. This resulted in a strong expression with 
excellent yields of 150-200 mg purified protein per litre cell culture and high purity (>95%) 
after Ni-NTA purification. Compared to the overexpression of the E. coli ribokinase in various 
studies [143,144,146,152], this represents a 15 to 25 times higher yield with comparable 
purity after only one chromatographic step. All RBK1 variants performed comparably during 
expression and purification with adequate yield and purity indicating no massive structural 
changes, e.g. leading to insolubility due to the mutations. 
4.2.2 Characterization of RBK1 
Purified RBK1 from high yield, heterologous expression in E. coli showed a turnover number 
kcat of 82.3 ± 0.3 s
-1 versus D-ribose at 22°C in 100 mM potassium phosphate (KPi) buffer at 
pH 6.0 with 2.5 mM magnesium chloride (MgCl2). The turnover number of 165.0 ± 4.3 s
-1 at 
37°C was comparable with the highest measured rate of the E. coli ribokinase of 130 s-1. 
Many annotations of genes from plants and fungi as ribokinases are only based on sequence 
similiarities without available biochemical characterization [143]. Based on the sequence 
similarity to other characterized ribokinases and the high activity versus D-ribose compared 
to other sugars (see Table 3-2), it can be assumed that RBK1 from S. cerevisiae is a true 
ribokinase. 
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For the measurement of activity and kinetic data, a NADH coupled assay was used [142] (see 
Figure 2-1). The assay was reported to be complicated to use, probably due to the coupled 
reaction in three steps and the influence of the composition of sample and buffer [144,154]. 
Other assays were reported such as a radioactive assay [154] and an assay based on a drop 
in pH [152]. However, these assays have various disadvantages. The radioactive assay is 
expensive, necessitates an isotope laboratory and is not usable for medium or 
high throughput screening. The pH assay was shown to have reaction rates, which were 
lower by a factor of 40 compared to the rates observed with the NADH coupled assay, and 
reproducibility was questionable. In this light, the NADH coupled assay was evaluated in this 
study and it was found that it was highly reproducible and amenable to medium or high-
throughput screening when performed conscientiously. Since it was already shown that 
ribokinases are dependent on mono-, di-, and pentavalent ion concentrations for their 
activity and can also be activitated by the assay component phosphoenol pyruvate (PEP) 
[152,154], it was especially important to assure a constant assay composition. Various 
controls were performed to assure that the other enzymatic steps catalyzed by pyruvate 
kinase and lactate dehydrogenase were not the rate limiting steps under the screened 
conditions.  
In addition to the NADH coupled assay, biotransformations with RBK1 and subsequent 
analysis by HPLC were performed. A HPLC method using a Bio-Rad Aminex HPX-87H column 
and a refractive index detector was established allowing the detection of the sugar 
substrates and phosphorylated products. The initial conversion rates achieved in 
biotransformations matched well with the activities measured in the NADH coupled assay 
verifying the performance of the latter. 
The RBK1 wild-type was characterized for the optimum concentrations of mono-, di-, and 
pentavalent ions as well as the pH value. The optimum activity of RBK1 was found at a pH of 
6.0. At a pH of 5 and up to pH 9, the relative activity was about 80%. A stronger drop in 
activity was observed below pH 5. At low pH values, aspartate is protonated and not able to 
function as the catalytic base anymore. While E. coli ribokinase showed a pH optimum 
around 7 to 8, a lower optimum for yeast RBK1 was expected, since yeast grows well at low 
pH values and the enzymes generally are adapted to these values. For the optimum ion 
concentrations, the best activity was found with a concentration of 100 mM potassium 
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phosphate and 2.5 mM magnesium at a pH of 6.0. The optimum concentration of 
magnesium is in the same range as found for bacterial and mammalian ribokinases [146,154] 
and activity decreases at higher concentrations. Since the chelate of ATP and magnesium is 
the real co-substrate for ribokinases [129], the optimum concentration of magnesium is 
likely to depend on the ATP concentration. However, this was not systematically evaluated. 
The characterized ribokinases from E. coli and Homo sapiens show an activation profile for 
potassium, which is comparable to RBK1. Low concentration of potassium up to 5 mM 
strongly activates the enzymes, while full activation is achieved at around 100 mM 
[143,152]. Interestingly, in the case of phosphate activation, five to ten times higher 
concentrations are needed for RBK1 compared to human and bacterial ribokinase [143,154]. 
When comparing the results from the NADH coupled assay and biotransformations at low 
phosphate concentrations, it was clear that PEP can substitute inorganic phosphate as 
activator to some extent as already found for bacterial ribokinase [154]. In a comparable 
manner, other mono- and divalent cations can facilitate the activation of ribokinases [146]. 
For divalent ions, yeast RBK1 behaved as was shown for the E. coli ribokinase with 
manganese facilitating activation, while calcium only showed marginal activation. For 
monovalent ions, caesium activated slightly more compared to ammonium, which was 
reversed for the E. coli ribokinase. Additionally, rubidium was tested, which activated the 
yeast enzyme comparably to potassium. It was shown for the E. coli ribokinase that the 
monovalent ion site favors binding of larger ions such as potassium, rubidium, or ammonium 
[152]. The yeast RBK1 exhibits a high structural similarity compared to the bacterial 
ribokinase and its binding site seems to favor larger ions as well. 
In order to enable a comparative evaluation of the RBK1 wild-type and all variants of the 
focused library, the stability of the enzyme was assessed. This was important for 
reproducible results in biotransformations of variants, which were produced at different 
times. Long- and short-term stability tests over 8 weeks and 24 h, respectively, showed 
excellent stability at -20°C and 30°C, respectively. The high stability of the enzymes allowed 
an unproblematic, comprehensive comparison of the focused library variants of RBK1. 
4.2.3 Enzyme engineering and evaluation of the focused library 
The small focused library was established by a combination of evaluation of a family 
alignment, which indicated variations that can be tolerated, and rational design based on a 
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homology model, which identified interesting residues involved in substrate binding. The 
library was screened for an altered substrate spectrum compared to the wild-type enzyme. 
The wild-type exhibits high activity versus D-ribose (82.3 ± 0.3 s-1) and very low activities 
towards other pentoses (D-xylose, D-arabinose, and 2-deoxy-D-ribose) and the tetrose D-
erythrose. Other tetroses, pentoses, and hexoses are not accepted. This underlines the high 
substrate specificity of RBK1. Human and bacterial ribokinase exhibit a substrate specificity 
comparable to RBK1, however E. coli ribokinase is able to phosphorylate 2-deoxy-D-ribose 
quite well (26.7 s-1) [143,146]. The high specificity reflects the importance of ribokinases for 
the central metabolism. 
Initial screening of the complete RBK1 focused library at low phosphate concentrations (5 
mM) revealed a few variants with higher activity towards the natural substrate D-ribose 
including, I101V, I113V, A319G, A319S, and I101V/I113V, while only I101V showed slightly 
higher activity towards D-xylose. Therefore, the goal to achieve a variant exhibiting an 
increase in activity towards D-xylose in the range of one to two orders of magnitude to 
support a possible D-xylose metabolizing pathway could not be achieved with the focused 
library. Also, the goal to generate as many active variants as possible was not realized, since 
all triple and quadruple variants exhibited no detectable activity at standard substrate 
concentrations of 10 to 50 mM. The quadruple mutants were also tested at very high D-
ribose concentrations up to 1 M (data not shown). Here, variant I101S/I113V/T279S/A319G 
exhibited about 50% activity of the wild-type (at 10 mM D-ribose) indicating that multiple 
mutations negatively affected the substrate binding. All variants showing increased activity 
are rather conservative, while stronger mutations completely abolished measurable activity. 
In this regard, additionally to the focused library single and double mutants at positions I101 
and I113 were established (data not shown). The isoleucines were exchanged against 
asparagine residues, which were shown to be frequently involved in sugar substrate binding 
sites [227]. Here, they can offer bidentate or cooperative hydrogen bonds important for 
effective binding [228,229]. However, the more drastic exchange to arginine completely 
abolished activity towards D-xylose as well as D-ribose. 
Further evaluation of the best performing variants from the initial screening revealed an 
altered phosphate dependency, which was strongest for the I113V variant. Compared to the 
wild-type, the variant was already strongly activated by phosphate at low concentrations of 
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25 to 50 mM, while the wild-type reaches full activation not until 100 mM. However, at the 
buffer conditions optimized for the wild-type (100 mM potassium phosphate at pH 6.0, 2.5 
mM magnesium chloride), all variants initially screened for a higher activity exhibited only 
about wild-type activity. The activation by phosphate was already shown to increase the 
catalytic turnover and the substrate affinity for D-ribose [154]. Therefore, it sounds 
interesting that the activation profile of enzymes by important ions can be altered in this 
way. However, for the evaluation of the focused library, this behavior was problematic, since 
not all variants could be screened at various buffer compositions. 
Although the initial goal in dramatically increasing the activity towards D-xylose could not be 
met with the focused library, variant I101V showed about twice the activity  (0.76 ± 0.00 s-1) 
at a concentration of 300 mM D-xylose compared to the wild-type. The chemical difference 
between the two epimers D-ribose and D-xylose seems marginal. They only differ at the 
position of the hydroxyl group at carbon atom three (C3-OH). For the generation of the 
variants, it was assumed that D-xylose binds in the same orientation and conformation as is 
known for D-ribose from the E. coli ribokinase crystal structure [135]. However, this 
assumption could be problematic. One way to elucidate the binding orientation is to 
establish a crystal structure of the yeast RBK1 with D-xylose bound as substrate, which will 
be discussed later. A problem could be basic thermodynamics of D-xylose in solution. While 
about 7% of D-ribose in solution is found in the α-furanose form, only under 1% of D-xylose is 
found in this form [132]. Assuming that D-xylose is also needed in the α-furanose form for 
efficient phosphorylation, this decreases the available concentration of D-xylose by about an 
order of a magnitude and thereby increases the apparent KM value. 
For the alteration of the substrate spectrum to other sugars, two interesting variants were 
identified, I101S/I113V and I101S/T279S. While the wild-type did not accept a variety of 
tetroses, pentoses, and hexoses, these two variants showed low activities for most of the 
tested substrates. The more open active site due to the smaller residues serine and valine 
and new hydrogen bonding possibilities with serine might help better facilitate binding of 
these non-natural substrates. For more information on the mechanisms, a bioinformatics 
approach featuring substrate docking studies, at best with a crystal structure of the yeast 
RBK1 itself, could be insightful. 
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To support the observed phosphorylation of the non-natural substrates, LC/MS analysis was 
performed exemplarily with D-ribose, D-xylose, and D-glucose. Samples from 
biotransformations were analyzed with LC/MS and masses corresponding to the substrates 
as well as phosphorylated products were identified validating the successful phosphorylation 
of the above-mentioned substrates. 
The hotspot residues identified during rational design of the focused library are found in the 
active site and are supposed to contribute to binding of the sugar substrate. Therefore, not 
only changes in the catalytic turnover, but also changes in the substrate affinity were 
expected. Kinetic data were collected for the wild-type and variants, which showed the best 
activity towards D-ribose, D-xylose, and D-glucose, namely I113V, I101V, and I101S/I113V, 
respectively. The substrate affinity for the co-substrate ATP was tested with the wild-type 
and variant I113V, which showed high activity towards D-ribose. As expected, no changes 
were found in the affinity for ATP since the mutations were not in the ATP binding site. In 
contrast, the affinity for D-ribose decreased about three-fold from 0.89 ± 1.2 mM to 2.47 ± 
0.05 mM for the I113V variation compared to the wild-type. At a high substrate 
concentration of 15 mM, the I113V variant showed a higher activity than the wild-type. The 
reason for this is that RBK1 shows substrate inhibition at higher concentrations of ATP and D-
ribose. Therefore, the kinetic data was fitted to a Michaelis-Menten equation describing a 
reaction with substrate inhibition (see 2.5.1). Substrate inhibition is a form of uncompetitive 
inhibition leading to a decline in the maximum velocity at high substrate concentrations. The 
inhibition constant Kiu for the I113V variant (416.5 ± 1.5 mM) was approximately an order of 
magnitude higher compared to the wild-type (33.9 ± 3.1 mM), indicating dramatically 
decreased substrate inhibition, which could be useful for possible applications at high 
substrate concentrations. Interestingly, Chuvikowsky et al. [146] found a about three-fold 
lower Km for D-ribose (0.279 mM) for the ribokinase from E. coli, while the Km for ATP (0.213) 
was about three-fold higher. It was shown that the activation by mono- and pentavalent ions 
not only increases catalytic turnover, but also increases the substrate affinity for ATP and D-
ribose, respectively [148,152,154]. This complicates collection of kinetic data. It was 
imperative to use the same setup regarding buffer conditions in all experiments. Since the 
results for the E. coli RBK1 were achieved with other ion concentrations, the results are not 
necessarily comparable and might also explain differences found for the substrate affinity as 
well as catalytic turnover. 
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The kinetic data for D-xylose showed high KM values of 148 ± 2 mM and 162 ± 2 mM for the 
wild-type and the I101V variant, respectively. This could be related to the problem, that D-
xylose exists only in less than 1% in the α-furanose form, which is necessary for 
phosphorylation, as discussed earlier. A basic problem with D-xylose is likely that the altered 
position of the C3-OH group prevents the formation of cooperative and bidentate hydrogen 
bonds with functional groups of adjacent residues and the backbone such as hydroxyl, 
carboxy, or amino groups. Again, a bioinformatics approach featuring docking studies and/or 
elucidation of a crystal structure with D-xylose bound in the active site could help in 
understanding these issues. While the mutation did not affect the binding affinity for D-
xylose compared to the wild-type, it increased the activity by about two-fold. However, this 
is still about two orders of magnitude lower compared to the natural activity versus D-ribose.  
4.2.4 Crystallization of RBK1 
Presently, crystal structures are only available for the bacterial ribokinases from E. coli and 
Staphylococcus aureus [135,148]. Enzyme engineering by rational design with the aim to 
alter the substrate spectrum of a given enzyme greatly benefits from structural data 
including the natural substrate, the targeted substrate, or a transition state analogue bound 
in the active site [13]. Since no crystal structure for the S. cerevisiae ribokinase RBK1 was 
available, homology modeling based on the E. coli structure was performed in this project. 
However, this led to some limitations like an unclear positioning of the targeted substrate D-
xylose. Also, it is not clear whether D-xylose binds in its α-furanose form comparable to D-
ribose. In parallel to this approach, the elucidation of the RBK1 crystal structure was 
promoted. For this, the protein was purified in two chromatographic steps including Ni-NTA 
and size exclusion chromatography leading to an apparently pure form of the protein. In this 
regard, analytical gel filtration showed that the protein is a native homodimer as was 
expected based on biochemical information for other ribokinases. Activity measurements 
verified the activity after the enzyme was prepared for crystallization trials to verify the 
structural integrity. Crystals, which were achieved from various screenings, were analyzed by 
x-ray diffraction and several datasets were collected (Dr. Daniele de Sanctis, ESRF, Grenoble, 
France). Based on the homologous E. coli structure (PDB: 1RKD) [135], molecular 
replacement was attempted to solve the structure and build a model (Dr. Domenico Lupo, 
University Hohenheim, Stuttgart). However, this attempt was unsuccessful. This is most 
likely due to a non-crystallographic symmetry (pseudotranslational) effect leading to ghost 
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peaks in the diffraction pattern [230], which cannot be correctly interpreted by the 
molecular replacement software. Since the crystals of RBK1 grew very fast (in a few hours), 
the reason for this could be that several crystal seeds grew together during the 
crystallization leading to a larger crystal.  
4.2.5 Outlook 
The established focused library of RBK1 variants was evaluated for alterations in the 
substrate spectrum and could show potential for further studies and applications. The 
performed biochemical characterization of the protein regarding optimum pH and ion 
concentrations as well the high, intrinsic stability of the protein serve as a strong basis for 
interesting applications. The focused library could be further evaluated for the 
phosphorylation of modified sugar substrates, which could be used for the enzymatic 
synthesis of nucleosides and their analogues (see 1.3.5) [146]. In this regard, the established 
high yield production of ribokinase could serve to eliminate the limitation of recombinant 
ribokinase availability for the chemo-enzymatic synthesis of phosphoribosyl-5-
pyrophosphate (PRPP) [157]. For a further pursuit of the work regarding the novel D-xylose 
metabolizing pathway, a crystal structure with D-xylose bound as ligand would be extremely 
helpful. While initial attempts to solve a structure by molecular replacement were 
unsuccessful, further options are still in process. This includes a heavy metal soaking of high-
quality crystals to allow another solution of the phase problem not involving molecular 
replacement [230]. An alternative approach would be the production of a seleno-methionine 
labeled RBK1 protein, which could allow solving of the structure by multiple anomalous 
dispersion (MAD) phasing. Although the characterized variant I101V, which showed twice 
the activity compared to the wild-type, could serve as a basis for further mutations at other 
hotspots, evaluating the basic binding mode and conformation of D-xylose should be 
attempted first. Since the low percentage of the α-furanose form in solution might be a 
severe limitation, approaches featuring mutarotases catalyzing the α-β anomeric change 
could solve this issue. Other approaches such as saturation transfer difference nuclear 
magnetic resonance (STD-NMR) studies might allow more insight whether low substrate 
affinity towards D-xylose or unproductive binding leading to low catalytic efficiencies is the 
main problem in the phosphorylation of this sugar epimer of D-ribose. Also, studying 
whether D-xylose fully induces the conformational changes in ribokinases necessary for 
efficient phosphorylation could be interesting. 
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4.3 Thiol-functionalization of acrylic ester monomers catalyzed by 
immobilized Humicola insolens cutinase 
In this case study, immobilized cutinase from Humicola insolens (H. insolens) was evaluated 
as a novel biocatalyst in the synthesis of functionalized acrylic esters by transesterification to 
serve as an example for critical challenges in the application and characterization of 
biocatalysts. The transesterification reaction was optimized in regard to the catalytic 
turnover, which is strongly influenced by parameters like the water concentration in the 
reaction and the optimum temperature. Furthermore, the formation of by-products, which 
can also be influenced by reaction parameters like the temperature as well as by the 
presence of radical inhibitors, was minimized. Furthermore, the biocatalyst was 
characterized regarding its substrate spectrum in transesterifications of acrylates. The 
evaluation of the kinetics for standard substrates in hydrolysis reactions allows a better 
comparison with other cutinases. 
4.3.1 Characterization of Humicola insolens cutinase 
Cutinases usually show a broad substrate spectrum and a strong dependence on the size of 
the substrate with a preference for shorter-chain substrates like the soluble ester para-
nitrophenylbutyrate (pNPB). The activity and kinetics of various cutinases has been tested 
with soluble pNP esters in the literature. For a comparative evaluation, the biochemical data 
were also collected for HiC for a range of pNP ester substrates in this study. Hic showed a 
preference for the shorter-chain substrates pNP-butyrate (C4) and pNP-octanoate (C8), 
while the substrate affinity KM and enzymatic activity towards pNP-palmitate were one order 
of magnitude higher and lower, respectively. The data corresponds well with values 
published for cutinases from Thermobifida fusca (TfC) and Fusarium solani pisi (FsC)  [231]. 
Recently, Baker et al. compared five cutinases from Alternaria brassicicola (AbC), Aspergillus 
fumigatus (AfC), Aspergillus oryzae (AoC), F. solani pisi (FsC), and H. insolens (HiC) and found 
that HiC demonstrated the second highest catalytic efficiency towards pNPB after AoC. 
However, the catalytic data from Baker et al. [181] is presented in an unusual way and the 
kcat values are about two orders of magnitude lower compared to the results in this work 
and other studies. HiC was found to exhibit a high stability up to 50°C with over 90% residual 
activity after 48 h of incubation, yet activity strongly decreased when incubated at 60°C 
[198,219]. In this regard, HiC showed the highest stability among the five cutinases at 
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elevated temperatures [181]. The highest activity towards soluble pNP esters and 
triglycerides  was found at 50°C [198,219], which is slightly higher compared to the cutinases 
FsC and AbC (35 to 40°C) [220,221].  
4.3.2 Transesterification of acrylic monomers 
HiC was used for the first time in the transesterification of acrylic monomers for thiol-
functionalized acrylic esters as a novel biocatalyst in this industrially relevant application. In 
the application of a biocatalyst for a biocatalytic process, many critical challenges have to be 
considered. 
For the application in organic media in the transesterification reactions, HiC was immobilized 
on the polystyrenic, micropourous resin Diaion HP20 [218]. In the first stage of the study 
[198], the immobilization was improved in regard to the pH value of the aqueous solution 
used during immobilization. As it was shown, that immobilized or lyophilized enzymes retain 
the ionization state influenced by the pH from the last aqueous solution, the activity in 
organic solvents can be optimized by working at the pH optimum [27,71]. For this study, HiC 
was immobilized at a pH of 7.8 since the pH optimum was found to be between 7 to 8 [198]. 
Interestingly, HiC showed no activity for the transesterification of acrylic monomers when 
used in lyophilized form (data not shown) [219]. Immobilization allows the easy separation 
of the biocatalyst after a batch production and can also enhance the stability of the enzyme 
in organic media [67]. 
The choice of the organic solvent and concentrations of substrates can have an remarked 
influence on the overall conversion and other factors like chemo-, regio- and 
stereoselectivitiy [70]. Compared to a setup of equimolar amounts of methyl acrylate and 6-
mercapto-1-hexanol (150 µM) in diisopropyl ether as solvent, the reaction in a solvent free 
system in methyl acrylate with a high molar ratio of methyl acrylate to 6-mercapto-1-
hexanol of 22 to 1 was far superior in the achieved conversion [198,219].  
While non-aqueous enzymology has emerged as a major area of biotechnology, it was soon 
discovered that enzymes are oftentimes up to 104 to 105 times less active in organic solvents 
than in water [68]. Reasons for this include diffusional limitations, structural changes or 
suboptimal pH conditions, which can occur during lyophilization or immobilization, 
unfavorable energetics of substrate dissolvation, transition state destabilization, or reduced 
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conformational mobility. Most of these issues can be solved by selecting an optimum way of 
preparing the biocatalyst, a solvent, which favors substrate binding and stabilization of the 
transition state, or a water activity, which allows the conformational mobility of the 
enzymes. The latter was optimized for HiC since this is especially important for 
transesterification reactions, which is a reverse reaction to hydrolysis in aqueous conditions 
[198,219]. Although the specific hydration of an enzyme is important for its activity, the 
water activity has to be low in transesterification reactions, which are usually conducted in 
organic solvents, in order not to favor hydrolysis [69,232–234]. The effect of the water 
activity on hydrolysis and transesterification has been studied for immobilized FsC in 
acetonitrile for the reaction between vinyl butyrate and 2-phenyl-1-propanol [235]. An 
increase in the water activity aw between 0.2 and 0.4 improved transesterification, while a 
further increase of aw to 0.7 shifted the equilibrium to hydrolysis. For the transesterification 
of acrylic monomers in this study, HiC was prepared with a water activity towards zero. 
Addition of 0.025% (w/w immobilisate) almost doubled the conversion in 6 h at 40°C from 
54.5 ± 1.0% to 84.1 ± 1.7% [198,219]. Formation of Michael-addition by-products did not 
increase, but was shifted to the Michael-addition product (6) (see Figure 3-28a). The 
increase in conversion was seen for the transesterification of ethyl acrylate and methyl 
methacrylate with 6-mercapto-1-hexanol as well. 
Radical inhibitors can be applied to avoid formation of unfavored Michael-addition products 
in transesterification reaction with acrylates. Recently, the addition of 3% (w/w acrylic ester) 
of the radical inhibitor butylated hydroxytoluol was used to reduce formation of Michael-
addition by-products in the lipase catalyzed synthesis of N-(2-hydroxyethyl)-acrylamide from 
ethyl acrylate and 2-amino-1-ethanol in diisopropyl ether [187]. While the formation of the 
Michael-addition products in the presence of BHT was further reduced, the overall 
conversion to the main product 6-mercaptohexyl acrylic ester was lowered as well. Although 
it was not further tested, this might be due to an inhibiting effect of BHT on the cutinase 
since the inhibition increased with increasing BHT concentration.  
The stability of immobilized HiC was tested by preincubation in methyl acrylate for up to 
24 h at 40°C in the presence or absence of 0.025% (w/w immobilisate) water [198,219]. 
Without water HiC displayed almost no residual activity, while with 0.025% (w/w) water, Hic 
showed about 68% conversion to the main product without preincubation in methyl 
Discussion 155 
 
acrylate. A loss of water from the enzyme or immobilisate during preincubation might 
explain the much stronger loss in activity in the absence of water. In polar organic solvents, 
unlike in nonpolar solvents, water is found fragmented in small clusters and loosely bound to 
the enzyme´s surface [236]. Leakage of water from the enzyme might have occurred during 
preincubation and addition of water prior to transesterification might have compensated for 
the loss, regaining the critical hydration state of the enzyme. 
With the optimized reaction conditions (40°C, 0.025% (w/w immobilisate) water, reaction in 
methyl acrylate without further solvent) [198,219], a large-scale conversion (5 mL) was 
performed. Here, no Michael-addition products were detected during routine GC/MS 
analysis, which can be explained by higher reaction rates leading to higher conversions 
concomitantly reducing by-product formation. The reason for this is likely a better and faster 
homogenization of the substrates and the immobilisate in the reaction mixture by more 
efficient stirring in the larger setup. This could have prevented sedimentation of the 
immobilisate and avoided diffusional limitations in the large scale batch compared to the 
small scale setup. The main product was purified by silica column chromatography and the 
structure of the compound was subsequently elucidated by NMR and FT-IR. The compound 
6-mercaptohexyl acrylic ester was verified as the main product, and importantly only the 
acrylic ester, not a possible thioester, was formed. This underlines the high chemoselectivity 
of the employed cutinase. The thiol group is thereby left as the reactive, functional end 
group, thus providing the possibility to synthesize functionalized polyacrylates from acrylic 
monomers. 
For the evaluation of the substrate spectrum, 4-mercapto-1-butanol, methyl methacrylate, 
and methyl propionate were applied in transesterification reactions under optimized 
conditions (see Table 3-8). HiC strongly preferred methyl acrylate over methyl methacrylate. 
Since methyl acrylate is sterically less demanding than methyl methacrylate, it might fit 
better into the active site of HiC, resulting in higher conversion compared to methyl 
methacrylate. Sterical hindrance at the α-carbon and electronic effects of the acyl donors as 
well as the nature of the acyl acceptor was shown to influence transacylation of several 
acrylates and corresponding saturated esters catalyzed by CalB [237]. Transesterification of 
methyl propionate with 6-mercapto-1-hexanol was about three times faster compared to 
the reaction with methyl acrylate. Syrén and Hult [237] explored the problem of the low 
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reaction rates with chemical and enzymatic transacylations of acrylates and compared 
apparent kcat values of CalB, HiC and Rhizomucor miehei lipase with molecular dynamics 
simulations. They found that acrylates, which exist in two low-energy conformations s-cis/s-
trans due to a stabilizing π-system, react with small deviations from their low-energy ground 
state. When comparing the reaction rates for the transacylation of methyl propionate and 
methyl acrylate with 1-propanol as acyl acceptor, respectively, a five to six times higher 
reaction rate for methyl propionate was found [238]. This was explained with the unnatural, 
predominantly flat substrate geometry of methyl acrylate. While there was only little 
difference observed for the transesterification with both mercaptoalcohols as acyl acceptors, 
the geometry of the acrylate seemed to have the strongest influence on conversion. 
Therefore, highest conversion can be achieved with sterically undemanding substrates like 
methyl acrylate. 
4.3.3 Outlook 
Cutinase from H. insolens was shown to be a promising candidate for the functionalization of 
polyacrylates for various industrial applications. The optimization of the reaction condition, 
especially controlling the critical water content and enzyme hydration state, will be most 
important for high space-time yields in industrial scale applications. HiC could now be 
further improved regarding its process stability, either by evaluation of more immobilization 
techniques or by improving the enzyme itself. By using rational protein design, directed 
evolution, or a combined approach, the stability as well as the substrate spectrum of HiC 
might be optimized to tailor this enzyme to a highly efficient transesterification biocatalyst. 
 
4.4 Conclusion 
The biocatalytic cycle [2] for establishing biocatalytic processes involves several key steps, 
the production, characterization, engineering, and application of a biocatalyst as well as 
down-stream processing. The present thesis features attempts and solutions to several 
critical challenges in these steps. 
As a case study on challenges in the production and characterization of biocatalysts, a high 
yield fed-batch fermentation process of the dirigent protein AtDIR6 in Pichia pastoris was 
established and the importance of the protein glycosylation for the structure, solubility, and 
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function of the protein was evaluated. The most critical step involved the heterologous 
production of the eukaryotic protein, which was found to be highly problematic for bacterial 
expression hosts. 
As a case study on challenges in the production, characterization, and engineering of 
biocatalysts, the ribokinase RBK1 from Saccharomyces cerevisiae was expressed in a 
recombinant host, characterized for optimum reaction conditions, and engineered towards 
altered substrate specificity. The rationale for this engineering approach was a strategy for 
developing a novel D-xylose metabolizing Saccharomyces cerevisiae strain for the production 
of second generation biofuels from lignocellulosic feedstocks. The ribokinase exhibits high 
substrate specificity for its natural substrate D-ribose. In this regard, the most critical step 
involved the alteration of the substrate spectrum of the ribokinase by rational design, which 
proved to be extremely problematic. From the established focused library only one variant 
showed improved activity towards D-xylose, which can now serve as a basis for further 
studies since the targeted increase in catalytic efficiency was not yet sufficient for the 
envisioned process. 
As a case study on challenges in the characterization and application of biocatalysts, 
immobilized cutinase from Humicola insolens was characterized regarding its substrate 
spectrum and kinetics and employed in the thiol-functionalization of acrylic ester monomers 
by transesterification. The critical step involved the meticulous optimization of the process 
parameters, especially controlling the critical water content in the non-aqueous reactions. 
In summary, in the scope of this thesis, numerous critical challenges involved in the key 
steps of establishing biocatalytic processes were highlighted. While few issues remained to 
be challenging, reasonable solutions were presented for several of these issues. 
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9. Appendix 
9.1 Supplementary figures 
 
Figure S 1 – Vector map of pPICZαA,B,C (Invitrogen, USA). 5´AOX1: methanol-inducible AOX1 promoter, also 
targets integration to the AOX1 locus; α-factor: secretion signal peptide; c-myc epitope: permits detection of 
recombinant fusion protein with anti-myc antibody; 6xHis: Polyhistidine tag; AOX1 TT: AOX1 transcription 
terminator; PTEF1: TEF1 promoter for expression of Zeocin™  resistance gene in P. pastoris; PEM7: EM7 
promoter for expression of Zeocin™  resistance gene in E. coli; Zeocin: Zeocin™ resistance gene; CYC1 TT: 
transcription terminator of the Zeocin™ resistance gene; pUC ori: origin of replication for replication and 
maintenance in E. coli. 
 
 
Figure S 2 – Vector map of pET16b (Merck, Darmstadt, Germany). Ap: ampicillin resistance gene; ori: pBR322 
origin of replication; lacI: coding sequence for the lac repressor; black arrow: multiple cloning site. 
Furthermore, single-cutting restriction enzyme sites are shown. The numbers in brackets indicate the position 
of genes and restriction enzymes in base pairs. The sequence is numbered according to the pBR322 
convention. 
Appendix 181 
 
 
 
Figure S 3 – Vector map of pET22b (Merck, Darmstadt, Germany). Ap: ampicillin resistance gene; ori: pBR322 
origin of replication; lacI: coding sequence for the lac repressor; black arrow: multiple cloning site; f1 origin: F1 
phage origin.  Furthermore, single-cutting restriction enzyme sites are shown. The numbers in brackets indicate 
the position of genes and restriction enzymes in base pairs. The sequence is numbered according to the 
pBR322 convention.  
 
 
Figure S 4 – Vector map of pET28a (Merck, Darmstadt, Germany). Kan: kanamycin resistance gene; ori: 
pBR322 origin of replication; lacI: coding sequence for the lac repressor; black arrow: multiple cloning site; f1 
origin: F1 phage origin.  Furthermore, single-cutting restriction enzyme sites are shown. The numbers in 
brackets indicate the position of genes and restriction enzymes in base pairs. The sequence is numbered 
according to the pBR322 convention.  
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Figure S 5 – Vector map of pET32a (Merck, Darmstadt, Germany). Ap: ampicillin resistance gene; ori: pBR322 
origin of replication; lacI: coding sequence for the lac repressor; trxA: thioredoxin gene included in the multiple 
cloning site (black arrow); f1 origin: F1 phage origin.  Furthermore, single-cutting restriction enzyme sites are 
shown. The numbers in brackets indicate the position of genes and restriction enzymes in base pairs. The 
sequence is numbered according to the pBR322 convention. 
 
 
Figure S 6 – Vector map of pTf16 (Takara, Japan). araG: araG promoter induced by L-arabinose; araC: gene for 
AraC repressor protein; Cm
r
: chloramphenicol resistance gene; pACYC ori: pACYC origin of replication; tig: gene 
for E. coli trigger factor protein. 
 
Appendix 183 
 
 
Figure S 7 – Vector map of pG-Tf2 (Takara, Japan). Pzt-1: tetracycline-inducible promoter; pACYC ori: : pACYC 
origin of replication; Cm
r
: chloramphenicol resistance gene; tetR: gene for Tet repressor protein; tig: gene for E. 
coli trigger factor protein; groEL: gene for GroEL chaperone protein; groES: gene for GroES chaperone protein. 
 
 
Figure S 8 – Vector map of pG-KJE8 (Takara, Japan). Cm
r
: chloramphenicol resistance gene; araC: gene for AraC 
repressor protein; araB: araB promoter induced by L-arabinose; dnaK: gene for DnaK chaperone protein; dnaJ: 
gene for DnaJ chaperone protein; grpE: gene for GrpE chaperone protein; pACYC ori: pACYC origin of 
replication; tetR: gene for Tet repressor protein; Pzt-1: tetracycline-inducible promoter; groES: gene for GroES 
chaperone protein; groEL: gene for GroEL chaperone protein. 
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Figure S 9 – Vector map of pJOE4782.1. Mob: mobilization site (origin of transfer); kan: kanamycin resistance 
gene; rhaR: transcriptional activator of the rhamnose operon; rhaS: transcriptional activator of the rhamnose 
operon; rhaP: L-rhamnose promoter; malE: gene for maltose-binding protein; ´eGFP: gene for enhanced green 
fluorescent protein; rep: pBBR1 origin of replication. Restriction sites NdeI and HindIII were used for cloning 
thereby eliminating the originally existing malE and ´eGFP genes. The vector was kindly provided by J. 
Altenbuchner (University of Stuttgart) [212,214]. 
 
 
Figure S 10 – Vector map of pRN754. Ura3: gene for orotidine 5-phosphate decarboxylase (auxotrophy 
selection marker); 2 µ ori: yeast origin of replication; pTPI: triose-phosphate-isomerase promoter; rbk1: gene 
for S. cerevisiae ribokinase; ori: E. coli origin of replication; amp: ampicillin resistance gene. The rbk1 gene was 
introduced into the vector using restriction sites XbaI and BamHI. The vector was provided by DSM, 
Netherlands. 
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Figure S 11 – Detailed view of the high molecular mass range of the PMF of glycosylated AtDIR6 (adapted 
from [215]). The figure was prepared by Dr. Jens Pfannstiel (Proteomics Core Facility, Life Science Center, 
University of Hohenheim).  In the high molecular mass range of the PMF of glycosylated AtDIR6 characteristic 
groups of glycopeptide ion signals spaced by 162 Da (Hexose) were observed. m/z values of these signals 
corresponded to tryptic peptides glycosylated at N30 and N94 with attached glycans structures of the high 
mannose type Hex9-13 GlcNAc2. The peptide sequences and the predicted glycan structures are indicated. 
Peptide sequence and glycan structure of the Hex10GlcNAc2 glycoforms were verified by MS/MS analysis 
(supplementary Figure S 13a and b). 
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Figure S 12 – Detailed view of the PMFs in Figure 3-7 showing deglycosylated peptides after PNGaseF 
treatment (adapted from [215]). The figure was prepared by Dr. Jens Pfannstiel (Proteomics Core Facility, Life 
Science Center, University of Hohenheim). Deglycosylated peptide ions corresponding to the glycosylation sites 
at N30 and N94 are marked by an asterisk. In the PMF of glycosylated AtDIR6 (a) none of the deglycosylated 
peptides could be identified. After PNGaseF treatment a 25 kDa and a 21 kDa band were detected in SDS-gels. 
In the PMF analysis of the 25 kDa band (b) only a peptide ion corresponding to the deglycosylated peptide 
including N30 was detected. In the PMF of the 21 kDa band (c) peptide ions corresponding to deglycosylated 
peptides including both sites N30 and N94 were detected. Peptide sequences were verified by MS/MS analysis 
(supplementary Figure S 13c and d). 
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Figure S 13 – MALDI-TOF MS/MS-Spectra of AtDIR6 glycopeptides and the corresponding deglycosylated 
peptides (modified from [215]). The figure was prepared by Dr. Jens Pfannstiel (Proteomics Core Facility, Life 
Science Center, University of Hohenheim). MALDI-TOF MS/MS analysis established the presence of glycans on 
N34 (a), and N90 (b). Glycan compositions and the fragment ions corresponding to oligosaccharide chain 
fragmentation are shown. The glycan composition depicted from the spectra is indicated. The amino acid 
sequence of the tryptic peptides is shown and the glycosylation site is underlined. The C- and N-terminal 
peptide fragment ions (y-ion and b-ion series, respectively) are indicated. The presence of the deyglycosylated 
peptides including N30 (c) and N94 (d) after PNGaseF treatment was verified by MS/MS analysis. The peptide 
sequence is shown above the spectrum and the deglycosylated Asparagines are underlined. The C- and N-
terminal peptide fragment ions (y-ion and b-ion series, respectively) are indicated. 
 
9.2 Nucleotide sequences 
9.2.1 AtDIR6 codon optimized for Escherichia coli 
The open reading frame (ORF) for AtDIR6 from Arabidopsis thaliana was obtained as 
synthetic gene from GeneArt (Germany) with NdeI and BamHI restriction sites flanking the 
gene, without the N-terminal secretion signal sequence and codon-optimized for E. coli. The 
sequence is shown below: 
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GGAATTCCATATGTTTCGTAAAACCATTGATCAGAAAAAACCGTGCAAACATTTTAGCTT 
TTATTTTCATGATATTCTGTATGATGGCGATAATGTTGCAAATGCAACCAGCGCAGCAAT 
TGTTAGTCCTCCGGGTCTGGGTAATTTCAAATTTGGCAAATTCGTGATTTTTGATGGTCC 
GATTACCATGGATAAAAATTATCTGAGCAAACCGGTTGCACGTGCACAGGGTTTTTATTT 
CTATGATATGAAAATGGATTTTAATAGCTGGTTTAGCTATACCCTGGTGTTTAATAGCAC 
CGAACATAAAGGCACCCTGAATATTATGGGTGCAGATCTGATGATGGAACCGACCCGTGA 
TCTGAGCGTTGTTGGTGGCACCGGTGATTTTTTTATGGCACGTGGTATTGCAACCTTTGT 
TACCGACCTGTTTCAGGGTGCCAAATATTTTCGCGTGAAAATGGATATTAAACTGTATGA 
ATGCTATGGATCCCG 
9.2.2 AtDIR6 codon optimized for Pichia pastoris 
The ORF for AtDIR6 from Arabidopsis thaliana was obtained as synthetic gene from GeneArt 
(Germany) with EcoRI and XbaI restrictions sites flanking the gene, without the N-terminal 
secretion signal sequence and codon-optimized for P. pastoris. The sequence is shown 
below: 
GGAATTCTTCAGAAAGACTATCGACCAGAAGAAGCCTTGTAAGCACTTCTCCTTCTACTT 
CCACGACATCTTGTACGACGGTGACAACGTTGCTAACGCTACTTCTGCTGCTATCGTTTC 
TCCACCAGGTTTGGGTAACTTCAAGTTCGGTAAGTTCGTTATCTTCGACGGTCCAATCAC 
TATGGACAAGAACTACTTGTCCAAGCCAGTTGCTAGAGCACAGGGTTTCTACTTCTACGA 
TATGAAGATGGACTTCAACTCCTGGTTCTCCTACACTTTGGTTTTCAACTCCACTGAGCA 
CAAGGGTACTTTGAACATCATGGGTGCTGACTTGATGATGGAACCTACTAGAGACTTGTC 
CGTTGTTGGTGGTACTGGTGACTTCTTCATGGCTAGAGGTATCGCTACTTTCGTTACTGA 
CTTGTTCCAGGGTGCTAAGTACTTCAGAGTTAAGATGGACATCAAGTTGTACGAGTGTTA 
CGCTCTAGAGC 
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9.2.3 Ribokinase RBK1 from Saccharomyces cerevisiae 
The gene for RBK1 from Saccharomyces cerevisiae was amplified with PCR from the 
construct pRN754 (DSM, Netherlands) using primers harboring NdeI and HindIII restriction 
sites. The sequence is shown below: 
GGAATTCCATATGGGTATTACAGTAATAGGTTCTCTAAACTATGATTTGGACACATTTAC 
GGATAGATTACCTAACGCTGGAGAAACTTTCAGGGCTAACCACTTCGAAACACATGCTGG 
TGGTAAGGGATTGAACCAAGCTGCGGCCATTGGTAAATTAAAAAACCCCAGCAGCAGATA 
TAGTGTTCGAATGATTGGTAATGTTGGAAATGATACATTTGGTAAACAATTGAAGGACAC 
TTTATCCGATTGCGGAGTCGATATCACTCACGTCGGTACTTACGAAGGCATTAATACGGG 
TACCGCTACCATACTAATTGAAGAGAAAGCTGGTGGCCAAAATAGGATATTGATTGTAGA 
AGGTGCTAACAGCAAGACTATTTATGACCCGAAACAGTTGTGTGAAATTTTTCCAGAGGG 
CAAGGAGGAAGAAGAGTATGTTGTTTTTCAACACGAAATTCCTGATCCTCTTTCCATTAT 
TAAATGGATACATGCGAACAGGCCGAATTTTCAGATCGTATATAACCCCTCACCTTTCAA 
GGCCATGCCTAAGAAAGATTGGGAGTTGGTAGACCTTTTGGTCGTTAATGAAATTGAGGG 
TCTTCAAATCGTGGAAAGTGTATTTGATAATGAACTTGTTGAAGAAATAAGGGAGAAGAT 
AAAGGACGACTTTTTAGGAGAATATCGTAAAATTTGTGAGCTTTTGTATGAAAAACTCAT 
GAATCGAAAGAAAAGAGGAATTGTGGTTATGACTTTGGGTTCGAGAGGGGTGCTTTTCTG 
TTCGCACGAAAGCCCTGAAGTACAATTCCTTCCGGCTATTCAAAATGTTTCGGTTGTTGA 
TACTACAGGAGCTGGAGATACTTTCCTGGGCGGTTTGGTTACTCAATTGTATCAAGGAGA 
GACCTTGTCTACGGCTATAAAGTTCTCTACATTAGCTAGTTCATTGACCATTCAAAGAAA 
AGGTGCTGCTGAAAGCATGCCACTGTATAAAGATGTTCAGAAAGATGCATAGAAGCTTGG 
G 
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9.2.4 Cutinase HiC from Humicola insolens 
The gene for HiC from Humicola insolens was available from a previous study [198]. The 
sequence is shown below: 
GGCGCAATCGAAAACGGCCTGGAATCCGGCTCCGCAAACGCATGCCCAGATGCAATCCTG 
ATCTTCGCACGCGGCTCCACCGAACCAGGCAACATGGGCATCACCGTGGGCCCAGCACTG 
GCAAACGGCCTGGAATCCCACATCCGCAACATCTGGATCCAGGGCGTGGGCGGCCCATAC 
GATGCAGCACTGGCAACCAACTTCCTGCCACGCGGCACCTCCCAGGCAAACATCGATGAA 
GGCAAGCGCCTGTTCGCACTGGCAAACCAGAAGTGCCCAAACACCCCAGTGGTGGCAGGC 
GGCTACTCCCAGGGCGCAGCACTGATCGCAGCAGCAGTGTCCGAACTGTCCGGCGCAGTG 
AAGGAACAGGTGAAGGGCGTGGCACTGTTCGGCTACACCCAGAACCTGCAGAACCGCGGC 
GGCATCCCAAACTACCCACGCGAACGCACCAAGGTGTTCTGCAACGTGGGCGATGCAGTG 
TGCACCGGCACCCTGATCATCACCCCAGCACACCTGTCCTACACCATCGAAGCACGCGGC 
GAAGCAGCACGCTTCCTGCGCGATCGCATCCGCGCA 
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